<SEC-DOCUMENT>0001178913-21-002429.txt : 20210728
<SEC-HEADER>0001178913-21-002429.hdr.sgml : 20210728
<ACCEPTANCE-DATETIME>20210728070546
ACCESSION NUMBER:		0001178913-21-002429
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		39
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210728
DATE AS OF CHANGE:		20210728

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COMPUGEN LTD
		CENTRAL INDEX KEY:			0001119774
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30902
		FILM NUMBER:		211119819

	BUSINESS ADDRESS:	
		STREET 1:		26 HAROKMIM STREET
		STREET 2:		BUILDING D
		CITY:			HOLON
		STATE:			L3
		ZIP:			5885849
		BUSINESS PHONE:		011-972-3-765-8585

	MAIL ADDRESS:	
		STREET 1:		26 HAROKMIM STREET
		STREET 2:		BUILDING D
		CITY:			HOLON
		STATE:			L3
		ZIP:			5885849
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>cgen6k0621.htm
<DESCRIPTION>6-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:i="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:cgen="http://cgen.com/20210630" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <head>
    <title>COMPUGEN LTD</title>
    <meta content="text/html" http-equiv="Content-Type"/>
  </head>
  <body style=" ">
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2021-01-01to2021-06-30" id="Fact_1627436568467">0001119774</ix:nonNumeric>
          <ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="From2021-01-01to2021-06-30" id="Fact_1627436568468">--12-31</ix:nonNumeric>
          <ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2021-01-01to2021-06-30" id="Fact_1627436568469">false</ix:nonNumeric>
          <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="From2021-01-01to2021-06-30" id="Fact_1627436568460">2021-06-30</ix:nonNumeric>
          <ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="From2021-01-01to2021-06-30" id="Fact_1627436568470">Q2</ix:nonNumeric>
          <ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="From2021-01-01to2021-06-30" id="Fact_1627436568471">2021</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <xbrll:schemaRef xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="cgen-20210630.xsd" xlink:type="simple"></xbrll:schemaRef>
        </ix:references>

      </ix:header>
    </div>
    <div> <div style="width:100%; clear:both;"> <hr style="border-top:3pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/><hr style="border-top:0.75pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; "></p> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">UNITED STATES</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:14pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">SECURITIES AND EXCHANGE COMMISSION</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Washington, D.C. 20549</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:14pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Form </span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_1627436568459" contextRef="From2021-01-01to2021-06-30" name="dei:DocumentType">6-K</ix:nonNumeric></span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">UNDER THE SECURITIES EXCHANGE ACT OF 1934</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">For the month of <span style="-sec-ix-hidden:Fact_1627436568460">July 2021</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">Commission File Number <ix:nonNumeric id="Fact_1627436568461" contextRef="From2021-01-01to2021-06-30" name="dei:EntityFileNumber">000-30902</ix:nonNumeric></p>
<p style="font-family:Times New Roman, Times, serif; font-size:16pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_1627436568462" contextRef="From2021-01-01to2021-06-30" name="dei:EntityRegistrantName">COMPUGEN LTD</ix:nonNumeric></span><span style="font-weight:bold; ">.</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:2pt; margin-bottom:0pt; ">(Translation of registrant&apos;s name into English)</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_1627436568463" contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressAddressLine1">26 Harokmim Street</ix:nonNumeric></span><span style="font-weight:bold; "></span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_1627436568464" contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressCityOrTown">Holon</ix:nonNumeric></span><span style="font-weight:bold; ">&#xA0;</span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_1627436568465" contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressPostalZipCode">5885849</ix:nonNumeric></span><span style="font-weight:bold; ">, </span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_1627436568466" contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">(Address of Principal Executive Offices) </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; ">Form 20-F &#x2612;&#x2003;&#x2003;Form 40-F &#x2610; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#x2610; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#x2610; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Compugen Ltd.</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">On July 28, 2021, Compugen Ltd. (the &#x201C;<span style="font-weight:bold; ">Company</span>&#x201D;) issued a press release, a copy of which is furnished as Exhibit 99.1 to this Report on Form 6-K and, excluding the 2<sup>nd</sup> and 3<sup>rd</sup> paragraphs and the sections titled &#x201C;Conference Call and Webcast Information&#x201D; and &#x201C;Forward-Looking Statement,&#x201D; is incorporated by reference herein. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; "><span style="font-weight:bold; font-style:italic; ">Second Quarter 2021 Financial Results</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; margin-bottom:0pt; ">The unaudited interim consolidated financial statements of the Company and its subsidiary as of June 30, 2021 and December 31, 2020 and for the six months ended June 30, 2021 and 2020 are furnished as Exhibit 99.2 to this Report on Form 6-K and incorporated by reference herein. Management&#x2019;s Discussion and Analysis of Results of Operations and Financial Condition of the Company as of and for the six months ended June 30, 2021 are furnished as Exhibit 99.3 to this Report on Form 6-K and incorporated by reference herein.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; margin-bottom:0pt; ">The information contained in this Report on Form 6-K is hereby incorporated by reference into the Company&#x2019;s Registration Statement on Form F-3, File No. 333-240183. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Exhibits</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <thead>
<tr class="odd" style="">
<td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Exhibit</span> </p> </td>
<td style="width:90%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr>
<tr class="even" style="">
<td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; font-weight:bold; ">Number</span> </p> </td>
<td style="width:90%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; font-weight:bold; ">Description of Exhibit</span> </p> </td> </tr>
<tr class="odd" style="">
<td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; ">&#xA0; </p> </td>
<td style="width:90%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody>
<tr class="odd" style="">
<td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="exhibit_99-1.htm">99.1</a></span><span style=""></span></p> </td>
<td style="width:90%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="exhibit_99-1.htm">Press Release dated July 28, 2021.</a></span><span style=""></span></p> </td> </tr>
<tr class="even" style="">
<td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="exhibit_99-2.htm">99.2</a></span><span style=""></span></p> </td>
<td style="width:90%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="exhibit_99-2.htm">Unaudited interim consolidated financial statements as of June 30, 2021 and December 31, 2020 and for the six months </a></span><span style=""><a href="exhibit_99-2.htm">ended June 30, 2021 and 2020.</a></span><span style=""></span></p> </td> </tr>
<tr class="odd" style="">
<td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="exhibit_99-3.htm">99.3</a></span><span style=""></span></p> </td>
<td style="width:90%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="exhibit_99-3.htm">Management&#x2019;s Discussion and Analysis of Results of Operations and Financial Condition of the Company as of and for the </a></span><span style=""><a href="exhibit_99-3.htm">six months ended June 30, 2021.</a></span><span style=""></span></p> </td> </tr>
<tr class="even" style="">
<td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">101 </p> </td>
<td style="width:90%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; margin-bottom:0pt; ">The following financial information from Compugen Ltd.&#x2019;s Report on Form 6-K, formatted in inline XBRL (ieXtensible Business Reporting Language): (i) consolidated balance sheets as of June 30, 2021 and December 31, 2020; (ii) consolidated statements of comprehensive loss for the six months ended June 30, 2021 and 2020; (iii) consolidated statements of changes in shareholders&#x2019; equity for the six months ended June 30, 2021 and 2020; (iv) consolidated statements of cash flows for the six months ended June 30, 2021 and 2020; and (v) notes to the consolidated financial statements. </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Signatures</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; margin-bottom:0pt; ">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:-30pt; margin-bottom:0pt; ">&#xA0; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody>
<tr class="odd" style="">
<td style="width:50%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td>
<td colspan="2" style="width:37%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:18pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD.</span> </p> </td>
<td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr>
<tr class="even" style="">
<td colspan="4" style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> </tr>
<tr class="odd" style="">
<td style="width:50%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Date: July 28, 2021 </p> </td>
<td style="width:7%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">By: </p> </td>
<td style="width:29%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">/s/ Eran Ben Dor </p> </td>
<td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr>
<tr class="even" style="">
<td style="width:50%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td>
<td style="width:7%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td>
<td style="width:29%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Eran Ben Dor </p> </td>
<td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr>
<tr class="odd" style="">
<td style="width:50%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td>
<td style="width:7%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td>
<td style="width:29%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">General Counsel </p> </td>
<td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </div> <div style="width:100%; clear:both;"> <hr style="border-top:0.75pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/><hr style="border-top:3pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; margin-bottom:0pt; "></p> </div> </div> </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 7.5.1.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div id="DSPFPageHeader">
      <div style="line-height: 1.25;">
        <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"></div>
      <div style="line-height: 1.25; font-weight: bold; text-align: right;"><u>Exhibit 99.1<br style="line-height: 1.25;">
        </u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;"><img src="image0.jpg" height="53" width="128"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Compugen Reports Second Quarter 2021 Results</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze7027870329f4618b5274860c0943803" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Compugen is the only company evaluating a potential synergistic triple blockade of PVRIG, TIGIT and PD-1 in the clinic, a comprehensive evaluation of the DNAM axis and a key differentiator in the TIGIT space</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z430e76ea0dd8420aaa4c16885a6bcf7c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Updated data from first in class anti-PVRIG, COM701 Phase 1 monotherapy and in combination with Opdivo&#174;, presented at ASCO 2021 show durable responses and disease control in patients who exhausted all prior treatment options as well as
              preliminary pharmacodynamic biomarker data supporting COM701 potential immune mediated mechanism of action</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z45fa15b121c242b795f8d0df4b65e3c6" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Strong execution with initiation of three clinical studies including Phase 1b cohort expansion of COM701 with Opdivo&#174;, Phase 1 combination of COM902 and COM701, and Phase 1/2 triple combination cohort expansion of COM701 in combination
              with Opdivo&#174; and Bristol Myers Squibb anti-TIGIT, BMS-986207</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5e532d7617e140ffaa2c3c9cc6416536" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Milestone rich 2021, including initial data from ongoing COM701 triple combination dose escalation study and COM902 monotherapy dose escalation study both on track for Q4 2021</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">HOLON, ISRAEL &#8211; July 28, 2021 &#8211; <u>Compugen Ltd.</u> (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the second quarter
      ended June 30, 2021.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',serif;">&#8220;Our continued execution in the clinic, which includes the recent initiation of three clinical studies, further strengthens Compugen&#8217;s leadership position in the DNAM axis space,&#8221;
        said Anat Cohen-Dayag, Ph.D., President and CEO of Compugen. &#8220;These new studies expand our comprehensive evaluation of the DNAM axis and leave us uniquely positioned as the only company, in a clinical setting, evaluating anti-PVRIG, anti-TIGIT and
        anti-PD-1 combinations, which is our key differentiator in the TIGIT space. We expect the remainder of the year to include data readouts from our triple combination study in collaboration with Bristol Myers Squibb and COM902 monotherapy study,
        which we expect to expand the foundation of our clinical data generated to date."</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Dr. Cohen-Dayag continued, &#8220;The updated data from our COM701 Phase 1 combination and monotherapy studies presented at ASCO support our continued excitement in our science and potential benefit it may bring to patients,
      showing durable responses and disease control in patients not eligible for or typically not responding to checkpoint inhibitors including those with prior progression. In addition, we shared our first preliminary pharmacodynamic biomarker data
      indicating that treatment with COM701 leads to immune activation and has the potential to drive anti-tumor activity in non-inflamed tumors as evidenced by activity in selected PD-L1 low, PVRL2 positive patients. Our combination strategy around our
      wholly owned assets targeting PVRIG and TIGIT give us a strong first mover advantage, and we look forward to continued progress through 2021 as we work to elucidate the potential of the DNAM axis pathways in immunotherapy.&#8221;</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-style: italic;">Recent and Second Quarter 2021 Corporate Highlights</div>
    <div style="line-height: 1.25; font-style: italic;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeb655b15f4e145628b635bd5e42d84aa" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Presented updated data from the COM701 monotherapy and combination with Opdivo&#174; (nivolumab) studies at the ASCO 2021 Annual Meeting including:</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4c6021c2cbc947b3963c6d5018fcd9aa" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 40.5pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">o</td>
          <td style="width: auto; vertical-align: top;">
            <div>Durable responses beyond one year, including one complete response, in tumor types typically unresponsive to checkpoint inhibitors</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z040364bf039e421ba50c6752e823e4cd" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 40.5pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">o</td>
          <td style="width: auto; vertical-align: top;">
            <div>Preliminary biomarker data reveal immune activation evidenced by a trend of increased proliferation of peripheral immune cells and IFN&#947;.&#160; IFN&#947; increased with increasing doses of COM701, suggesting the observed activity is likely derived
              from the combination treatment and not Opdivo&#174; alone</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z813c2e2b5a42434faed748faf3a46149" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 40.5pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">o</td>
          <td style="width: auto; vertical-align: top;">
            <div>Preliminary anti-tumor activity in PD-L1 low, PVRL2 positive patients, with non-inflamed tumor microenvironment/immune desert phenotype</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6b13d72c6b2645408ffc2fe13fb6dd3b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Dosed the first patient in the Phase 1b cohort expansion study of COM701 in combination with Opdivo&#174; in patients with ovarian, breast, endometrial and microsatellite-stable colorectal cancers</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z33c63c87300043239c9a84968ff38bcb" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Dosed the first patient in the Phase 1 dual combination study of COM902 and COM701 in patients with advanced malignancies, the first clinical study of dual blockade of TIGIT and PVRIG independent of anti-PD-1</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z02ec120d531d4fdd8669bbc82ba9016b" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Dosed the first patient in the Phase 1/2 triple combination cohort expansion of COM701 with Opdivo&#174; and Bristol Myers Squibb&#8217;s anti-TIGIT antibody, BMS-986207</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd18dc938eb2a4dfdaab2f3776a27134f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Presented research at the Society for Immunotherapy of Cancer (SITC) Targets for Cancer Immunotherapy: A Deep Dive Seminar Series, supporting PVRIG as a novel and differentiated checkpoint in the DNAM axis</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-style: italic;">Financial Results</div>
    <div style="line-height: 1.25; font-style: italic;"> <br>
    </div>
    <div style="line-height: 1.25;">R&amp;D expenses for the second quarter ended June 30, 2021, were $6.8 million compared with $4.4 million for the comparable period in 2020.&#160; The increase in R&amp;D expenses reflects the strong execution and expansion
      of the Phase 1 clinical programs.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">General and administrative expenses for the second quarter ended June 30, 2021, were $2.7 million compared with $2.1 million for the comparable period in 2020. The increase in expenses is attributed mainly to corporate
      related expenses.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Net loss for the second quarter of 2021 was $9.5 million, or $0.11 per basic and diluted share, compared with a net loss of $6.2 million, or $0.08 per basic and diluted share, in the comparable period of 2020.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">As of June 30, 2021, cash, cash related accounts, short-term and long-term bank deposits totaled approximately $111 million, compared with approximately $124 million on December 31, 2020. The Company has no debt.</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Conference Call and Webcast Information</div>
    <div style="line-height: 1.25;">The Company will hold a conference call today, July 28, 2021, at 8:30 AM ET to review its second quarter 2021 results. To access the live conference call by telephone, please dial 1-866-744-5399 from the U.S., or
      +972-3-918-0644 internationally. The call will also be available via live webcast through Compugen&#8217;s website, located at the following <u>link</u>. Following the live audio webcast, a replay will be available on the Company&#8217;s website.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><font style="font-weight: bold;">About&#160;Compugen&#160;</font>&#160;</div>
    <div style="line-height: 1.25;">Compugen&#160;is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable, predictive computational discovery platforms to identify novel drug targets and develop therapeutics in the
      field of cancer immunotherapy.&#160;Compugen&#8217;s&#160;lead product candidate, COM701, a first-in-class anti-PVRIG antibody, for the treatment of solid tumors, is undergoing&#160;Phase 1 single,&#160;dual,&#160;and triple combination studies.&#160;In addition,
      COM902,&#160;Compugen&#8217;s&#160;antibody targeting TIGIT, is in a Phase 1 clinical study.&#160;Compugen&#8217;s&#160;therapeutic pipeline also includes&#160;early-stage&#160;immuno-oncology programs focused largely on myeloid targets.&#160;Compugen&#160;is headquartered in Israel, with offices in
      South San Francisco, CA.&#160;Compugen&#8217;s&#160;shares are listed on Nasdaq and the Tel Aviv&#160;Stock Exchange under the ticker symbol CGEN. For additional information, please visit&#160;Compugen&#8217;s&#160;corporate website at&#160;www.cgen.com.&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Opdivo&#174; is a registered trademark of Bristol Myers Squibb.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;"><font style="font-weight: bold;">Forward-Looking Statement&#160;</font>&#160;</div>
    <div style="line-height: 1.25;">This press release contains &#8220;forward-looking statements&#8221; within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended, and the safe-harbor provisions of the Private Securities
      Litigation Reform Act of 1995. Such forward-looking statements are based on the current beliefs,&#160;expectations,&#160;and assumptions of&#160;Compugen. Forward-looking statements can be identified&#160;using&#160;terminology such as &#8220;will,&#8221; &#8220;may,&#8221; &#8220;expects,&#8221;
      &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;potential,&#8221; &#8220;plan,&#8221; &#8220;goal,&#8221; &#8220;estimate,&#8221; &#8220;likely,&#8221; &#8220;should,&#8221; &#8220;confident,&#8221; and &#8220;intends,&#8221; and similar expressions that are intended to identify forward-looking statements, although not all forward-looking statements contain
      these identifying words.&#160;Forward-looking statements include, but are not limited to, statements relating to our expectations regarding the timing and readouts of data from our escalation, triple combination and monotherapy studies and our expectation
      that such readouts from the triple combination and monotherapy studies would expand the foundation of clinical data generated to date with COM701, statements to the effect that treatment with COM701 leads to immune activation and has the potential to
      drive anti-tumor activity in non-inflamed tumors, statements that preliminary biomarker data reveal immune activation suggesting the observed activity is derived from the combination treatment of COM701 together with Opdivo&#174; and not Opdivo&#174; alone and
      statements that suggest that COM701 may drive anti-tumor activity also in non-inflamed tumors.&#160;These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results,&#160;performance,&#160;or achievements
      of&#160;Compugen&#160;to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Among these risks: the&#160;effect of the&#160;global&#160;COVID-19&#160;pandemic may continue to negatively impact the
      global economy and may also adversely affect&#160;Compugen&#8217;s&#160;business;&#160;clinical development involves a lengthy and expensive process, with an uncertain outcome and&#160;Compugen&#160;may encounter substantial delays or even an inability to begin clinical studies
      for any specific product, or may not be able to conduct or complete its studies on the timelines it expects;&#160;Compugen&#160;relies and expects to continue to rely on third parties to conduct its clinical studies and these third parties&#160;may&#160;not successfully
      carry out their contractual duties, comply with regulatory requirements or meet expected deadlines, and&#160;Compugen&#160;may experience significant delays in the conduct of its clinical studies&#160;as well as significant increased
      expenditures;&#160;Compugen&#8217;s&#160;business model is substantially dependent on entering into collaboration agreements with third parties and&#160;Compugen&#160;may not be successful in generating adequate revenues or commercializing aspects of its business
      model;&#160;Compugen&#8217;s&#160;approach to the discovery of therapeutic products is based on its proprietary&#160;computational target discovery infrastructure, which is unproven clinically; and&#160;Compugen&#160;does not know whether it will be able to discover and develop
      additional potential product candidates or products of commercial value.&#160;These risks and other risks are more fully discussed in the &#8220;Risk Factors&#8221; section of&#160;Compugen&#8217;s&#160;most recent Annual Report on Form 20-F as filed with the Securities and Exchange
      Commission (SEC) as well as other documents that may be subsequently filed by&#160;Compugen&#160;from time to time with the SEC. In addition, any forward-looking statements represent&#160;Compugen&#8217;s&#160;views only as of the date of this release and should not be relied
      upon as representing its views as of any subsequent date.&#160;Compugen&#160;does not assume any obligation to update any forward-looking statements unless required by law.&#160;&#160;&#160;</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;"><font style="font-weight: bold;">Company contact:&#160;</font>&#160;</div>
    <div style="line-height: 1.25;">Yvonne Naughton, PhD&#160;&#160;</div>
    <div style="line-height: 1.25;">Head of Investor Relations and Corporate Communications</div>
    <div style="line-height: 1.25;">Email:&#160;ir@cgen.com&#160;&#160;</div>
    <div style="line-height: 1.25;">Tel: +1&#160;(628)&#160;241-0071&#160;&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6a76ea9c1bfe42c08d4c43cbce2571b8" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">COMPUGEN LTD.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">(U.S. dollars in thousands, except for share and per share amounts)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table id="zcfea18adb8584657a9343d203524fb50" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" cellpadding="0" cellspacing="0">

        <tr>
          <td style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="6" style="vertical-align: top;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Three Months Ended</div>
          </td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="6" style="vertical-align: top;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Six Months Ended,</div>
          </td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> June 30,</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">June 30,</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2021</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Unaudited</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Unaudited</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Unaudited</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Unaudited</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Operating expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 52%;" valign="bottom">
            <div style="line-height: 1.25;">Research and development expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">6,797</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">4,447</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">14,123</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">9,159</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">Marketing and business development expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">241</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">204</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">465</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">414</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px;" valign="bottom">
            <div style="line-height: 1.25;">General and administrative expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">2,659</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">2,131</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">5,373</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">4,607</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Total operating expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">9,697</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">6,782</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">19,961</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">14,180</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px;" valign="bottom">
            <div style="line-height: 1.25;">Financial and other income, net</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">200</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">536</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">559</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">806</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Loss before taxes on income</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">(9,497</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">(6,246</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">(19,402</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">(13,374</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%; padding-bottom: 2px;" valign="bottom">
            <div style="line-height: 1.25;">Taxes on income</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Net loss</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">(9,497</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">(6,246</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">(19,402</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">(13,374</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 52%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 52%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">Basic and diluted net loss per ordinary share</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">(0.11</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">(0.08</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">(0.23</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">(0.18</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: middle; width: 52%;" valign="bottom">
            <div style="line-height: 1.25;">Weighted average number of ordinary shares used in computing basic and diluted net loss per share</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">83,799,634</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">81,273,240</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">83,739,983</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">75,774,881</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7b30498366bb40a69e516772c9711f9a" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 100%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">COMPUGEN LTD.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">CONDENSED CONSOLIDATED BALANCE SHEETS DATA</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">(U.S. dollars, in thousands)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table id="zaed68a100cd34021a7f92ab7b3985f96" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" cellpadding="0" cellspacing="0">

        <tr>
          <td style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> June 30,</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2021</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Unaudited</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">ASSETS</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom;" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Current assets</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="line-height: 1.25;">Cash, cash equivalents, short-term bank deposits and restricted cash</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">111,092</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">124,432</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">Trade receivables</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">2,000</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="line-height: 1.25;">Other accounts receivable and prepaid expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">2,662</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">2,658</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Total current assets</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">113,754</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">129,090</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 76%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Non-current assets</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="line-height: 1.25;">Long-term prepaid expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">1,906</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">1,880</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">Severance pay fund</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">3,017</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">2,863</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="line-height: 1.25;">Operating lease right to use asset</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">2,415</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">2,772</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">Property and equipment, net</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">1,724</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">1,711</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Total non-current assets</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">9,062</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">9,226</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Total assets</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">122,816</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">138,316</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">LIABILITIES AND SHAREHOLDERS EQUITY</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Current liabilities</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">Other accounts payable, accrued expenses and trade payables</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">10,484</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">9,216</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="line-height: 1.25;">Current maturity of operating lease liability</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">706</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">639</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">Short-term deferred participation in R&amp;D expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">660</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">668</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Total current liabilities</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">11,850</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">10,523</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Non-current liabilities</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">Long-term deferred participation in R&amp;D expenses</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">1,798</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">1,968</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="line-height: 1.25;">Long-term operating lease liability</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">2,141</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="line-height: 1.25;">2,527</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">Accrued severance pay</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">3,606</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">3,516</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Total non-current liabilities</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">7,545</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">8,011</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Total shareholders' equity</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">103,421</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25;">119,782</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">Total liabilities and shareholders' equity</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">122,816</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" nowrap="nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="line-height: 1.25; font-weight: bold;">138,316</div>
          </td>
          <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" nowrap="nowrap" valign="bottom">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit_99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:i="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:cgen="http://cgen.com/20210630" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:iso4217="http://www.xbrl.org/2003/iso4217">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <head>
    <title>COMPUGEN LTD</title>
    <meta content="text/html" http-equiv="Content-Type"/>
  </head>
  <body style=" ">
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2020-12-31" unitRef="usd" id="Fact_304" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2021-06-30" unitRef="usd" id="Fact_305" xsi:nil="true"></ix:nonFraction>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2021-01-01to2021-06-30" id="Fact_306">0001119774</ix:nonNumeric>
          <ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="From2021-01-01to2021-06-30" id="Fact_307">--12-31</ix:nonNumeric>
          <ix:nonNumeric name="dei:DocumentType" contextRef="From2021-01-01to2021-06-30" id="Fact_308">6-K</ix:nonNumeric>
          <ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2021-01-01to2021-06-30" id="Fact_309">false</ix:nonNumeric>
          <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="From2021-01-01to2021-06-30" id="Fact_310">2021-06-30</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <xbrll:schemaRef xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="cgen-20210630.xsd" xlink:type="simple"></xbrll:schemaRef>
        </ix:references>
        <ix:resources>
          <i:context id="AsOf2019-12-31">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2019-12-31</i:instant>
            </i:period>
          </i:context>
          <i:unit id="usd">
            <i:measure>iso4217:USD</i:measure>
          </i:unit>
          <i:context id="AsOf2020-06-30">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2020-06-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-06-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-06-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-06-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2019-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2019-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2019-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-06-30">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2021-06-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-06-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-06-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-06-30</i:instant>
            </i:period>
          </i:context>
          <i:unit id="Shares">
            <i:measure>i:shares</i:measure>
          </i:unit>
          <i:context id="AsOf2018-05-25_custom_AtTheMarketOfferingProgramMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:AtTheMarketOfferingProgramMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2018-05-25</i:instant>
            </i:period>
          </i:context>
          <i:unit id="ILSPerShare">
            <i:divide>
              <i:unitNumerator>
                <i:measure>iso4217:ILS</i:measure>
              </i:unitNumerator>
              <i:unitDenominator>
                <i:measure>i:shares</i:measure>
              </i:unitDenominator>
            </i:divide>
          </i:unit>
          <i:context id="AsOf2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:AgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cgen:RegisteredDirectOfferingMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2018-06-14</i:instant>
            </i:period>
          </i:context>
          <i:context id="From2020-01-01to2020-06-30">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-01-01to2020-06-30_us-gaap_CommonStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30_us-gaap_CommonStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_115" toRefs="FN_5f067295be4d443bcdbba938"></ix:relationship>
          <i:context id="From2021-01-01to2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2019-01-01to2019-12-31_custom_AtTheMarketOfferingProgramMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:AtTheMarketOfferingProgramMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2019-01-01</i:startDate>
              <i:endDate>2019-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-03-01to2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:SvbLeerinkLlcAndStifelNicolausAndCompanyMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-03-01</i:startDate>
              <i:endDate>2020-03-16</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-04-01to2020-04-14_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember_custom_UnderwritersMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:SvbLeerinkLlcAndStifelNicolausAndCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cgen:UnderwritersMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-04-01</i:startDate>
              <i:endDate>2020-04-14</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:SvbLeerinkLlcAndStifelNicolausAndCompanyMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-01-01to2020-06-30_us-gaap_RetainedEarningsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30_us-gaap_RetainedEarningsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:unit id="USDPerShare">
            <i:divide>
              <i:unitNumerator>
                <i:measure>iso4217:USD</i:measure>
              </i:unitNumerator>
              <i:unitDenominator>
                <i:measure>i:shares</i:measure>
              </i:unitDenominator>
            </i:divide>
          </i:unit>
          <i:context id="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_119" toRefs="FN_5f067295be4d443bcdbba938"></ix:relationship>
          <i:context id="From2018-03-01to2018-03-30">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
            </i:entity>
            <i:period>
              <i:startDate>2018-03-01</i:startDate>
              <i:endDate>2018-03-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2013-08-01to2013-08-05">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
            </i:entity>
            <i:period>
              <i:startDate>2013-08-01</i:startDate>
              <i:endDate>2013-08-05</i:endDate>
            </i:period>
          </i:context>
          <i:context id="AsOf2013-08-05">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2013-08-05</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-06-30_us-gaap_PropertyLeaseGuaranteeMember_country_IL">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:PropertyLeaseGuaranteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-06-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember_srt_MinimumMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">cgen:GovernmentAndOtherGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:unit id="Pure">
            <i:measure>i:pure</i:measure>
          </i:unit>
          <i:context id="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember_srt_MaximumMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">cgen:GovernmentAndOtherGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">cgen:GovernmentAndOtherGrantsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-06-30_custom_GovernmentAndOtherGrantsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">cgen:GovernmentAndOtherGrantsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-06-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30_custom_May2012AgreementMember_srt_MinimumMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="cgen:GovernmentAndOtherGrantsAxis">cgen:May2012AgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30_custom_May2012AgreementMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="cgen:GovernmentAndOtherGrantsAxis">cgen:May2012AgreementMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2018-01-01to2018-01-05_custom_CommercialLicenseAgreementMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="cgen:GovernmentAndOtherGrantsAxis">cgen:CommercialLicenseAgreementMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2018-01-01</i:startDate>
              <i:endDate>2018-01-05</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30_custom_CollaborationAgreementWithUSAntibodyCompanyMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">cgen:CollaborationAgreementWithUSAntibodyCompanyMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2018-05-01to2018-05-25_custom_AtTheMarketOfferingProgramMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:AtTheMarketOfferingProgramMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2018-05-01</i:startDate>
              <i:endDate>2018-05-25</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2018-06-01to2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:AgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cgen:RegisteredDirectOfferingMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2018-06-01</i:startDate>
              <i:endDate>2018-06-14</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2018-10-01to2018-10-10_custom_MasterClinicalAgreementMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:MasterClinicalAgreementMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2018-10-01</i:startDate>
              <i:endDate>2018-10-10</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30_custom_CollaborativeArrangementsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:CollaborativeArrangementsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="AsOf2018-10-10_custom_MasterClinicalAgreementMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:MasterClinicalAgreementMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2018-10-10</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:SvbLeerinkLlcAndStifelNicolausAndCompanyMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-03-16</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember_custom_UnderwritersMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:SvbLeerinkLlcAndStifelNicolausAndCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cgen:UnderwritersMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-03-16</i:instant>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_299" toRefs="FN_60e66b41df40f60778298cb2"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_298" toRefs="FN_60e66b41df40f60778298cb2"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_301" toRefs="FN_60e66b41df40f60778298cb2"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_300" toRefs="FN_60e66b41df40f60778298cb2"></ix:relationship>
          <i:context id="AsOf2021-06-30_us-gaap_EmployeeStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-06-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="From2020-01-01to2020-06-30_us-gaap_EmployeeStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-01-01to2020-06-30_us-gaap_MinimumMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-01-01to2020-06-30_us-gaap_MaximumMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember_srt_MinimumMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember_srt_MaximumMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="AsOf2018-03-30">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001119774</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2018-03-30</i:instant>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_123" toRefs="FN_5f067295be4d443bcdbba938"></ix:relationship>
        </ix:resources>
      </ix:header>
    </div>
    <div> <div style="width:100%; clear:both;"> <hr style="border-top:3pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/><hr style="border-top:0.75pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; "></p> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; font-weight:bold; ">Exhibit 99.2</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">AS OF JUNE 30, 2021</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. DOLLARS IN THOUSANDS</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">UNAUDITED</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">INDEX</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td style="width:90%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; border-bottom:1.5pt solid #000000; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Page</span></p> </td> </tr> </thead> <tbody> <tr class="odd" style=""> <td style="width:90%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:10pt; margin-bottom:0pt; "><span style="font-weight:bold; "><a href="#d1e62_anchor">Consolidated Balance Sheets</a></span></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">F&#x2009;-&#x2009;2</span><span style="font-weight:bold; ">&#x2009;-&#x2009;F&#x2009;-&#x2009;3</span></p> </td> </tr> <tr class="even" style=""> <td style="width:90%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:10pt; margin-bottom:0pt; "><span style="font-weight:bold; "><a href="#d1e1813_anchor">Consolidated Statements of Comprehensive Loss</a></span></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">F&#x2009;-&#x2009;4</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:90%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:10pt; margin-bottom:0pt; "><span style="font-weight:bold; "><a href="#d1e2521_anchor">Consolidated Statements of Changes in Shareholders&#x2019; Equity</a></span></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">F&#x2009;-&#x2009;5</span></p> </td> </tr> <tr class="even" style=""> <td style="width:90%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:10pt; margin-bottom:0pt; "><span style="font-weight:bold; "><a href="#d1e4039_anchor">Consolidated Statements of Cash Flows</a></span></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">F&#x2009;-&#x2009;6</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:90%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:10pt; margin-bottom:0pt; "><span style="font-weight:bold; "><a href="#d1e5538_anchor">Notes to Consolidated Financial Statements</a></span></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">F&#x2009;-&#x2009;7</span><span style="font-weight:bold; ">&#x2009;-&#x2009;F&#x2009;-&#x2009;14</span></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; ">- - - - - - - - - - - - - </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; " id="d1e62_anchor"><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">CONSOLIDATED BALANCE SHEETS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">ASSETS </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">CURRENT ASSETS: </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Cash and cash equivalents </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_1" contextRef="AsOf2021-06-30" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">7,847</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_2" contextRef="AsOf2020-12-31" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">7,143</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Restricted cash </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_3" contextRef="AsOf2021-06-30" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">681</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_4" contextRef="AsOf2020-12-31" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">667</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Short-term bank deposits </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_5" contextRef="AsOf2021-06-30" name="us-gaap:OtherShortTermInvestments" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">102,564</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_6" contextRef="AsOf2020-12-31" name="us-gaap:OtherShortTermInvestments" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">116,622</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Trade receivables </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_7" contextRef="AsOf2021-06-30" name="us-gaap:AccountsReceivableNetCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_8" contextRef="AsOf2020-12-31" name="us-gaap:AccountsReceivableNetCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,000</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Other accounts receivable and prepaid expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_9" contextRef="AsOf2021-06-30" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,662</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_10" contextRef="AsOf2020-12-31" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,658</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Total</span> current assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_11" contextRef="AsOf2021-06-30" name="us-gaap:AssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">113,754</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_12" contextRef="AsOf2020-12-31" name="us-gaap:AssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">129,090</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">NON-CURRENT ASSETS: </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Long-term prepaid expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_13" contextRef="AsOf2021-06-30" name="us-gaap:PrepaidExpenseNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,906</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_14" contextRef="AsOf2020-12-31" name="us-gaap:PrepaidExpenseNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,880</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Severance pay fund </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_15" contextRef="AsOf2021-06-30" name="cgen:SeverancePayFundNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,017</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_16" contextRef="AsOf2020-12-31" name="cgen:SeverancePayFundNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,863</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Operating lease right to use asset </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_17" contextRef="AsOf2021-06-30" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,415</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_18" contextRef="AsOf2020-12-31" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,772</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Property and equipment, net </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_19" contextRef="AsOf2021-06-30" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,724</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_20" contextRef="AsOf2020-12-31" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,711</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Total</span> non-current assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_21" contextRef="AsOf2021-06-30" name="us-gaap:AssetsNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">9,062</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_22" contextRef="AsOf2020-12-31" name="us-gaap:AssetsNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">9,226</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Total</span> assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_23" contextRef="AsOf2021-06-30" name="us-gaap:Assets" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">122,816</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_24" contextRef="AsOf2020-12-31" name="us-gaap:Assets" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">138,316</ix:nonFraction> </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:16pt; margin-bottom:0pt; ">The accompanying notes are an integral part of the consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;2</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">CONSOLIDATED BALANCE SHEETS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share data)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">LIABILITIES AND SHAREHOLDERS&apos; EQUITY </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">CURRENT LIABILITIES: </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Trade payables </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_25" contextRef="AsOf2021-06-30" name="us-gaap:AccountsPayableCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,809</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_26" contextRef="AsOf2020-12-31" name="us-gaap:AccountsPayableCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,413</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Short-term deferred participation in R&amp;D expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_27" contextRef="AsOf2021-06-30" name="cgen:ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">660</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_28" contextRef="AsOf2020-12-31" name="cgen:ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">668</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Current maturity of operating lease liability </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_29" contextRef="AsOf2021-06-30" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">706</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_30" contextRef="AsOf2020-12-31" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">639</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Other accounts payable and accrued expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_31" contextRef="AsOf2021-06-30" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">8,675</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_32" contextRef="AsOf2020-12-31" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">7,803</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Total</span> current liabilities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_33" contextRef="AsOf2021-06-30" name="us-gaap:LiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">11,850</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_34" contextRef="AsOf2020-12-31" name="us-gaap:LiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">10,523</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">NON-CURRENT LIABILITIES: </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Long-term deferred participation in R&amp;D expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_35" contextRef="AsOf2021-06-30" name="cgen:LongTermDeferredParticipationInResearchAndDevelopmentExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,798</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_36" contextRef="AsOf2020-12-31" name="cgen:LongTermDeferredParticipationInResearchAndDevelopmentExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,968</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Long term operating lease liability </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_37" contextRef="AsOf2021-06-30" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,141</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_38" contextRef="AsOf2020-12-31" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,527</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Accrued severance pay </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_39" contextRef="AsOf2021-06-30" name="us-gaap:PostemploymentBenefitsLiabilityNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,606</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_40" contextRef="AsOf2020-12-31" name="us-gaap:PostemploymentBenefitsLiabilityNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,516</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Total</span> non-current liabilities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_41" contextRef="AsOf2021-06-30" name="us-gaap:LiabilitiesNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">7,545</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_42" contextRef="AsOf2020-12-31" name="us-gaap:LiabilitiesNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">8,011</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">COMMITMENTS AND CONTINGENT LIABILITIES (NOTE 4) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">SHAREHOLDERS&apos; EQUITY: </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Share capital: </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-8pt !important; padding-left:24pt !important; margin-bottom:0pt; ">Ordinary shares of NIS <ix:nonFraction id="Fact_44" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="ILSPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_43" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="ILSPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction></ix:nonFraction> par value per share: <ix:nonFraction id="Fact_46" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockSharesAuthorized" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_45" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockSharesAuthorized" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized on June 30, 2021 and December 31, 2020; <ix:nonFraction id="Fact_48" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_47" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockSharesIssued" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">83,917,929</ix:nonFraction></ix:nonFraction> and <ix:nonFraction id="Fact_50" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_49" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockSharesIssued" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">83,675,856</ix:nonFraction></ix:nonFraction> shares issued and outstanding on June 30, 2021 and December 31, 2020, respectively </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_51" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">231</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_52" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">231</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Additional paid-in capital </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_53" contextRef="AsOf2021-06-30" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">510,468</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_54" contextRef="AsOf2020-12-31" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">507,427</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Accumulated deficit </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_55" contextRef="AsOf2021-06-30" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">407,278</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:1pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_56" contextRef="AsOf2020-12-31" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">387,876</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:1pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Total</span> shareholders&apos; equity </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_57" contextRef="AsOf2021-06-30" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">103,421</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_58" contextRef="AsOf2020-12-31" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">119,782</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Total</span> liabilities and shareholders&apos; equity </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_59" contextRef="AsOf2021-06-30" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">122,816</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_60" contextRef="AsOf2020-12-31" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">138,316</ix:nonFraction> </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:16pt; margin-bottom:0pt; ">The accompanying notes are an integral part of the consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;3</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; " id="d1e1813_anchor"><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:24%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:24%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Operating expenses: </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Research and development expenses, net </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_61" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">14,123</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_62" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">9,159</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Marketing and business development expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_63" contextRef="From2021-01-01to2021-06-30" name="us-gaap:BusinessDevelopment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">465</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_64" contextRef="From2020-01-01to2020-06-30" name="us-gaap:BusinessDevelopment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">414</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">General and administrative expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_65" contextRef="From2021-01-01to2021-06-30" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">5,373</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_66" contextRef="From2020-01-01to2020-06-30" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">4,607</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Total</span> operating expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_67" contextRef="From2021-01-01to2021-06-30" name="us-gaap:OperatingExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">19,961</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_68" contextRef="From2020-01-01to2020-06-30" name="us-gaap:OperatingExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">14,180</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Financial and other income, net </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_69" contextRef="From2021-01-01to2021-06-30" name="cgen:FinancialAndOtherIncomeNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">559</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_70" contextRef="From2020-01-01to2020-06-30" name="cgen:FinancialAndOtherIncomeNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">806</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss before taxes on income </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_71" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">19,402</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_72" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">13,374</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Taxes on income </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_73" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_74" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_75" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">19,402</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_76" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">13,374</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Basic and diluted net loss per share </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_77" contextRef="From2021-01-01to2021-06-30" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="USDPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.23</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_78" contextRef="From2020-01-01to2020-06-30" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="USDPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.18</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total comprehensive loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_79" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">19,402</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_80" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">13,374</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Weighted average number of ordinary shares used in computing basic and diluted net loss per share </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_81" contextRef="From2021-01-01to2021-06-30" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">83,739,983</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_82" contextRef="From2020-01-01to2020-06-30" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">75,774,881</ix:nonFraction> </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:16pt; margin-bottom:0pt; ">The accompanying notes are an integral part of the consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;4</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; " id="d1e2521_anchor"><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#x2019; EQUITY</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share data)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:22%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Ordinary shares</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Additional </span><span style="font-weight:bold; ">paid-in</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Accumulated</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total </span><span style="font-weight:bold; ">shareholders&apos;</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Number</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Amount</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">capital</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">deficit</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">equity</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance as of January 1, 2020 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_83" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">67,922,836</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_84" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">187</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_85" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">396,312</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_86" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">358,178</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_87" contextRef="AsOf2019-12-31" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">38,321</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Options exercised </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_88" contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">2,450,973</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_89" contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">6</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_90" contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">12,790</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_91" contextRef="From2020-01-01to2020-06-30" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">12,796</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Warrants exercised </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_92" contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember" name="cgen:NumberOfWarrantsExercised" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">3,504,061</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_93" contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember" name="cgen:StockIssuedDuringPeriodValueWarrantsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_94" contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember" name="cgen:StockIssuedDuringPeriodValueWarrantsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">16,599</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_95" contextRef="From2020-01-01to2020-06-30" name="cgen:StockIssuedDuringPeriodValueWarrantsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">16,609</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Issuance of shares, net </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_96" contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">8,816,339</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_97" contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_98" contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">74,123</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_99" contextRef="From2020-01-01to2020-06-30" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">74,147</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-8pt !important; padding-left:8pt !important; margin-bottom:0pt; ">Stock-based compensation relating to options issued to employees, directors and non-employees </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_100" contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">968</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_101" contextRef="From2020-01-01to2020-06-30" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">968</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_102" contextRef="From2020-01-01to2020-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">13,374</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_103" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">13,374</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance as of June 30, 2020&#xA0;(unaudited) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_104" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">82,694,209</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_105" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">227</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_106" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">500,792</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_107" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">371,552</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_108" contextRef="AsOf2020-06-30" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">129,467</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance as of January 1, 2021 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_109" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">83,675,856</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_110" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">231</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_111" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">507,427</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_112" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">387,876</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_113" contextRef="AsOf2020-12-31" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">119,782</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Options exercised </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_114" contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">115,877</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_115" contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>* </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_116" contextRef="From2021-01-01to2021-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">461</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_117" contextRef="From2021-01-01to2021-06-30" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">461</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Warrants exercised </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_118" contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember" name="cgen:NumberOfWarrantsExercised" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">89,557</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_119" contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember" name="cgen:StockIssuedDuringPeriodValueWarrantsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>* </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_120" contextRef="From2021-01-01to2021-06-30_us-gaap_AdditionalPaidInCapitalMember" name="cgen:StockIssuedDuringPeriodValueWarrantsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">425</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_121" contextRef="From2021-01-01to2021-06-30" name="cgen:StockIssuedDuringPeriodValueWarrantsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">425</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Issuance of ordinary shares pursuant to the ESPP </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_122" contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">36,639</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_123" contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="usd" xsi:nil="true"></ix:nonFraction>* </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_124" contextRef="From2021-01-01to2021-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">239</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_125" contextRef="From2021-01-01to2021-06-30" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">239</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-8pt !important; padding-left:8pt !important; margin-bottom:0pt; ">Stock-based compensation issued to employees, directors and non-employees </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_126" contextRef="From2021-01-01to2021-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,916</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_127" contextRef="From2021-01-01to2021-06-30" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,916</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_128" contextRef="From2021-01-01to2021-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">19,402</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_129" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">19,402</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:40%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance as of June 30, 2021 (unaudited) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_130" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">83,917,929</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_131" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">231</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_132" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">510,468</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_133" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">407,278</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_134" contextRef="AsOf2021-06-30" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">103,421</ix:nonFraction> </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">*&#xA0;&#xA0;&#xA0;<ix:footnote id="FN_5f067295be4d443bcdbba938" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Represents an amount lower than $1.</ix:footnote> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">The accompanying notes are an integral part of the consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;5</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; " id="d1e4039_anchor"><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:24%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:24%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Cash flows from operating activities:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Net loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_135" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">19,402</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_136" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">13,374</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Adjustments required to reconcile net loss to net cash used in operating activities: </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Stock-based compensation </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_137" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,916</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_138" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ShareBasedCompensation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">968</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Depreciation </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_139" contextRef="From2021-01-01to2021-06-30" name="us-gaap:Depreciation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">240</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_140" contextRef="From2020-01-01to2020-06-30" name="us-gaap:Depreciation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">377</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Increase (decrease) in severance pay, net </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_141" contextRef="From2021-01-01to2021-06-30" name="cgen:SeverancePayNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">64</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_142" contextRef="From2020-01-01to2020-06-30" name="cgen:SeverancePayNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">200</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Gain from property and equipment disposal </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_143" contextRef="From2021-01-01to2021-06-30" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_144" contextRef="From2020-01-01to2020-06-30" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Decrease in operating lease right of use asset </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_145" contextRef="From2021-01-01to2021-06-30" name="cgen:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">357</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_146" contextRef="From2020-01-01to2020-06-30" name="cgen:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">235</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Decrease (increase) in interest receivables from short-term bank deposits </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_147" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">403</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_148" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">316</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Decrease in trade receivables </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_149" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">2,000</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_150" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Decrease in other accounts receivable and prepaid expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_151" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">212</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_152" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">40</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Increase in long-term prepaid expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_153" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncreaseDecreaseInPrepaidExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">26</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_154" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncreaseDecreaseInPrepaidExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">526</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Increase in trade payables </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_155" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">361</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_156" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">70</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Increase in other accounts payable and accrued expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_157" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">872</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_158" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,325</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Decrease in operating lease liability </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_159" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">319</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_160" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">271</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:16pt; margin-bottom:0pt; ">Decrease in deferred participation in R&amp;D expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_161" contextRef="From2021-01-01to2021-06-30" name="cgen:IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">178</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:1pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_162" contextRef="From2020-01-01to2020-06-30" name="cgen:IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">294</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:1pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net cash used in operating activities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_163" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">13,629</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:1pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_164" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">11,566</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:1pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Cash flows from investing activities:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Proceeds from maturity of short-term bank deposits </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_165" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">71,100</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_166" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">15,500</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Investment in short-term bank deposits </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_167" contextRef="From2021-01-01to2021-06-30" name="us-gaap:PaymentsToAcquireShortTermInvestments" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">57,445</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_168" contextRef="From2020-01-01to2020-06-30" name="us-gaap:PaymentsToAcquireShortTermInvestments" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">104,100</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Purchase of property and equipment </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_169" contextRef="From2021-01-01to2021-06-30" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">218</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_170" contextRef="From2020-01-01to2020-06-30" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">108</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Proceeds from sales of property and equipment </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_171" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_172" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net cash provided by (used in) investing activities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_173" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">13,438</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_174" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">88,708</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Cash flows from financing activities:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Proceeds from issuance of ordinary shares, net </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_175" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">239</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_176" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">74,147</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Proceeds from exercise of warrants </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_177" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ProceedsFromWarrantExercises" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">425</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_178" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ProceedsFromWarrantExercises" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">16,609</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:8pt; margin-bottom:0pt; ">Proceeds from exercise of options </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_179" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">245</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_180" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">12,789</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net cash provided by financing activities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_181" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">909</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_182" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">103,545</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Increase in cash, cash equivalents and restricted cash </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_183" contextRef="From2021-01-01to2021-06-30" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">718</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_184" contextRef="From2020-01-01to2020-06-30" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,271</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash, cash equivalents and restricted cash at the beginning of the period </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_185" contextRef="AsOf2020-12-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">7,810</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_186" contextRef="AsOf2019-12-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">9,839</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash, cash equivalents and restricted cash at the end of the period </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_187" contextRef="AsOf2021-06-30" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">8,528</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_188" contextRef="AsOf2020-06-30" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">13,110</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">Supplemental disclosure of non-cash investing and financing activities:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Purchase of property and equipment </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_189" contextRef="From2021-01-01to2021-06-30" name="us-gaap:FairValueOfAssetsAcquired" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">35</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_190" contextRef="From2020-01-01to2020-06-30" name="us-gaap:FairValueOfAssetsAcquired" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">47</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:74%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Receivables on account of shares </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_191" contextRef="From2021-01-01to2021-06-30" name="cgen:ReceivablesOnAccountOfShares" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">216</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_192" contextRef="From2020-01-01to2020-06-30" name="cgen:ReceivablesOnAccountOfShares" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">7</ix:nonFraction> </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:16pt; margin-bottom:0pt; ">The accompanying notes are an integral part of the consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;6</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; " id="d1e5538_anchor"><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span> </p> <ix:nonNumeric id="Fact_200" contextRef="From2021-01-01to2021-06-30" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 1:-</span><span style="font-weight:bold; padding-left:16.68pt; ">GENERAL</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">a.<span style="padding-left:13.06pt; ">Compugen Ltd. (the &quot;Company&quot; or &#x201C;Compugen&#x201D;) is a clinical-stage, therapeutic discovery and development company </span>utilizing its proprietary computational discovery platforms to identify novel drug targets and develop first-in-class therapeutics in the field of cancer immunotherapy. The Company&#x2019;s innovative immuno-oncology pipeline consists of three clinical stage programs, targeting immune checkpoints the Company discovered computationally, COM701, COM902 and BAY 1905254. The Company&#x2019;s therapeutic pipeline also includes early-stage immuno-oncology programs focused largely on myeloid targets. The innovative immuno-oncology pipeline, the strategic collaborations and the Company&#x2019;s computational discovery engine serve as the three key corporate building blocks. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">b.<span style="padding-left:12.5pt; ">The Company is headquartered in Holon, Israel. Its clinical development activities operate through its U.S. subsidiary </span>in South San Francisco, California. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">c.<span style="padding-left:13.06pt; ">On August 5, 2013, the Company entered into a Research and Development Collaboration and License Agreement </span>(&quot;Bayer Agreement&quot;) with Bayer Pharma AG (&quot;Bayer&quot;) for the research, development, and commercialization of antibody-based therapeutics against two novel Compugen-discovered immune checkpoint regulators. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">Under the terms of the Bayer Agreement, the Company received an upfront payment of $<ix:nonFraction id="Fact_193" contextRef="From2013-08-01to2013-08-05" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">10,000</ix:nonFraction>, and, following the return of the CGEN 15022 program in 2017, the Company is eligible to receive an aggregate of over $<ix:nonFraction id="Fact_194" contextRef="AsOf2013-08-05" name="cgen:ResearchAndDevelopmentArrangementPaymentsReceivable" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">250,000</ix:nonFraction> in potential milestone payments, not including aggregate milestone payments of approximately $<ix:nonFraction id="Fact_195" contextRef="AsOf2013-08-05" name="cgen:ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">23,000</ix:nonFraction> received to date. Additionally, the Company is eligible to receive mid to high single digit royalties on global net sales of any approved products under the collaboration.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">Pursuant to the terms of Bayer Agreement, BAY 1905254 program (formerly CGEN-15001T) was transferred to Bayer&#x2019;s full control for further preclinical and clinical development activities, and worldwide commercialization under milestone and royalty bearing licenses from Compugen.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">d.<span style="padding-left:12.5pt; ">Effective March 30, 2018, the Company entered into an exclusive license agreement with MedImmune Limited, the </span>global biologics research and development arm of AstraZeneca (&quot;AstraZeneca&quot;) to enable the development of bi-specific and multi-specific immuno-oncology antibody products. Under the terms of the agreement, Compugen provided an exclusive license to AstraZeneca for the development of bi-specific and multi-specific antibody products derived from a Compugen pipeline program. AstraZeneca has the right to create multiple products under this license and will be solely responsible for all research, development and commercial activities under the agreement. Compugen received a $<ix:nonFraction id="Fact_196" contextRef="From2018-03-01to2018-03-30" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">10,000</ix:nonFraction> upfront payment and an additional $<ix:nonFraction id="Fact_197" contextRef="AsOf2018-03-30" name="cgen:ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,000</ix:nonFraction> milestone payment out of up to an aggregate milestone amount of $<ix:nonFraction id="Fact_198" contextRef="From2018-03-01to2018-03-30" name="cgen:DevelopmentRegulatoryAndCommercialMilestonesCompensation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">200,000</ix:nonFraction> that the Company is eligible to receive in development, regulatory and commercial milestones for the first product as well as tiered royalties on future product sales. If additional products are developed, additional milestones and royalties would be due to Compugen for each product. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;7</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 1:-</span><span style="font-weight:bold; padding-left:16.68pt; ">GENERAL (Cont.)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">e.<span style="padding-left:13.06pt; ">On October 10, 2018, the Company entered into a Master Clinical Trial Collaboration Agreement (the &quot;Master </span>Clinical Agreement&quot;) with the Bristol-Myers Squibb Company (&quot;Bristol-Myers Squibb&quot;) to evaluate the safety and tolerability of Compugen&#x2019;s COM701 in combination with Bristol-Myers Squibb&#x2019;s programmed death-1 (PD-1) immune checkpoint inhibitor Opdivo&#xAE; (nivolumab), in patients with advanced solid tumors. Pursuant to the Master Clinical Agreement, Compugen is responsible for and will continue sponsoring the ongoing two-part Phase 1 trial, which includes the evaluation of the combination of COM701 and Opdivo&#xAE;. The collaboration was also designed to address potential future combinations, including trials sponsored by Bristol-Myers Squibb to investigate combined inhibition of checkpoint mechanisms, such as PVRIG and TIGIT. Bristol-Myers Squibb and Compugen each supplies the other company with its own compound(s) for the studies. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">In conjunction with the signing of the Master Clinical Agreement, Bristol-Myers Squibb made a $<ix:nonFraction id="Fact_199" contextRef="AsOf2021-06-30" name="us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">12,000</ix:nonFraction> investment in Compugen, see Note 5a.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">On February 14, 2020, the Master Clinical Agreement with Bristol-Myers Squibb was amended to include a triple combination clinical trial to evaluate the safety, tolerability and antitumor activity of COM701 in combination with Opdivo&#xAE; (nivolumab), and Bristol-Myers Squibb&#x2019;s antibody targeting TIGIT known as BMS-986207, in patients with advanced solid tumors, instead of the planned expansion of the combined therapy study designed to evaluate the dual combination of COM701 and Opdivo&#xAE;. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">Pursuant to the Master Clinical Agreement, as amended, the Company sponsors the two-part Phase 1/2 trial, which includes the evaluation of the triple combination of COM701, Opdivo&#xAE; and BMS-986207, in patients with advanced solid tumors where Bristol-Myers Squibb provides Opdivo&#xAE; and BMS-986207 at no cost to the Company. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">As part of the said amendment, it was agreed that the Company will complete the dose escalation arm of the dual combination of COM701 with Opdivo&#xAE; under the Phase 1 study and will not continue the expansion cohorts of the dual combination.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">On February 19, 2021, the Master Clinical Agreement was further amended to include an expansion of the Phase 1 combination study designed to evaluate the dual combination of COM701 and Opdivo&#xAE; in patients with advanced solid tumors, where Compugen is responsible for and sponsors the expansion cohort and Bristol-Myers Squibb provides Opdivo&#xAE; at no cost to us for this study. The amendment also revises the exclusivity period granted to Bristol-Myers Squibb to include a specific date for termination of the exclusivity period, so that it ends at the earlier of (i) six months after the study completion of the triple combination and the dual combination; or (ii) December 31, 2023. </p></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;8</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span> </p> <ix:nonNumeric id="Fact_201" contextRef="From2021-01-01to2021-06-30" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 2:-</span><span style="font-weight:bold; padding-left:16.68pt; ">SIGNIFICANT ACCOUNTING POLICIES</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:60pt; margin-bottom:0pt; ">These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes for the year ended December 31, 2020. The significant accounting policies applied in the annual financial statements of the Company as of December 31, 2020, are applied consistently in these interim consolidated financial statements. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_202" contextRef="From2021-01-01to2021-06-30" name="cgen:UnauditedInterimConsolidatedFinancialStatementsTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 3:-</span><span style="font-weight:bold; padding-left:16.68pt; ">UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:60pt; margin-bottom:0pt; ">The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:60pt; margin-bottom:0pt; ">Operating results for the six-month period ended June 30, 2021 are not necessarily indicative of the results that may be expected for the year ended December 31, 2021. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_217" contextRef="From2021-01-01to2021-06-30" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 4:-</span><span style="font-weight:bold; padding-left:16.68pt; ">COMMITMENTS AND CONTINGENCIES</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">a.<span style="padding-left:13.06pt; ">The Company provided bank guarantees in the amount of $</span><ix:nonFraction id="Fact_203" contextRef="AsOf2021-06-30_us-gaap_PropertyLeaseGuaranteeMember_country_IL" name="us-gaap:GuaranteeObligationsMaximumExposure" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">672</ix:nonFraction> in favor of its offices in Israel, car leases in Israel and credit card security for its U.S. subsidiary. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">b.<span style="padding-left:12.5pt; ">The Company received in the past grants from the office of the Israel Innovation Authority of the Israeli Ministry of </span>Industry, Trade and Labor, formerly known as the Office of the Chief Scientist, (&quot;IIA&quot;). The Company is not obligated to repay any amounts received from the IIA if it does not generate any income from products which incorporate technologies which were funded by such research program(s). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">If income is generated from products which incorporate technologies which were funded by a research program, the Company is committed to pay royalties at a rate of between <ix:nonFraction id="Fact_204" contextRef="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember_srt_MinimumMember" name="cgen:RoyaltyPercentageBasedOnFutureRevenues" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">3</ix:nonFraction>% to <ix:nonFraction id="Fact_205" contextRef="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember_srt_MaximumMember" name="cgen:RoyaltyPercentageBasedOnFutureRevenues" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">5</ix:nonFraction>% of future revenue generated from products that incorporate technologies that were funded by such research program(s), up to a maximum of <ix:nonFraction id="Fact_206" contextRef="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember" name="cgen:MaximumRoyaltyRepaidAsPercentageOfGrantReceived" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of the amount received, linked to the U.S. dollar (for grants received under programs approved subsequent to January 1, 1999, the maximum amount to be repaid is 100% plus interest at LIBOR).</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">As of June 30, 2021, the Company&apos;s aggregate contingent obligations for payments to IIA, based on royalty-bearing participation received or accrued, net of royalties paid or accrued, totaled $<ix:nonFraction id="Fact_207" contextRef="AsOf2021-06-30_custom_GovernmentAndOtherGrantsMember" name="cgen:RoyaltyContingentObligations" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">9,540</ix:nonFraction>. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;9</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 4:-</span><span style="font-weight:bold; padding-left:16.68pt; ">COMMITMENTS AND CONTINGENCIES (Cont.)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">c.<span style="padding-left:13.06pt; ">On June 25, 2012, the Company entered into an Antibodies Discovery Collaboration Agreement (the &quot;Antibodies </span>Discovery Agreement&quot;) with a U.S. antibody technology company (&quot;mAb Technology Company&quot;), providing an established source for fully human mAbs. Under the Antibodies Discovery Agreement, the mAb Technology Company will be entitled to certain royalties that could be eliminated upon payment of certain one-time fees (all milestone and royalties payments referred together as &quot;Contingent Fees&quot;). For the six-month periods ended June 30, 2021 and 2020, the Company incurred Contingent Fees in the amounts of $<ix:nonFraction id="Fact_208" contextRef="AsOf2021-06-30" name="cgen:ContingentFees" unitRef="usd" decimals="-3" scale="0" format="ixt:numdotdecimal">0</ix:nonFraction> and $<ix:nonFraction id="Fact_209" contextRef="AsOf2020-06-30" name="cgen:ContingentFees" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">500</ix:nonFraction>, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">d.<span style="padding-left:12.5pt; ">On </span><ix:nonNumeric id="Fact_210" contextRef="From2021-01-01to2021-06-30_custom_May2012AgreementMember" name="cgen:AgreementStartDate" format="ixt:datemonthdayyearen">May 9, 2012</ix:nonNumeric>, the Company entered into agreement (the &quot;May 2012 Agreement&quot;) with a U.S. Business Development Strategic Advisor (&quot;Advisor&quot;) for the purpose of entering into transactions with Pharma companies related to selected Pipeline Program Candidates. Under the agreement the Advisor shall be entitled to <ix:nonFraction id="Fact_211" contextRef="From2021-01-01to2021-06-30_custom_May2012AgreementMember_srt_MinimumMember" name="cgen:ParticipationRights" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">4</ix:nonFraction>% of the cash considerations that may be received under such transactions. <ix:nonNumeric id="Fact_212" contextRef="From2021-01-01to2021-06-30_custom_May2012AgreementMember" name="cgen:AgreementTerminationDescription">In 2014, the May 2012 Agreement was terminated, except with respect to certain payments arising from the Bayer Agreement which survive termination until August 5, 2025.</ix:nonNumeric> For the six months ended June 30, 2021 and 2020, the Company had not paid or accrued expenses related to the May 2012 Agreement. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">e.<span style="padding-left:13.06pt; ">Effective as of January 5, 2018, the Company entered into a Commercial License Agreement (&#x201C;CLA&#x201D;) with a </span>European cell line development company. Under the agreement the Company is required to pay an annual maintenance fee, certain amounts upon the occurrence of specified milestones events, and <ix:nonFraction id="Fact_213" contextRef="From2018-01-01to2018-01-05_custom_CommercialLicenseAgreementMember" name="cgen:PercentageOfRoyaltiesOnNetSales" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% royalties on annual net sales with respect to each commercialized product manufactured using the company&#x2019;s cell line. Royalties due under the CLA are creditable against the annual maintenance fee. In addition, the Company may at any time prior to the occurrence of a specific milestone event buy-out the royalty payment obligations in a single fixed amount. For the six-month periods ended June 30, 2021 and 2020, the Company incurred milestone payments in the amounts of $<ix:nonFraction id="Fact_214" contextRef="From2021-01-01to2021-06-30" name="cgen:AmountIncurredMilestonePayments" unitRef="usd" decimals="-3" scale="0" format="ixt:numdotdecimal">0</ix:nonFraction> and $<ix:nonFraction id="Fact_215" contextRef="From2020-01-01to2020-06-30" name="cgen:AmountIncurredMilestonePayments" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">52</ix:nonFraction>, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">f.<span style="padding-left:14.17pt; ">Effective as of October 28, 2020, the Company entered into a collaboration agreement with a U.S. antibody </span>discovery and optimization company for generation and optimization of therapeutic antibodies for the Company. Under the agreement the Company is required to pay service fees per services performed and certain amounts upon the occurrence of specified milestones events, and single-digit percent royalties on annual net sales with respect to each product sold that comprises or contains one or more antibodies so generated or optimized. The royalty rate is dependent upon the product type and any third-party contribution. For the six-month period ended June 30, 2021, the Company incurred milestone payments in the amounts of $<ix:nonFraction id="Fact_216" contextRef="From2021-01-01to2021-06-30_custom_CollaborationAgreementWithUSAntibodyCompanyMember" name="cgen:AmountIncurredMilestonePayments" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">150</ix:nonFraction>. </p></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;10</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span> </p> <ix:nonNumeric id="Fact_289" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 5:-</span><span style="font-weight:bold; padding-left:16.68pt; ">SHAREHOLDERS&#x2019; EQUITY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; ">a.<span style="padding-left:13.06pt; ">Issuance of Shares:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">On May 25, 2018, the Company entered into a sales agreement with Cantor Fitzgerald &amp; Co. (&quot;Cantor&quot;), as sales agent, pursuant to which the Company was entitled to offer and sell, from time to time through Cantor, ordinary shares, par value NIS <ix:nonFraction id="Fact_218" contextRef="AsOf2018-05-25_custom_AtTheMarketOfferingProgramMember" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="ILSPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction> per share, of the Company (the &quot;Ordinary Shares&quot;), under an At-the-Market (&quot;ATM&quot;) program, having an aggregate offering price of up to $<ix:nonFraction id="Fact_219" contextRef="From2018-05-01to2018-05-25_custom_AtTheMarketOfferingProgramMember" name="cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">25,000</ix:nonFraction> (the &quot;ATM Shares&quot;). Any ATM Shares offered and sold were issued pursuant to the Company&#x2019;s shelf registration statement on Form F-3 (Registration No. 333-213007) and the related prospectus previously declared effective by the Securities and Exchange Commission on October 11, 2016 (the &quot;Registration Statement&quot;), as supplemented by a prospectus supplement, dated May 25, 2018. As of December 31, 2019, <ix:nonFraction id="Fact_220" contextRef="From2019-01-01to2019-12-31_custom_AtTheMarketOfferingProgramMember" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">7,245,268</ix:nonFraction> ATM Shares were issued and sold under the ATM, with proceeds of approximately $<ix:nonFraction id="Fact_221" contextRef="From2019-01-01to2019-12-31_custom_AtTheMarketOfferingProgramMember" name="cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">22,914</ix:nonFraction> (net of $<ix:nonFraction id="Fact_222" contextRef="From2019-01-01to2019-12-31_custom_AtTheMarketOfferingProgramMember" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">781</ix:nonFraction> issuance expenses). The program was terminated in 2019. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">On June 14, 2018, the Company entered into agreements in connection with a registered direct offering (the &quot;Offering&quot;) of an aggregate of <ix:nonFraction id="Fact_223" contextRef="AsOf2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember" name="us-gaap:CommonStockSharesAuthorized" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">5,316,457</ix:nonFraction> Ordinary Shares (the &quot;RD Shares&quot;) of the Company at a purchase price of $<ix:nonFraction id="Fact_224" contextRef="AsOf2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember" name="us-gaap:SharesIssuedPricePerShare" unitRef="USDPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">3.95</ix:nonFraction> per RD Share. In connection with the issuance of the RD Shares, the Company also issued warrants to purchase an aggregate of up to <ix:nonFraction id="Fact_225" contextRef="AsOf2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">4,253,165</ix:nonFraction> additional Ordinary Shares (the &quot;Warrants&quot;). The Warrants are exercisable at a price of $<ix:nonFraction id="Fact_226" contextRef="AsOf2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">4.74</ix:nonFraction> per Ordinary Share and have a term of <ix:nonNumeric id="Fact_227" contextRef="From2018-06-01to2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember" name="cgen:ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable" format="ixt-sec:durwordsen">five years</ix:nonNumeric> from the date of issuance. The Offering was made pursuant to the Company&#x2019;s Registration Statement. Proceeds from the Offering were $<ix:nonFraction id="Fact_228" contextRef="From2018-06-01to2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember" name="cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">19,767</ix:nonFraction> (net of $<ix:nonFraction id="Fact_229" contextRef="From2018-06-01to2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,233</ix:nonFraction> issuance expenses). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">During the six-month periods ended June 30, 2021 and 2020, Warrants to purchase an aggregate of <ix:nonFraction id="Fact_230" contextRef="AsOf2021-06-30" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">89,557</ix:nonFraction> and <ix:nonFraction id="Fact_231" contextRef="AsOf2020-06-30" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">3,504,061</ix:nonFraction> Ordinary Shares were exercised with proceeds of approximately $<ix:nonFraction id="Fact_232" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ProceedsFromWarrantExercises" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">425</ix:nonFraction> and $<ix:nonFraction id="Fact_233" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ProceedsFromWarrantExercises" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">16,609</ix:nonFraction>, respectively, and Warrants to purchase up to <ix:nonFraction id="Fact_234" contextRef="AsOf2021-06-30" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">297,469</ix:nonFraction> Ordinary Shares remain outstanding as of June 30, 2021.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">On October 10, 2018, the Company entered into a Master Clinical Trial Collaboration Agreement with Bristol-Myers Squibb to evaluate the safety and tolerability of the Company&#x2019;s COM701 in combination with Bristol-Myers Squibb&#x2019;s programmed death-1 (PD-1) immune checkpoint inhibitor Opdivo&#xAE; (nivolumab), in patients with advanced solid tumors. In conjunction with the Master Clinical Agreement, Bristol-Myers Squibb made a $<ix:nonFraction id="Fact_235" contextRef="AsOf2018-10-10_custom_MasterClinicalAgreementMember" name="us-gaap:EquityMethodInvestmentAggregateCost" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">12,000</ix:nonFraction> equity investment in the Company. Under the terms of the securities purchase agreement, Bristol-Myers Squibb purchased <ix:nonFraction id="Fact_236" contextRef="From2018-10-01to2018-10-10_custom_MasterClinicalAgreementMember" name="cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,424,243</ix:nonFraction> Ordinary Shares of the Company at a purchase price of $<ix:nonFraction id="Fact_237" contextRef="AsOf2018-10-10_custom_MasterClinicalAgreementMember" name="us-gaap:SharesIssuedPricePerShare" unitRef="USDPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">4.95</ix:nonFraction> per share. The share price represents a <ix:nonFraction id="Fact_238" contextRef="From2018-10-01to2018-10-10_custom_MasterClinicalAgreementMember" name="cgen:PercentageOfClosingPrice" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">33</ix:nonFraction>% premium over the average closing price of Compugen&#x2019;s Ordinary Shares for twenty (20) Nasdaq trading days prior to the execution of the securities purchase agreement. The investment closed on October 12, 2018.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">The premium over the fair market value in the amount of $<ix:nonFraction id="Fact_239" contextRef="From2021-01-01to2021-06-30" name="cgen:DeferredParticipationOfBmsInRdExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">4,121</ix:nonFraction> represents the relative fair value of deferred participation of Bristol-Myers Squibb in R&amp;D expenses which will be amortized over the period of the clinical trial based on the progress in the R&amp;D, in accordance with ASC 808 &quot;Collaborative Arrangements&quot; and $<ix:nonFraction id="Fact_240" contextRef="From2021-01-01to2021-06-30_custom_CollaborativeArrangementsMember" name="cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">7,788</ix:nonFraction> (net of $<ix:nonFraction id="Fact_241" contextRef="From2021-01-01to2021-06-30_custom_CollaborativeArrangementsMember" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">91</ix:nonFraction> issuance expenses) were considered equity investment. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;11</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 5:-</span><span style="font-weight:bold; padding-left:16.68pt; ">SHAREHOLDERS&#x2019; EQUITY (Cont.)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">In March 2020, the Company entered into an underwriting agreement with SVB Leerink LLC and Stifel, Nicolaus &amp; Company, Incorporated, as representatives of the several underwriters relating to the issuance and sale in a public offering of <ix:nonFraction id="Fact_242" contextRef="From2020-03-01to2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">8,333,334</ix:nonFraction> of the Company&apos;s Ordinary Shares at a price to the public of $<ix:nonFraction id="Fact_243" contextRef="AsOf2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" name="us-gaap:SharesIssuedPricePerShare" unitRef="USDPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">9.00</ix:nonFraction> per share (and a price of $<ix:nonFraction id="Fact_244" contextRef="AsOf2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember_custom_UnderwritersMember" name="us-gaap:SharesIssuedPricePerShare" unitRef="USDPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">8.46</ix:nonFraction> per share to the underwriters). Such shares were issued on March 16, 2020. In addition, the Company granted the underwriters a 30-day option to purchase additional Ordinary Shares at the price set forth above. On April 14, 2020, the Company issued and sold, pursuant to that underwriting agreement an additional <ix:nonFraction id="Fact_245" contextRef="From2020-04-01to2020-04-14_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember_custom_UnderwritersMember" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">483,005</ix:nonFraction> Ordinary Shares pursuant to the underwriters&#x2019; option specified above. The Company sold a total of <ix:nonFraction id="Fact_246" contextRef="From2021-01-01to2021-06-30_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">8,816,339</ix:nonFraction> Ordinary Shares in the offering with proceeds of $<ix:nonFraction id="Fact_247" contextRef="From2021-01-01to2021-06-30_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">74,147</ix:nonFraction> (net of $<ix:nonFraction id="Fact_248" contextRef="From2021-01-01to2021-06-30_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">5,200</ix:nonFraction> issuance expenses). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; ">b.<span style="padding-left:12.5pt; ">Stock option plan:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">During the six-month period ended June 30, 2021, the Company&apos;s Board of Directors granted <ix:nonFraction id="Fact_249" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">66,500</ix:nonFraction> options to purchase Ordinary Shares of the Company to employees. The exercise prices for such options range from $<ix:nonFraction id="Fact_250" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" unitRef="USDPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">7.59</ix:nonFraction> to $<ix:nonFraction id="Fact_251" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" unitRef="USDPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">13.32</ix:nonFraction> per Ordinary Share, with vesting to occur in up to <ix:nonNumeric id="Fact_252" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen">four years</ix:nonNumeric>.</p> <ix:nonNumeric id="Fact_266" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "> The following table presents the assumptions used to estimate the fair value of the options granted in the periods presented: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:80pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Volatility </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_253" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">66</ix:nonFraction>%-<ix:nonFraction id="Fact_254" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">67</ix:nonFraction>% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_255" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">55</ix:nonFraction>%-<ix:nonFraction id="Fact_256" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">59</ix:nonFraction>% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Risk-free interest rate </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_257" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.5</ix:nonFraction>%-<ix:nonFraction id="Fact_258" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.8</ix:nonFraction>% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_259" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.5</ix:nonFraction>%-<ix:nonFraction id="Fact_260" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">1.6</ix:nonFraction>% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Dividend yield </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_261" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction>% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_262" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction>% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected life (years) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_263" contextRef="From2021-01-01to2021-06-30" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear">5.1</ix:nonNumeric> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_264" contextRef="From2020-01-01to2020-06-30_us-gaap_MinimumMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear">5.0</ix:nonNumeric>-<ix:nonNumeric id="Fact_265" contextRef="From2020-01-01to2020-06-30_us-gaap_MaximumMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear">5.1</ix:nonNumeric> </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">Weighted average fair value of options granted during the six-month periods ended June 30, 2021 and 2020 were $<ix:nonFraction id="Fact_267" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="USDPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">5.54</ix:nonFraction> and $<ix:nonFraction id="Fact_268" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="USDPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">3.10</ix:nonFraction>, respectively.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">During the six-month periods ended June 30, 2021 and 2020, the Company recorded share based compensation in a total amount of $<ix:nonFraction id="Fact_269" contextRef="From2021-01-01to2021-06-30" name="us-gaap:StockOptionPlanExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,805</ix:nonFraction> and $<ix:nonFraction id="Fact_270" contextRef="From2020-01-01to2020-06-30" name="us-gaap:StockOptionPlanExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">968</ix:nonFraction>, respectively.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">As of June 30, 2021, the total unrecognized estimated compensation cost related to non-vested stock options granted prior to that date was $<ix:nonFraction id="Fact_271" contextRef="AsOf2021-06-30" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">9,596</ix:nonFraction> which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric id="Fact_272" contextRef="From2021-01-01to2021-06-30" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear">3.00</ix:nonNumeric> years.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">For the six months ended June 30, 2021 and 2020, the total weighted average number of shares related to outstanding options and warrants excluded from the calculations of diluted net loss per share were <ix:nonFraction id="Fact_273" contextRef="From2021-01-01to2021-06-30" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">6,242,283</ix:nonFraction> and <ix:nonFraction id="Fact_274" contextRef="From2020-01-01to2020-06-30" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">7,984,232</ix:nonFraction>, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;12</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 5:-</span><span style="font-weight:bold; padding-left:16.68pt; ">SHAREHOLDERS&apos; EQUITY (Cont.)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; ">c.<span style="padding-left:13.06pt; ">Employee Stock Purchase Plan:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">The Company selected the Black-Scholes-Merton option-pricing model as the most appropriate fair value method for its stock-option awards and Employee Stock Purchase Plan (&#x201C;ESPP&#x201D;). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">As of June 30, 2021, <ix:nonFraction id="Fact_275" contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">36,639</ix:nonFraction> Ordinary Shares had been purchased under the ESPP and <ix:nonFraction id="Fact_276" contextRef="AsOf2021-06-30_us-gaap_EmployeeStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">563,361</ix:nonFraction> Ordinary Shares were available for future issuance under the ESPP. </p> <ix:nonNumeric id="Fact_287" contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:80pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Volatility </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_277" contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">64</ix:nonFraction>%-<ix:nonFraction id="Fact_278" contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_279" contextRef="From2020-01-01to2020-06-30_us-gaap_EmployeeStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="Pure" scale="-2" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Risk-free interest rate </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_280" contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.0</ix:nonFraction>%-<ix:nonFraction id="Fact_281" contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.1</ix:nonFraction>% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_282" contextRef="From2020-01-01to2020-06-30_us-gaap_EmployeeStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="Pure" scale="-2" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Dividend yield </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_283" contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction>% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_284" contextRef="From2020-01-01to2020-06-30_us-gaap_EmployeeStockMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="Pure" scale="-2" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected life (years) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_285" contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember_srt_MinimumMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear">0.4</ix:nonNumeric>-<ix:nonNumeric id="Fact_286" contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember_srt_MaximumMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear">0.5</ix:nonNumeric> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">During the six-month period ended June 30, 2021, the Company recorded ESPP compensation in a total amount of $<ix:nonFraction id="Fact_288" contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">111</ix:nonFraction>. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_297" contextRef="From2021-01-01to2021-06-30" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 6:-</span><span style="font-weight:bold; padding-left:16.68pt; ">FINANCIAL AND OTHER INCOME, NET</span></p> <ix:nonNumeric id="Fact_296" contextRef="From2021-01-01to2021-06-30" name="us-gaap:InterestAndOtherIncomeTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:60pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Interest income </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_290" contextRef="From2021-01-01to2021-06-30" name="us-gaap:InterestIncomeDepositsWithFinancialInstitutions" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">528</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_291" contextRef="From2020-01-01to2020-06-30" name="us-gaap:InterestIncomeDepositsWithFinancialInstitutions" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">878</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exchange rate differences and other </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_292" contextRef="From2021-01-01to2021-06-30" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">31</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_293" contextRef="From2020-01-01to2020-06-30" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">72</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Financial and other income, net </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_294" contextRef="From2021-01-01to2021-06-30" name="cgen:FinancialAndOtherIncomeNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">559</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_295" contextRef="From2020-01-01to2020-06-30" name="cgen:FinancialAndOtherIncomeNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">806</ix:nonFraction> </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;13</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span> </p> <ix:nonNumeric id="Fact_303" contextRef="From2021-01-01to2021-06-30" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 7:-</span><span style="font-weight:bold; padding-left:16.68pt; ">RELATED PARTY BALANCES AND TRANSACTIONS</span></p> <ix:nonNumeric id="Fact_302" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; "> Balances with related parties: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:60pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">31, 2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Trade and other payables (a) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_298" contextRef="AsOf2021-06-30" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">62</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_299" contextRef="AsOf2020-12-31" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">83</ix:nonFraction> </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; ">Related parties&apos; expenses: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:60pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Amounts charged to: </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development expenses (a) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_300" contextRef="From2021-01-01to2021-06-30" name="us-gaap:CostsAndExpensesRelatedParty" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">110</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_301" contextRef="From2020-01-01to2020-06-30" name="us-gaap:CostsAndExpensesRelatedParty" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">146</ix:nonFraction> </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> <div style="margin-left:60pt; ">
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:4%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">(a) </p> </td> <td style="width:96%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><ix:footnote id="FN_60e66b41df40f60778298cb2" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">The Company incurred expenses for research and development services provided by related party for cancer studies in animal models, and breeding and maintenance of animals (mice) to support such studies.</ix:footnote> </p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;14</p> </div> <div style="width:100%; clear:both;"> <hr style="border-top:0.75pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/><hr style="border-top:3pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; margin-bottom:0pt; "></p> </div> </div> </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>exhibit_99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.5.1.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center">
    <div style="text-align: right;"><u><font style="font-weight: bold;"> Exhibit 99.3</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 12pt;">MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 12pt;">FINANCIAL CONDITION</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br>
        </div>
        <div style="line-height: 1.25; font-weight: bold;">RESULTS OF OPERATIONS</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Six months ended June 30, 2021 and 2020</div>
        <div style="line-height: 1.25;"><font style="font-style: italic;">Research and Development Expenses</font>.&#160;Research and development, or R&amp;D, expenses increased by approximately 54%&#160;to approximately $14.1 million for the first six months of
          2021 from approximately $9.2 million for the comparable period of 2020. The increase is mainly due to an increase in expenses associated with COM701 and COM902 manufacturing and other chemistry, manufacturing, and controls, or CMC, activities and
          headcount to support the expansion of the various ongoing clinical trials. Research and development expenses, as a percentage of total operating expenses, were 71% for the first six months of 2021 compared to 65% for the comparable period of
          2020.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;"><font style="font-style: italic;">Marketing and Business Development Expenses</font>. Marketing and business development expenses increased by approximately 12% to approximately $0.5 million for the first six months
          of 2021 from approximately $0.4 million for the comparable period of 2020. Marketing and business development expenses, as a percentage of total operating expenses, were 2% for the first six months of 2021 compared with 3% for the comparable
          period of 2020.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;"><font style="font-style: italic;">General and Administrative Expenses</font>.&#160;General and administrative expenses increased by approximately 17%&#160;to approximately $5.4 million for the first six months of 2021 from
          approximately $4.6 million for the comparable period of 2020. The increase is attributable mainly to various corporate related expenses. General and administrative expenses, as a percentage of total operating expenses, decreased to 27% for the
          first six months of 2021 from 32% for the comparable period of 2020.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;"><font style="font-style: italic;">Financial and other Income, Net</font>.&#160;Financial and other income, net, were approximately $0.6 million for the first six months of 2021 compared with approximately $0.8 million for
          the comparable period of 2020. The decrease is attributable to lower interest rates in the first six months of 2021 compared with the comparable period of 2020.</div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">&#160;</div>
          <div style="line-height: 1.25">
            <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
          <div style="line-height: 1.25"> <br>
          </div>
          <div style="line-height: 1.25; font-weight: bold;">LIQUIDITY AND CAPITAL RESOURCES</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
      <div style="line-height: 1.25;"><font style="font-style: italic;">Net Cash Used in Operating Activities.&#160;</font>Net cash used in operating activities was approximately $13.6 million in the first six months of 2021 compared with approximately $11.6
        million in the comparable period of 2020. Net cash used during the first six months of 2021 reflects mainly the higher level of cash expenses related to clinical, CMC, other R&amp;D and headcount, offset by collection of the 2.0 million preclinical
        milestone pursuant to the license agreement with AstraZeneca PLC during this period.&#160;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><font style="font-style: italic;">Net Cash Provided by (Used in) Investing Activities.&#160;</font>Net cash provided by investing activities during the first six months of 2021 was approximately $13.4 million compared with
        approximately $88.7 million net cash used in investing activities in the comparable period of 2020. Changes in net cash during the periods are affected by the level of cash in the Company over the periods which is deposited or withdrawn from bank
        deposits based on the cash needs to fund our operating activities. During the first six months of 2021 cash used in investing activities was lower as a result of higher cash balances from the Company&#8217;s underwritten public offering in March 2020
        (the &#8220;<font style="font-weight: bold;">Public Offering</font>&#8221;) and exercises of outstanding warrants and employee share options in the first six months of 2020.</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;"><font style="font-style: italic;">Net Cash Provided by Financing Activities.&#160;</font>Net cash provided by financing activities was $0.9 million in the first six months of 2021 compared with $103.5 million in the
          comparable period of 2020. The sources of cash provided by financing activities for the first six months of 2021 consisted of proceeds received from exercises of outstanding warrants and employee share options and proceeds received from shares
          purchased under our 2021 Employee Share Purchase Plan, while the sources of cash provided by financing activities for the first six months of 2020 consisted of proceeds received from the Public Offering and exercises of outstanding warrants and
          employee share options during that period.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;"><font style="font-style: italic;">Net Liquidity.&#160;</font>Liquidity refers to liquid financial assets available to fund the Company&#8217;s business operations and pay for near-term obligations. These liquid financial assets
          mostly consist of cash and cash equivalents, as well as short-term bank deposits. As of June 30, 2021, the Company had total cash, cash equivalents, restricted cash and short-term bank deposits of approximately $111.1 million.</div>
        <div style="line-height: 1.25">&#160;
          <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"></div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cgen-20210630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<schema attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" targetNamespace="http://cgen.com/20210630" xmlns:cgen="http://cgen.com/20210630">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <annotation>
    <appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cgen-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cgen-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cgen-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cgen-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:roleType roleURI="http://cgen.com/role/cgen-daei1" id="cgen-daei1">
        <link:definition>00010 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-cbs" id="cgen-cbs">
        <link:definition>00020 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-cbsp" id="cgen-cbsp">
        <link:definition>00030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-csocl" id="cgen-csocl">
        <link:definition>00040 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-socise1" id="cgen-socise1">
        <link:definition>00050 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>00060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-g" id="cgen-g">
        <link:definition>00070 - Disclosure - GENERAL</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-sap1" id="cgen-sap1">
        <link:definition>00080 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/UnauditedInterimConsolidatedFinancialStatements" id="UnauditedInterimConsolidatedFinancialStatements">
        <link:definition>00090 - Disclosure - UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-cac" id="cgen-cac">
        <link:definition>00100 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-se1" id="cgen-se1">
        <link:definition>00110 - Disclosure - SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/TaxesOnIncome" id="TaxesOnIncome">
        <link:definition>00120 - Disclosure - TAXES ON INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-fin" id="cgen-fin">
        <link:definition>00130 - Disclosure - FINANCIAL AND OTHER INCOME, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-rpbat" id="cgen-rpbat">
        <link:definition>00140 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESPolicies" id="Disclosure-SIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>00150 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-set" id="cgen-set">
        <link:definition>00160 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-fint" id="cgen-fint">
        <link:definition>00170 - Disclosure - FINANCIAL AND OTHER INCOME, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/RelatedPartyBalancesAndTransactionsTables" id="RelatedPartyBalancesAndTransactionsTables">
        <link:definition>00180 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-gd1" id="cgen-gd1">
        <link:definition>00190 - Disclosure - GENERAL (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
        <link:definition>00200 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails" id="ShareholdersEquityIssuanceOfSharesDetails">
        <link:definition>00210 - Disclosure - SHAREHOLDERS' EQUITY (Issuance of Shares) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails" id="ShareholdersEquityScheduleOfStock-basedCompensationDetails">
        <link:definition>00220 - Disclosure - SHAREHOLDERS' EQUITY (Schedule of Stock-Based Compensation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-find" id="cgen-find">
        <link:definition>00230 - Disclosure - FINANCIAL AND OTHER INCOME, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cgen.com/role/cgen-rpbatd" id="cgen-rpbatd">
        <link:definition>00240 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
  <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd"/>
  <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd"/>
  <element name="DocumentAndEntityInformationAbstract" id="cgen_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="SeverancePayFundNoncurrent" id="cgen_SeverancePayFundNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="debit"/>
  <element name="ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" id="cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="credit"/>
  <element name="LongTermDeferredParticipationInResearchAndDevelopmentExpenses" id="cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="credit"/>
  <element name="FinancialAndOtherIncomeNet" id="cgen_FinancialAndOtherIncomeNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodValueWarrantsExercised" id="cgen_StockIssuedDuringPeriodValueWarrantsExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="NumberOfWarrantsExercised" id="cgen_NumberOfWarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="SeverancePayNet" id="cgen_SeverancePayNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="IncreaseDecreaseInOperatingLeaseRightOfUseAsset" id="cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" id="cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="ReceivablesOnAccountOfShares" id="cgen_ReceivablesOnAccountOfShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="UnauditedInterimConsolidatedFinancialStatementsAbstract" id="cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="UnauditedInterimConsolidatedFinancialStatementsTextBlock" id="cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" id="cgen_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="RelatedPartyBalancesAndTransactionsTablesAbstract" id="cgen_RelatedPartyBalancesAndTransactionsTablesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="DevelopmentRegulatoryAndCommercialMilestonesCompensation" id="cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="ResearchAndDevelopmentArrangementPaymentsReceivable" id="cgen_ResearchAndDevelopmentArrangementPaymentsReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="debit"/>
  <element name="ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable" id="cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="debit"/>
  <element name="ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable" id="cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="debit"/>
  <element name="ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram" id="cgen_ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="debit"/>
  <element name="GovernmentAndOtherGrantsTable" id="cgen_GovernmentAndOtherGrantsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="GovernmentAndOtherGrantsMember" id="cgen_GovernmentAndOtherGrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="GovernmentAndOtherGrantsAxis" id="cgen_GovernmentAndOtherGrantsAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="GovernmentAndOtherGrantsDomain" id="cgen_GovernmentAndOtherGrantsDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="May2012AgreementMember" id="cgen_May2012AgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="CommercialLicenseAgreementMember" id="cgen_CommercialLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="CollaborationAgreementWithUSAntibodyCompanyMember" id="cgen_CollaborationAgreementWithUSAntibodyCompanyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="GovernmentAndOtherGrantsLineItems" id="cgen_GovernmentAndOtherGrantsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="RoyaltyPercentageBasedOnFutureRevenues" id="cgen_RoyaltyPercentageBasedOnFutureRevenues" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="MaximumRoyaltyRepaidAsPercentageOfGrantReceived" id="cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="RoyaltyContingentObligations" id="cgen_RoyaltyContingentObligations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="credit"/>
  <element name="ContingentFees" id="cgen_ContingentFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="debit"/>
  <element name="ParticipationRights" id="cgen_ParticipationRights" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="RetainerFee" id="cgen_RetainerFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="AgreementStartDate" id="cgen_AgreementStartDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="AgreementTerminationDescription" id="cgen_AgreementTerminationDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="PercentageOfRoyaltiesOnNetSales" id="cgen_PercentageOfRoyaltiesOnNetSales" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="AmountIncurredMilestonePayments" id="cgen_AmountIncurredMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="AtTheMarketOfferingProgramMember" id="cgen_AtTheMarketOfferingProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="AgreementMember" id="cgen_AgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="MasterClinicalAgreementMember" id="cgen_MasterClinicalAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="CollaborativeArrangementsMember" id="cgen_CollaborativeArrangementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="SvbLeerinkLlcAndStifelNicolausAndCompanyMember" id="cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="RegisteredDirectOfferingMember" id="cgen_RegisteredDirectOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="UnderwritersMember" id="cgen_UnderwritersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="MaximumAuthorizedProceedsFromIssuanceOfCommonStock" id="cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable" id="cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="PercentageOfClosingPrice" id="cgen_PercentageOfClosingPrice" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="DeferredParticipationOfBmsInRdExpenses" id="cgen_DeferredParticipationOfBmsInRdExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>cgen-20210630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <roleRef roleURI="http://cgen.com/role/cgen-cbs" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-cbs"/>
  <roleRef roleURI="http://cgen.com/role/cgen-csocl" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-csocl"/>
  <roleRef roleURI="http://cgen.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="cgen-20210630.xsd#ConsolidatedStatementsOfCashFlows"/>
  <roleRef roleURI="http://cgen.com/role/cgen-find" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-find"/>
  <calculationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-cbs">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="locator_us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="locator_us-gaap_AssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_Assets" xlink:to="locator_us-gaap_AssetsCurrent" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="locator_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermInvestments" xlink:label="locator_us-gaap_OtherShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="locator_us-gaap_OtherShortTermInvestments" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="locator_us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="locator_us-gaap_AccountsReceivableNetCurrent" use="optional" priority="0" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" priority="0" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="locator_us-gaap_AssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_Assets" xlink:to="locator_us-gaap_AssetsNoncurrent" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="locator_us-gaap_PrepaidExpenseNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsNoncurrent" xlink:to="locator_us-gaap_PrepaidExpenseNoncurrent" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_SeverancePayFundNoncurrent" xlink:label="locator_cgen_SeverancePayFundNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsNoncurrent" xlink:to="locator_cgen_SeverancePayFundNoncurrent" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsNoncurrent" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentNet" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="locator_us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsNoncurrent" xlink:to="locator_us-gaap_OperatingLeaseRightOfUseAsset" use="optional" priority="0" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="locator_us-gaap_LiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="locator_us-gaap_LiabilitiesCurrent" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="locator_us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_us-gaap_AccountsPayableCurrent" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="locator_us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_us-gaap_OtherAccountsPayableAndAccruedLiabilities" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" xlink:label="locator_cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_us-gaap_OperatingLeaseLiabilityCurrent" use="optional" priority="0" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="locator_us-gaap_LiabilitiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="locator_us-gaap_LiabilitiesNoncurrent" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="locator_us-gaap_PostemploymentBenefitsLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesNoncurrent" xlink:to="locator_us-gaap_PostemploymentBenefitsLiabilityNoncurrent" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesNoncurrent" xlink:to="locator_us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses" xlink:label="locator_cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesNoncurrent" xlink:to="locator_cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="locator_us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="locator_us-gaap_CommonStockValue" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="locator_us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="locator_us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="locator_us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="locator_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" priority="0" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-csocl">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="locator_us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetIncomeLoss" xlink:to="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="locator_us-gaap_OperatingExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="locator_us-gaap_OperatingExpenses" use="optional" priority="0" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_OperatingExpenses" xlink:to="locator_us-gaap_ResearchAndDevelopmentExpense" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDevelopment" xlink:label="locator_us-gaap_BusinessDevelopment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_OperatingExpenses" xlink:to="locator_us-gaap_BusinessDevelopment" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_OperatingExpenses" xlink:to="locator_us-gaap_GeneralAndAdministrativeExpense" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_FinancialAndOtherIncomeNet" xlink:label="locator_cgen_FinancialAndOtherIncomeNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="locator_cgen_FinancialAndOtherIncomeNet" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="locator_us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetIncomeLoss" xlink:to="locator_us-gaap_IncomeTaxExpenseBenefit" use="optional" priority="0" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://cgen.com/role/ConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="locator_us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_ShareBasedCompensation" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="locator_us-gaap_Depreciation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_Depreciation" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_SeverancePayNet" xlink:label="locator_cgen_SeverancePayNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_cgen_SeverancePayNet" use="optional" priority="0" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="locator_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" use="optional" priority="0" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" priority="0" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInPrepaidExpense" use="optional" priority="0" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" use="optional" priority="0" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="locator_us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" use="optional" priority="0" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" xlink:label="locator_cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" use="optional" priority="0" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" use="optional" priority="0" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:label="locator_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" use="optional" priority="0" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade" use="optional" priority="0" order="13" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsReceivable" use="optional" priority="0" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:label="locator_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="locator_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="locator_us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="locator_us-gaap_PaymentsToAcquireShortTermInvestments" use="optional" priority="0" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" priority="0" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="locator_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="locator_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" use="optional" priority="0" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="locator_us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="locator_us-gaap_ProceedsFromStockOptionsExercised" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="locator_us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="locator_us-gaap_ProceedsFromIssuanceOfCommonStock" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="locator_us-gaap_ProceedsFromWarrantExercises"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="locator_us-gaap_ProceedsFromWarrantExercises" use="optional" priority="0" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-find">
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_FinancialAndOtherIncomeNet" xlink:label="locator_cgen_FinancialAndOtherIncomeNet"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:label="locator_us-gaap_InterestIncomeDepositsWithFinancialInstitutions"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_cgen_FinancialAndOtherIncomeNet" xlink:to="locator_us-gaap_InterestIncomeDepositsWithFinancialInstitutions" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="locator_us-gaap_GainLossOnInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_cgen_FinancialAndOtherIncomeNet" xlink:to="locator_us-gaap_GainLossOnInvestments" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="locator_us-gaap_OtherNonoperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_cgen_FinancialAndOtherIncomeNet" xlink:to="locator_us-gaap_OtherNonoperatingIncomeExpense" use="optional" priority="0" order="3" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>cgen-20210630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <roleRef roleURI="http://cgen.com/role/cgen-socise1" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-socise1"/>
  <roleRef roleURI="http://cgen.com/role/cgen-set" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-set"/>
  <roleRef roleURI="http://cgen.com/role/CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="cgen-20210630.xsd#CommitmentsAndContingenciesDetails"/>
  <roleRef roleURI="http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails" xlink:type="simple" xlink:href="cgen-20210630.xsd#ShareholdersEquityIssuanceOfSharesDetails"/>
  <roleRef roleURI="http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails" xlink:type="simple" xlink:href="cgen-20210630.xsd#ShareholdersEquityScheduleOfStock-basedCompensationDetails"/>
  <definitionLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-socise1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesOutstanding" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="locator_cgen_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_StockIssuedDuringPeriodValueWarrantsExercised" use="optional" priority="0" order="5"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_NumberOfWarrantsExercised" xlink:label="locator_cgen_NumberOfWarrantsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_NumberOfWarrantsExercised" use="optional" priority="0" order="6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" priority="0" order="7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="0" order="8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" use="optional" priority="0" order="9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="locator_us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementEquityComponentsAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="locator_us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_EquityComponentDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="locator_us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_EquityComponentDomain" xlink:to="locator_us-gaap_CommonStockMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="locator_us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_EquityComponentDomain" xlink:to="locator_us-gaap_AdditionalPaidInCapitalMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="locator_us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_EquityComponentDomain" xlink:to="locator_us-gaap_RetainedEarningsMember" use="optional" priority="0" order="21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="locator_us-gaap_EquityComponentDomain_c57df871-c042-c875-7fe1-eec948a7077d_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_EquityComponentDomain_c57df871-c042-c875-7fe1-eec948a7077d_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-set">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="locator_us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_SubsidiarySaleOfStockAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="locator_us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="locator_us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="locator_us-gaap_EmployeeStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="locator_us-gaap_EmployeeStockMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="locator_us-gaap_SaleOfStockNameOfTransactionDomain_b2708836-72d8-33a7-34e1-3bb74959cd2d_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="locator_us-gaap_SaleOfStockNameOfTransactionDomain_b2708836-72d8-33a7-34e1-3bb74959cd2d_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cgen.com/role/CommitmentsAndContingenciesDetails">
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsLineItems" xlink:label="locator_cgen_GovernmentAndOtherGrantsLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure" xlink:label="locator_us-gaap_GuaranteeObligationsMaximumExposure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_us-gaap_GuaranteeObligationsMaximumExposure" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RoyaltyPercentageBasedOnFutureRevenues" xlink:label="locator_cgen_RoyaltyPercentageBasedOnFutureRevenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_RoyaltyPercentageBasedOnFutureRevenues" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived" xlink:label="locator_cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RoyaltyContingentObligations" xlink:label="locator_cgen_RoyaltyContingentObligations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_RoyaltyContingentObligations" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ContingentFees" xlink:label="locator_cgen_ContingentFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_ContingentFees" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ParticipationRights" xlink:label="locator_cgen_ParticipationRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_ParticipationRights" use="optional" priority="0" order="5"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RetainerFee" xlink:label="locator_cgen_RetainerFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_RetainerFee" use="optional" priority="0" order="6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="locator_us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_us-gaap_PaymentsOfStockIssuanceCosts" use="optional" priority="0" order="7"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AgreementStartDate" xlink:label="locator_cgen_AgreementStartDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_AgreementStartDate" use="optional" priority="0" order="8"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AgreementTerminationDescription" xlink:label="locator_cgen_AgreementTerminationDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_AgreementTerminationDescription" use="optional" priority="0" order="9"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsTable" xlink:label="locator_cgen_GovernmentAndOtherGrantsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_GovernmentAndOtherGrantsTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:label="locator_us-gaap_GuaranteeObligationsByNatureAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_us-gaap_GuaranteeObligationsByNatureAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:label="locator_us-gaap_GuaranteeObligationsNatureDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="locator_us-gaap_GuaranteeObligationsNatureDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyLeaseGuaranteeMember" xlink:label="locator_us-gaap_PropertyLeaseGuaranteeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_GuaranteeObligationsNatureDomain" xlink:to="locator_us-gaap_PropertyLeaseGuaranteeMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="locator_srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_srt_StatementGeographicalAxis" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="locator_srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_StatementGeographicalAxis" xlink:to="locator_srt_SegmentGeographicalDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:label="locator_country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_SegmentGeographicalDomain" xlink:to="locator_country_IL" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesByNatureAxis" xlink:label="locator_us-gaap_GainContingenciesByNatureAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_us-gaap_GainContingenciesByNatureAxis" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingencyNatureDomain" xlink:label="locator_us-gaap_GainContingencyNatureDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_GainContingenciesByNatureAxis" xlink:to="locator_us-gaap_GainContingencyNatureDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsMember" xlink:label="locator_cgen_GovernmentAndOtherGrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_GainContingencyNatureDomain" xlink:to="locator_cgen_GovernmentAndOtherGrantsMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="locator_srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_srt_RangeAxis" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="locator_srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_RangeAxis" xlink:to="locator_srt_RangeMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="locator_srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MinimumMember" use="optional" priority="0" order="12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="locator_srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MaximumMember" use="optional" priority="0" order="22"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsAxis" xlink:label="locator_cgen_GovernmentAndOtherGrantsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_cgen_GovernmentAndOtherGrantsAxis" use="optional" priority="0" order="5"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsDomain" xlink:label="locator_cgen_GovernmentAndOtherGrantsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_cgen_GovernmentAndOtherGrantsAxis" xlink:to="locator_cgen_GovernmentAndOtherGrantsDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_May2012AgreementMember" xlink:label="locator_cgen_May2012AgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsDomain" xlink:to="locator_cgen_May2012AgreementMember" use="optional" priority="0" order="71"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_CommercialLicenseAgreementMember" xlink:label="locator_cgen_CommercialLicenseAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsDomain" xlink:to="locator_cgen_CommercialLicenseAgreementMember" use="optional" priority="0" order="91"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentAxis" xlink:label="locator_us-gaap_SupplyCommitmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_us-gaap_SupplyCommitmentAxis" use="optional" priority="0" order="6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember" xlink:label="locator_us-gaap_SupplyCommitmentArrangementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_SupplyCommitmentAxis" xlink:to="locator_us-gaap_SupplyCommitmentArrangementMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_CollaborationAgreementWithUSAntibodyCompanyMember" xlink:label="locator_cgen_CollaborationAgreementWithUSAntibodyCompanyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_SupplyCommitmentArrangementMember" xlink:to="locator_cgen_CollaborationAgreementWithUSAntibodyCompanyMember" use="optional" priority="0" order="121"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_PercentageOfRoyaltiesOnNetSales" xlink:label="locator_cgen_PercentageOfRoyaltiesOnNetSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_PercentageOfRoyaltiesOnNetSales" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AmountIncurredMilestonePayments" xlink:label="locator_cgen_AmountIncurredMilestonePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_AmountIncurredMilestonePayments" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:label="locator_us-gaap_GuaranteeObligationsNatureDomain_5c855fc1-8339-63d8-2b87-82362c02e0fa_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="locator_us-gaap_GuaranteeObligationsNatureDomain_5c855fc1-8339-63d8-2b87-82362c02e0fa_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="locator_srt_SegmentGeographicalDomain_04dd96e2-bea9-dde6-b167-7498408c33f1_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_StatementGeographicalAxis" xlink:to="locator_srt_SegmentGeographicalDomain_04dd96e2-bea9-dde6-b167-7498408c33f1_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingencyNatureDomain" xlink:label="locator_us-gaap_GainContingencyNatureDomain_45a856fd-6f27-c940-3e13-e6b9a2abd15f_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_GainContingenciesByNatureAxis" xlink:to="locator_us-gaap_GainContingencyNatureDomain_45a856fd-6f27-c940-3e13-e6b9a2abd15f_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="locator_srt_RangeMember_b552dabb-94ad-c791-132e-a8fca14de59b_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_RangeAxis" xlink:to="locator_srt_RangeMember_b552dabb-94ad-c791-132e-a8fca14de59b_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsDomain" xlink:label="locator_cgen_GovernmentAndOtherGrantsDomain_fe137f8e-eed3-f6d7-1495-80a71a4da3b5_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_cgen_GovernmentAndOtherGrantsAxis" xlink:to="locator_cgen_GovernmentAndOtherGrantsDomain_fe137f8e-eed3-f6d7-1495-80a71a4da3b5_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember" xlink:label="locator_us-gaap_SupplyCommitmentArrangementMember_c0528f76-c8a6-5dd5-3f5c-19953c67adb2_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_SupplyCommitmentAxis" xlink:to="locator_us-gaap_SupplyCommitmentArrangementMember_c0528f76-c8a6-5dd5-3f5c-19953c67adb2_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockParOrStatedValuePerShare" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock" xlink:label="locator_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="locator_us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_PaymentsOfStockIssuanceCosts" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="locator_us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesAuthorized" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="locator_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" use="optional" priority="0" order="5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="locator_us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_SharesIssuedPricePerShare" use="optional" priority="0" order="6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="locator_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" use="optional" priority="0" order="7"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable" xlink:label="locator_cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable" use="optional" priority="0" order="8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="locator_us-gaap_EquityMethodInvestmentAggregateCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_EquityMethodInvestmentAggregateCost" use="optional" priority="0" order="9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="locator_srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_srt_StatementScenarioAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="locator_srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_StatementScenarioAxis" xlink:to="locator_srt_ScenarioUnspecifiedDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AtTheMarketOfferingProgramMember" xlink:label="locator_cgen_AtTheMarketOfferingProgramMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_cgen_AtTheMarketOfferingProgramMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AgreementMember" xlink:label="locator_cgen_AgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_cgen_AgreementMember" use="optional" priority="0" order="31"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_MasterClinicalAgreementMember" xlink:label="locator_cgen_MasterClinicalAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_cgen_MasterClinicalAgreementMember" use="optional" priority="0" order="51"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_CollaborativeArrangementsMember" xlink:label="locator_cgen_CollaborativeArrangementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_cgen_CollaborativeArrangementsMember" use="optional" priority="0" order="91"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" xlink:label="locator_cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" use="optional" priority="0" order="121"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="locator_us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_AwardTypeAxis" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_AwardTypeAxis" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RegisteredDirectOfferingMember" xlink:label="locator_cgen_RegisteredDirectOfferingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="locator_cgen_RegisteredDirectOfferingMember" use="optional" priority="0" order="32"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_UnderwritersMember" xlink:label="locator_cgen_UnderwritersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="locator_cgen_UnderwritersMember" use="optional" priority="0" order="142"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_PercentageOfClosingPrice" xlink:label="locator_cgen_PercentageOfClosingPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_PercentageOfClosingPrice" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_DeferredParticipationOfBmsInRdExpenses" xlink:label="locator_cgen_DeferredParticipationOfBmsInRdExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_DeferredParticipationOfBmsInRdExpenses" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="locator_us-gaap_ProceedsFromWarrantExercises"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ProceedsFromWarrantExercises" use="optional" priority="0" order="12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="locator_us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ClassOfWarrantOrRightOutstanding" use="optional" priority="0" order="13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="locator_us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ProceedsFromIssuanceInitialPublicOffering" use="optional" priority="0" order="14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="locator_srt_ScenarioUnspecifiedDomain_9befc25c-483e-d4ec-09bc-9276e2296a16_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_StatementScenarioAxis" xlink:to="locator_srt_ScenarioUnspecifiedDomain_9befc25c-483e-d4ec-09bc-9276e2296a16_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_631ec162-114a-c9e8-091a-d8ca94c7dfa9_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_AwardTypeAxis" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_631ec162-114a-c9e8-091a-d8ca94c7dfa9_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" use="optional" priority="0" order="5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" use="optional" priority="0" order="6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" use="optional" priority="0" order="7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" use="optional" priority="0" order="8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" use="optional" priority="0" order="9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="locator_srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="locator_srt_RangeAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="locator_srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_RangeAxis" xlink:to="locator_srt_RangeMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="locator_srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MinimumMember" use="optional" priority="0" order="31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="locator_srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MaximumMember" use="optional" priority="0" order="41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="locator_us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="locator_us-gaap_SubsidiarySaleOfStockAxis" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="locator_us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="locator_us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="locator_us-gaap_EmployeeStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="locator_us-gaap_EmployeeStockMember" use="optional" priority="0" order="51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" use="optional" priority="0" order="12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" use="optional" priority="0" order="13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="locator_us-gaap_StockOptionPlanExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_StockOptionPlanExpense" use="optional" priority="0" order="14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="locator_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" use="optional" priority="0" order="15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" use="optional" priority="0" order="16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" use="optional" priority="0" order="17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" use="optional" priority="0" order="18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="locator_srt_RangeMember_6287ece2-979e-bff6-289d-c9f06f1873c9_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_RangeAxis" xlink:to="locator_srt_RangeMember_6287ece2-979e-bff6-289d-c9f06f1873c9_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="locator_us-gaap_SaleOfStockNameOfTransactionDomain_75d451e2-a954-f328-21f1-78147b5013fd_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="locator_us-gaap_SaleOfStockNameOfTransactionDomain_75d451e2-a954-f328-21f1-78147b5013fd_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>cgen-20210630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_DocumentAndEntityInformationAbstract" xlink:label="locator_cgen_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document And Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="label_cgen_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="locator_dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityRegistrantName" xlink:to="label_dei_EntityRegistrantName"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="locator_dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityCentralIndexKey" xlink:to="label_dei_EntityCentralIndexKey"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="locator_dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_CurrentFiscalYearEndDate" xlink:to="label_dei_CurrentFiscalYearEndDate"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="locator_dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentType" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentType" xlink:to="label_dei_DocumentType"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="locator_dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_AmendmentFlag" xlink:to="label_dei_AmendmentFlag"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="locator_dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentPeriodEndDate" xlink:to="label_dei_DocumentPeriodEndDate"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="locator_dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentFiscalPeriodFocus" xlink:to="label_dei_DocumentFiscalPeriodFocus"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="locator_dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentFiscalYearFocus" xlink:to="label_dei_DocumentFiscalYearFocus"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="locator_dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityFileNumber" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityFileNumber" xlink:to="label_dei_EntityFileNumber"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="locator_dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityIncorporationStateCountryCode" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityIncorporationStateCountryCode" xlink:to="label_dei_EntityIncorporationStateCountryCode"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="locator_dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressAddressLine1" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressAddressLine1" xlink:to="label_dei_EntityAddressAddressLine1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="locator_dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressAddressLine2" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressAddressLine2" xlink:to="label_dei_EntityAddressAddressLine2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="locator_dei_EntityAddressAddressLine3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressAddressLine3" xml:lang="en-US">Entity Address, Address Line Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressAddressLine3" xlink:to="label_dei_EntityAddressAddressLine3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="locator_dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressCityOrTown" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressCityOrTown" xlink:to="label_dei_EntityAddressCityOrTown"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="locator_dei_EntityAddressCountry"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressCountry" xml:lang="en-US">Entity Address Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressCountry" xlink:to="label_dei_EntityAddressCountry"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="locator_dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressPostalZipCode" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressPostalZipCode" xlink:to="label_dei_EntityAddressPostalZipCode"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="locator_us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="label_us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="locator_us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="label_us-gaap_AssetsAbstract" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="label_us-gaap_AssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="locator_us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="label_us-gaap_AssetsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermInvestments" xlink:label="locator_us-gaap_OtherShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OtherShortTermInvestments" xml:lang="en-US">Short-term bank deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OtherShortTermInvestments" xlink:to="label_us-gaap_OtherShortTermInvestments"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="locator_us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccountsReceivableNetCurrent" xlink:to="label_us-gaap_AccountsReceivableNetCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Other accounts receivable and prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="locator_us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="label_us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="locator_us-gaap_AssetsNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsNoncurrentAbstract" xml:lang="en-US">NON-CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="label_us-gaap_AssetsNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="locator_us-gaap_PrepaidExpenseNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PrepaidExpenseNoncurrent" xml:lang="en-US">Long-term prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PrepaidExpenseNoncurrent" xlink:to="label_us-gaap_PrepaidExpenseNoncurrent"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_SeverancePayFundNoncurrent" xlink:label="locator_cgen_SeverancePayFundNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_SeverancePayFundNoncurrent" xml:lang="en-US">Severance pay fund</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_SeverancePayFundNoncurrent" xml:lang="en-US">Monthly deposits in externally managed funds which primarily cover Israeli law severance pay liability of one month's salary for each year of employment upon the retirement or death of an employee or termination of employment without a valid legal reason.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_SeverancePayFundNoncurrent" xlink:to="label_cgen_SeverancePayFundNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="locator_us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Operating lease right to use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="label_us-gaap_OperatingLeaseRightOfUseAsset"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="label_us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="locator_us-gaap_AssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_AssetsNoncurrent" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsNoncurrent" xml:lang="en-US">Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsNoncurrent" xlink:to="label_us-gaap_AssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="locator_us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_Assets" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_Assets" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_Assets" xlink:to="label_us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="locator_us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="label_us-gaap_LiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="locator_us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccountsPayableCurrent" xlink:to="label_us-gaap_AccountsPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" xlink:label="locator_cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" xml:lang="en-US">Short-term deferred participation in R&amp;D expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" xml:lang="en-US">Short term deferred participation in R&amp;amp;amp;amp;D expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" xlink:to="label_cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingLeaseLiabilityCurrent" xml:lang="en-US">Current maturity of operating lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="label_us-gaap_OperatingLeaseLiabilityCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="locator_us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Other accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:to="label_us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="locator_us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="label_us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="locator_us-gaap_LiabilitiesNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesNoncurrentAbstract" xml:lang="en-US">NON- CURRENT LIABILITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="label_us-gaap_LiabilitiesNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses" xlink:label="locator_cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses" xml:lang="en-US">Long-term deferred participation in R&amp;D expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses" xml:lang="en-US">Long term deferred participation in R&amp;amp;amp;amp;D expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses" xlink:to="label_cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingLeaseLiabilityNoncurrent" xml:lang="en-US">Long term operating lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="label_us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="locator_us-gaap_PostemploymentBenefitsLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xml:lang="en-US">Accrued severance pay</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:to="label_us-gaap_PostemploymentBenefitsLiabilityNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="locator_us-gaap_LiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_LiabilitiesNoncurrent" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesNoncurrent" xml:lang="en-US">Liabilities, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesNoncurrent" xlink:to="label_us-gaap_LiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="locator_us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES (NOTE 4)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommitmentsAndContingencies" xlink:to="label_us-gaap_CommitmentsAndContingencies"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="locator_us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">SHAREHOLDERS' EQUITY:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockholdersEquityAbstract" xlink:to="label_us-gaap_StockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="locator_us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockValue" xml:lang="en-US">Ordinary shares of NIS 0.01 par value per share: 200,000,000 shares authorized on June 30, 2021 and December 31, 2020; 83,917,929 and 83,675,856 shares issued and outstanding on June 30, 2021 and December 31, 2020, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockValue" xlink:to="label_us-gaap_CommonStockValue"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="locator_us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="label_us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US">Accumulated other comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="locator_us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="label_us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Total shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Ordinary shares, par value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Ordinary shares, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="label_us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="locator_us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Ordinary shares, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockSharesAuthorized" xlink:to="label_us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="locator_us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Ordinary shares, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Ordinary shares, shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Balance, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Balance, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockSharesOutstanding" xlink:to="label_us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="locator_us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="label_us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="locator_us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingExpensesAbstract" xlink:to="label_us-gaap_OperatingExpensesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ResearchAndDevelopmentExpense" xlink:to="label_us-gaap_ResearchAndDevelopmentExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDevelopment" xlink:label="locator_us-gaap_BusinessDevelopment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_BusinessDevelopment" xml:lang="en-US">Marketing and business development expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_BusinessDevelopment" xlink:to="label_us-gaap_BusinessDevelopment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpense" xlink:to="label_us-gaap_GeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="locator_us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_OperatingExpenses" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingExpenses" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingExpenses" xlink:to="label_us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_FinancialAndOtherIncomeNet" xlink:label="locator_cgen_FinancialAndOtherIncomeNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_FinancialAndOtherIncomeNet" xml:lang="en-US">Financial and other income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_cgen_FinancialAndOtherIncomeNet" xml:lang="en-US">Financial and other income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_FinancialAndOtherIncomeNet" xml:lang="en-US">The aggregate of financial and other income net of expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_FinancialAndOtherIncomeNet" xlink:to="label_cgen_FinancialAndOtherIncomeNet"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Loss before taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="locator_us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeTaxExpenseBenefit" xlink:to="label_us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="label_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetIncomeLoss" xlink:to="label_us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="locator_us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Basic and diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="label_us-gaap_EarningsPerShareBasicAndDiluted"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="locator_us-gaap_ComprehensiveIncomeNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="label_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US">Total comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="label_us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted average number of ordinary shares used in computing basic and diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementTable" xlink:to="label_us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="locator_us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="label_us-gaap_StatementEquityComponentsAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="locator_us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockMember" xml:lang="en-US">Ordinary shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockMember" xlink:to="label_us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="locator_us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional paid-in capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdditionalPaidInCapitalMember" xlink:to="label_us-gaap_AdditionalPaidInCapitalMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="locator_us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RetainedEarningsMember" xml:lang="en-US">Accumulated deficit [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RetainedEarningsMember" xlink:to="label_us-gaap_RetainedEarningsMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="label_us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xml:lang="en-US">Options exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Options exercised, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="locator_cgen_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_StockIssuedDuringPeriodValueWarrantsExercised" xml:lang="en-US">Warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_StockIssuedDuringPeriodValueWarrantsExercised" xml:lang="en-US">Value of stock issued as a result of the exercise of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="label_cgen_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_NumberOfWarrantsExercised" xlink:label="locator_cgen_NumberOfWarrantsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_NumberOfWarrantsExercised" xml:lang="en-US">Warrants exercised, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_NumberOfWarrantsExercised" xml:lang="en-US">Number of warrants exercised.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_NumberOfWarrantsExercised" xlink:to="label_cgen_NumberOfWarrantsExercised"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Issuance of shares, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Issuance of shares, net, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xml:lang="en-US">Issuance of ordinary shares pursuant to the ESPP</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xml:lang="en-US">Issuance of ordinary shares pursuant to the ESPP, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xml:lang="en-US">Stock-based compensation issued to employees, directors and non-employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="locator_us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="label_us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments required to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="locator_us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensation" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensation" xlink:to="label_us-gaap_ShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="locator_us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_Depreciation" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_Depreciation" xlink:to="label_us-gaap_Depreciation"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_SeverancePayNet" xlink:label="locator_cgen_SeverancePayNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_SeverancePayNet" xml:lang="en-US">Increase (decrease) in severance pay, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_SeverancePayNet" xml:lang="en-US">Severance pay, net.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_SeverancePayNet" xlink:to="label_cgen_SeverancePayNet"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="locator_us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xml:lang="en-US">Gain from property and equipment disposal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="label_us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:label="locator_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xml:lang="en-US">Decrease in operating lease right of use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xml:lang="en-US">Decrease in operating lease right of use asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xml:lang="en-US">Operating Leases, Future Minimum Payments Due After Year Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:to="label_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="locator_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xml:lang="en-US">Decrease (increase) in interest receivables from short-term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xml:lang="en-US">Increase (Decrease) in Accrued Interest Receivable, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="label_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Decrease in trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Decrease in other accounts receivable and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Increase in long-term prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="label_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xml:lang="en-US">Increase in trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Increase in other accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xml:lang="en-US">Decrease in operating lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" xlink:label="locator_cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" xml:lang="en-US">Decrease in deferred participation in R&amp;D expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" xml:lang="en-US">Increase (decrease) in deferred participation in R&amp;amp;amp;amp;D expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" xlink:to="label_cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:label="locator_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xml:lang="en-US">Proceeds from maturity of short-term bank deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:to="label_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="locator_us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_PaymentsToAcquireShortTermInvestments" xml:lang="en-US">Investment in short-term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PaymentsToAcquireShortTermInvestments" xml:lang="en-US">Payments to Acquire Short-term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="label_us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="locator_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xml:lang="en-US">Proceeds from sales of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="label_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net cash provided by (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="locator_us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Proceeds from issuance of ordinary shares, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="locator_us-gaap_ProceedsFromWarrantExercises"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromWarrantExercises" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_ProceedsFromWarrantExercises" xml:lang="en-US">Proceeds from warrant exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromWarrantExercises" xlink:to="label_us-gaap_ProceedsFromWarrantExercises"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="locator_us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromStockOptionsExercised" xml:lang="en-US">Proceeds from exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="label_us-gaap_ProceedsFromStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xml:lang="en-US">Increase in cash, cash equivalents and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="locator_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="locator_us-gaap_FairValueOfAssetsAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_FairValueOfAssetsAcquired" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_FairValueOfAssetsAcquired" xlink:to="label_us-gaap_FairValueOfAssetsAcquired"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ReceivablesOnAccountOfShares" xlink:label="locator_cgen_ReceivablesOnAccountOfShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_ReceivablesOnAccountOfShares" xml:lang="en-US">Receivables on account of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_ReceivablesOnAccountOfShares" xml:lang="en-US">Receivables on account of shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_ReceivablesOnAccountOfShares" xlink:to="label_cgen_ReceivablesOnAccountOfShares"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">GENERAL [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xml:lang="en-US">GENERAL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="label_us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="locator_us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="label_us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract" xlink:label="locator_cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract" xml:lang="en-US">Unaudited Interim Consolidated Financial Statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract" xlink:to="label_cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock" xlink:label="locator_cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock" xml:lang="en-US">UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock" xml:lang="en-US">The entire disclosure of unaudited interim consolidated financial statements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock" xml:lang="en-US">Unaudited Interim Consolidated Financial Statements Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock" xlink:to="label_cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="locator_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US">SHAREHOLDERS' EQUITY [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="label_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="locator_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xml:lang="en-US">SHAREHOLDERS' EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="label_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="locator_us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US">TAXES ON INCOME [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="label_us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="locator_us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">TAXES ON INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="label_us-gaap_IncomeTaxDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="locator_us-gaap_OtherIncomeAndExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OtherIncomeAndExpensesAbstract" xml:lang="en-US">FINANCIAL AND OTHER INCOME, NET [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_OtherIncomeAndExpensesAbstract" xml:lang="en-US">Other Income and Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="label_us-gaap_OtherIncomeAndExpensesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:label="locator_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="label_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xml:lang="en-US">FINANCIAL AND OTHER INCOME, NET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="label_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="locator_us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">RELATED PARTY BALANCES AND TRANSACTIONS [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="label_us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">RELATED PARTY BALANCES AND TRANSACTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="locator_us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration of credit risks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ConcentrationRiskCreditRisk" xlink:to="label_us-gaap_ConcentrationRiskCreditRisk"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US">Stock-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="locator_us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="label_us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="locator_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">Recently adopted accounting pronouncements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="locator_cgen_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xml:lang="en-US">Recently issued accounting pronouncements, not yet adopted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xml:lang="en-US">Disclosure of accounting policy pertaining to new accounting pronouncements not yet adopted, that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:to="label_cgen_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="locator_us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Basic and diluted loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="label_us-gaap_EarningsPerSharePolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="locator_us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="label_us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="locator_us-gaap_EmployeeStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EmployeeStockMember" xml:lang="en-US">Employee Stock Purchase Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EmployeeStockMember" xlink:to="label_us-gaap_EmployeeStockMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US">Schedule of Weighted-average Assumptions Used to Estimate Fair Value of Options Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncomeTableTextBlock" xlink:label="locator_us-gaap_InterestAndOtherIncomeTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_InterestAndOtherIncomeTableTextBlock" xml:lang="en-US">Schedule of Financial And Other Income, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_InterestAndOtherIncomeTableTextBlock" xlink:to="label_us-gaap_InterestAndOtherIncomeTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RelatedPartyBalancesAndTransactionsTablesAbstract" xlink:label="locator_cgen_RelatedPartyBalancesAndTransactionsTablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_RelatedPartyBalancesAndTransactionsTablesAbstract" xml:lang="en-US">Related Party Balances And Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_RelatedPartyBalancesAndTransactionsTablesAbstract" xlink:to="label_cgen_RelatedPartyBalancesAndTransactionsTablesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xml:lang="en-US">Schedule of Related Party Balances and Transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:label="locator_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xml:lang="en-US">Percentage of workforce reduction from restructuring activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:to="label_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:label="locator_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xml:lang="en-US">Upfront payment received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:to="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation" xlink:label="locator_cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation" xml:lang="en-US">Development, regulatory and commercial milestones compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation" xml:lang="en-US">Development, regulatory and commercial milestones compensation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation" xlink:to="label_cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ResearchAndDevelopmentArrangementPaymentsReceivable" xlink:label="locator_cgen_ResearchAndDevelopmentArrangementPaymentsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="label_cgen_ResearchAndDevelopmentArrangementPaymentsReceivable" xml:lang="en-US">Potential milestone compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_ResearchAndDevelopmentArrangementPaymentsReceivable" xml:lang="en-US">Potential milestone revenue from arrangements for research and development, including collaboration and licenses agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_ResearchAndDevelopmentArrangementPaymentsReceivable" xml:lang="en-US">Retainer Fee [Default Label]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_ResearchAndDevelopmentArrangementPaymentsReceivable" xlink:to="label_cgen_ResearchAndDevelopmentArrangementPaymentsReceivable"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable" xlink:label="locator_cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable" xml:lang="en-US">Additional milestone compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable" xml:lang="en-US">Addition Potential milestone revenue from arrangements for research and development, including collaboration and licenses agreements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable" xlink:to="label_cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable" xlink:label="locator_cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable" xml:lang="en-US">Preclinical milestone compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable" xml:lang="en-US">Potential milestone revenue for preclinical stages of research from arrangements for research and development, including collaboration and licenses agreements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable" xlink:to="label_cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram" xlink:label="locator_cgen_ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram" xml:lang="en-US">Potential milestone compensation company is now eligible for</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram" xml:lang="en-US">Potential milestone compensation company is now eligible for.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram" xlink:to="label_cgen_ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue" xlink:label="locator_us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue" xml:lang="en-US">Amount of investment in Compugen</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue" xlink:to="label_us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsTable" xlink:label="locator_cgen_GovernmentAndOtherGrantsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_GovernmentAndOtherGrantsTable" xml:lang="en-US">Government and Other Grants [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_GovernmentAndOtherGrantsTable" xml:lang="en-US">Government And Other Grants [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="label_cgen_GovernmentAndOtherGrantsTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:label="locator_us-gaap_GuaranteeObligationsByNatureAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GuaranteeObligationsByNatureAxis" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="label_us-gaap_GuaranteeObligationsByNatureAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyLeaseGuaranteeMember" xlink:label="locator_us-gaap_PropertyLeaseGuaranteeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PropertyLeaseGuaranteeMember" xml:lang="en-US">Office leases [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PropertyLeaseGuaranteeMember" xlink:to="label_us-gaap_PropertyLeaseGuaranteeMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="locator_srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_StatementGeographicalAxis" xml:lang="en-US">Statement Geographical [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_srt_StatementGeographicalAxis" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_StatementGeographicalAxis" xlink:to="label_srt_StatementGeographicalAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:label="locator_country_IL"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_country_IL" xml:lang="en-US">Israel [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_country_IL" xlink:to="label_country_IL"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesByNatureAxis" xlink:label="locator_us-gaap_GainContingenciesByNatureAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GainContingenciesByNatureAxis" xml:lang="en-US">Gain Contingencies, Nature [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GainContingenciesByNatureAxis" xlink:to="label_us-gaap_GainContingenciesByNatureAxis"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsMember" xlink:label="locator_cgen_GovernmentAndOtherGrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_GovernmentAndOtherGrantsMember" xml:lang="en-US">Government and Other Grants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_GovernmentAndOtherGrantsMember" xml:lang="en-US">Government and Other Grants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_GovernmentAndOtherGrantsMember" xlink:to="label_cgen_GovernmentAndOtherGrantsMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="locator_srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_RangeAxis" xml:lang="en-US">Range [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_srt_RangeAxis" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_RangeAxis" xlink:to="label_srt_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="locator_srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_MinimumMember" xlink:to="label_srt_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="locator_srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_MaximumMember" xlink:to="label_srt_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsAxis" xlink:label="locator_cgen_GovernmentAndOtherGrantsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_GovernmentAndOtherGrantsAxis" xml:lang="en-US">Government and Other Grants [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_GovernmentAndOtherGrantsAxis" xml:lang="en-US">Government and Other Grants [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_GovernmentAndOtherGrantsAxis" xlink:to="label_cgen_GovernmentAndOtherGrantsAxis"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_May2012AgreementMember" xlink:label="locator_cgen_May2012AgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_May2012AgreementMember" xml:lang="en-US">May 2012 Agreement With Advisor [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_May2012AgreementMember" xml:lang="en-US">Information pertaining to the May 2012 Agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_May2012AgreementMember" xlink:to="label_cgen_May2012AgreementMember"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_CommercialLicenseAgreementMember" xlink:label="locator_cgen_CommercialLicenseAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_CommercialLicenseAgreementMember" xml:lang="en-US">Commercial License Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_CommercialLicenseAgreementMember" xml:lang="en-US">Commercial License Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_CommercialLicenseAgreementMember" xlink:to="label_cgen_CommercialLicenseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentAxis" xlink:label="locator_us-gaap_SupplyCommitmentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SupplyCommitmentAxis" xml:lang="en-US">Supply Commitment [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SupplyCommitmentAxis" xlink:to="label_us-gaap_SupplyCommitmentAxis"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_CollaborationAgreementWithUSAntibodyCompanyMember" xlink:label="locator_cgen_CollaborationAgreementWithUSAntibodyCompanyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_CollaborationAgreementWithUSAntibodyCompanyMember" xml:lang="en-US">Collaboration Agreement With U.S. Antibody Company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_CollaborationAgreementWithUSAntibodyCompanyMember" xml:lang="en-US">Collaboration Agreement With U.S. Antibody Company [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_CollaborationAgreementWithUSAntibodyCompanyMember" xlink:to="label_cgen_CollaborationAgreementWithUSAntibodyCompanyMember"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsLineItems" xlink:label="locator_cgen_GovernmentAndOtherGrantsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_GovernmentAndOtherGrantsLineItems" xml:lang="en-US">Government and Other Grants [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_GovernmentAndOtherGrantsLineItems" xml:lang="en-US">Government And Other Grants [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="label_cgen_GovernmentAndOtherGrantsLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure" xlink:label="locator_us-gaap_GuaranteeObligationsMaximumExposure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GuaranteeObligationsMaximumExposure" xml:lang="en-US">Bank guarantees in favor of lessor, foreign currency derivative contracts and credit card security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="label_us-gaap_GuaranteeObligationsMaximumExposure"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RoyaltyPercentageBasedOnFutureRevenues" xlink:label="locator_cgen_RoyaltyPercentageBasedOnFutureRevenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_RoyaltyPercentageBasedOnFutureRevenues" xml:lang="en-US">Royalty percentage based on future revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_RoyaltyPercentageBasedOnFutureRevenues" xml:lang="en-US">Royalty Percentage Based On Future Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_RoyaltyPercentageBasedOnFutureRevenues" xlink:to="label_cgen_RoyaltyPercentageBasedOnFutureRevenues"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived" xlink:label="locator_cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived" xml:lang="en-US">Maximum royalty repaid as percentage of grant received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived" xml:lang="en-US">Maximum Royalty Repaid As Percentage Of Grant Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived" xlink:to="label_cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RoyaltyContingentObligations" xlink:label="locator_cgen_RoyaltyContingentObligations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_RoyaltyContingentObligations" xml:lang="en-US">Contingent royalty obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_RoyaltyContingentObligations" xml:lang="en-US">The contingent obligations for payments based on royalty-bearing participation received or accrued, net of royalties paid or accrued.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_RoyaltyContingentObligations" xlink:to="label_cgen_RoyaltyContingentObligations"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ContingentFees" xlink:label="locator_cgen_ContingentFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_ContingentFees" xml:lang="en-US">Contingent fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_ContingentFees" xml:lang="en-US">Contingent fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_ContingentFees" xlink:to="label_cgen_ContingentFees"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ParticipationRights" xlink:label="locator_cgen_ParticipationRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_ParticipationRights" xml:lang="en-US">Participation Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_ParticipationRights" xml:lang="en-US">Percentage of the cash consideration received by the Company or its affiliates from third parties to be paid back to advisor.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_ParticipationRights" xlink:to="label_cgen_ParticipationRights"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RetainerFee" xlink:label="locator_cgen_RetainerFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_RetainerFee" xml:lang="en-US">Retainer Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_RetainerFee" xml:lang="en-US">Retainer fee per month.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_RetainerFee" xlink:to="label_cgen_RetainerFee"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="locator_us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US">Issuance expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="label_us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AgreementStartDate" xlink:label="locator_cgen_AgreementStartDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_AgreementStartDate" xml:lang="en-US">Agreement, start date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_AgreementStartDate" xml:lang="en-US">Start date of the agreement, in CCYY-MM-DD format.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_AgreementStartDate" xlink:to="label_cgen_AgreementStartDate"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AgreementTerminationDescription" xlink:label="locator_cgen_AgreementTerminationDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_AgreementTerminationDescription" xml:lang="en-US">Agreement termination description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_AgreementTerminationDescription" xml:lang="en-US">Agreement termination description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_AgreementTerminationDescription" xlink:to="label_cgen_AgreementTerminationDescription"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_PercentageOfRoyaltiesOnNetSales" xlink:label="locator_cgen_PercentageOfRoyaltiesOnNetSales"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_PercentageOfRoyaltiesOnNetSales" xml:lang="en-US">Percentage of royalties on net sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_PercentageOfRoyaltiesOnNetSales" xml:lang="en-US">Percentage of royalties on net sales.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_PercentageOfRoyaltiesOnNetSales" xlink:to="label_cgen_PercentageOfRoyaltiesOnNetSales"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AmountIncurredMilestonePayments" xlink:label="locator_cgen_AmountIncurredMilestonePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_AmountIncurredMilestonePayments" xml:lang="en-US">Amount incurred milestone payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_AmountIncurredMilestonePayments" xml:lang="en-US">Amount incurred milestone payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_AmountIncurredMilestonePayments" xlink:to="label_cgen_AmountIncurredMilestonePayments"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="locator_srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_StatementScenarioAxis" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_StatementScenarioAxis" xlink:to="label_srt_StatementScenarioAxis"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AtTheMarketOfferingProgramMember" xlink:label="locator_cgen_AtTheMarketOfferingProgramMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_AtTheMarketOfferingProgramMember" xml:lang="en-US">At The Market Offering Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_AtTheMarketOfferingProgramMember" xml:lang="en-US">At The Market Offering Program [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_AtTheMarketOfferingProgramMember" xlink:to="label_cgen_AtTheMarketOfferingProgramMember"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AgreementMember" xlink:label="locator_cgen_AgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_AgreementMember" xml:lang="en-US">Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_AgreementMember" xml:lang="en-US">Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_AgreementMember" xlink:to="label_cgen_AgreementMember"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_MasterClinicalAgreementMember" xlink:label="locator_cgen_MasterClinicalAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_MasterClinicalAgreementMember" xml:lang="en-US">Master Clinical Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_MasterClinicalAgreementMember" xml:lang="en-US">Master Clinical Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_MasterClinicalAgreementMember" xlink:to="label_cgen_MasterClinicalAgreementMember"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_CollaborativeArrangementsMember" xlink:label="locator_cgen_CollaborativeArrangementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_CollaborativeArrangementsMember" xml:lang="en-US">Collaborative Arrangements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_CollaborativeArrangementsMember" xml:lang="en-US">Collaborative Arrangements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_CollaborativeArrangementsMember" xlink:to="label_cgen_CollaborativeArrangementsMember"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" xlink:label="locator_cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" xml:lang="en-US">SVB Leerink LLC and Stifel, Nicolaus &amp; Company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" xml:lang="en-US">SVB Leerink LLC and Stifel, Nicolaus &amp;amp; Company [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" xlink:to="label_cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="locator_us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AwardTypeAxis" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AwardTypeAxis" xlink:to="label_us-gaap_AwardTypeAxis"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RegisteredDirectOfferingMember" xlink:label="locator_cgen_RegisteredDirectOfferingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_RegisteredDirectOfferingMember" xml:lang="en-US">Registered direct offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_RegisteredDirectOfferingMember" xml:lang="en-US">Registered direct offering [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_RegisteredDirectOfferingMember" xlink:to="label_cgen_RegisteredDirectOfferingMember"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_UnderwritersMember" xlink:label="locator_cgen_UnderwritersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_UnderwritersMember" xml:lang="en-US">Underwriters [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_UnderwritersMember" xml:lang="en-US">Underwriters [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_UnderwritersMember" xlink:to="label_cgen_UnderwritersMember"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock" xlink:label="locator_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Proceeds from issuance of common stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Maximum authorized proceeds from issuance of common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock" xlink:to="label_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="locator_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Warrants purchase to ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="locator_us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Offering price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SharesIssuedPricePerShare" xlink:to="label_us-gaap_SharesIssuedPricePerShare"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="locator_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Exercise price of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable" xlink:label="locator_cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable" xml:lang="en-US">Expiration period of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable" xml:lang="en-US">Expiration period of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable" xlink:to="label_cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="locator_us-gaap_EquityMethodInvestmentAggregateCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EquityMethodInvestmentAggregateCost" xml:lang="en-US">Equity investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="label_us-gaap_EquityMethodInvestmentAggregateCost"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_PercentageOfClosingPrice" xlink:label="locator_cgen_PercentageOfClosingPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_PercentageOfClosingPrice" xml:lang="en-US">Percentage of closing price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_PercentageOfClosingPrice" xml:lang="en-US">Percentage of closing price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_PercentageOfClosingPrice" xlink:to="label_cgen_PercentageOfClosingPrice"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_DeferredParticipationOfBmsInRdExpenses" xlink:label="locator_cgen_DeferredParticipationOfBmsInRdExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cgen_DeferredParticipationOfBmsInRdExpenses" xml:lang="en-US">Deferred participation of BMS in R&amp;D expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cgen_DeferredParticipationOfBmsInRdExpenses" xml:lang="en-US">Deferred participation of BMS in R&amp;amp;amp;amp;D expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cgen_DeferredParticipationOfBmsInRdExpenses" xlink:to="label_cgen_DeferredParticipationOfBmsInRdExpenses"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="locator_us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Warrants purchase to ordinary shares remain outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="label_us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="locator_us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xml:lang="en-US">Proceeds from ordinary shares in offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="label_us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xml:lang="en-US">Options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US">Ordinary shares available for issuance | shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Stock options granted, exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xml:lang="en-US">Stock options granted, exercise price, minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xml:lang="en-US">Stock options granted, exercise price, maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US">Vesting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xml:lang="en-US">Expected volatility, minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xml:lang="en-US">Expected volatility, maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xml:lang="en-US">Expected risk free interest rates range, minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xml:lang="en-US">Expected risk free interest rate range, maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Expected life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted average fair value of options granted during period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="locator_us-gaap_StockOptionPlanExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockOptionPlanExpense" xml:lang="en-US">Share based compensation stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockOptionPlanExpense" xlink:to="label_us-gaap_StockOptionPlanExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="locator_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xml:lang="en-US">Share based compensation ESPP</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:to="label_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xml:lang="en-US">Unrecognized compensation cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US">Period over which compensation expense will be recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Total weighted average number of shares related to outstanding options and warrants excluded from the calculations of diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:label="locator_us-gaap_InterestIncomeDepositsWithFinancialInstitutions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:to="label_us-gaap_InterestIncomeDepositsWithFinancialInstitutions"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="locator_us-gaap_GainLossOnInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GainLossOnInvestments" xml:lang="en-US">Income from sales of marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GainLossOnInvestments" xlink:to="label_us-gaap_GainLossOnInvestments"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="locator_us-gaap_OtherNonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="label_us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US">Exchange rate differences and other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US">Other Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="label_us-gaap_OtherNonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xml:lang="en-US">Trade and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="label_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="locator_us-gaap_CostsAndExpensesRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CostsAndExpensesRelatedParty" xml:lang="en-US">Related parties' expenses amounts charged to research and development expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CostsAndExpensesRelatedParty" xlink:to="label_us-gaap_CostsAndExpensesRelatedParty"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>cgen-20210630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <roleRef roleURI="http://cgen.com/role/cgen-daei1" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-daei1"/>
  <roleRef roleURI="http://cgen.com/role/cgen-cbs" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-cbs"/>
  <roleRef roleURI="http://cgen.com/role/cgen-cbsp" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-cbsp"/>
  <roleRef roleURI="http://cgen.com/role/cgen-csocl" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-csocl"/>
  <roleRef roleURI="http://cgen.com/role/cgen-socise1" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-socise1"/>
  <roleRef roleURI="http://cgen.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="cgen-20210630.xsd#ConsolidatedStatementsOfCashFlows"/>
  <roleRef roleURI="http://cgen.com/role/cgen-g" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-g"/>
  <roleRef roleURI="http://cgen.com/role/cgen-sap1" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-sap1"/>
  <roleRef roleURI="http://cgen.com/role/UnauditedInterimConsolidatedFinancialStatements" xlink:type="simple" xlink:href="cgen-20210630.xsd#UnauditedInterimConsolidatedFinancialStatements"/>
  <roleRef roleURI="http://cgen.com/role/cgen-cac" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-cac"/>
  <roleRef roleURI="http://cgen.com/role/cgen-se1" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-se1"/>
  <roleRef roleURI="http://cgen.com/role/TaxesOnIncome" xlink:type="simple" xlink:href="cgen-20210630.xsd#TaxesOnIncome"/>
  <roleRef roleURI="http://cgen.com/role/cgen-fin" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-fin"/>
  <roleRef roleURI="http://cgen.com/role/cgen-rpbat" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-rpbat"/>
  <roleRef roleURI="http://cgen.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="cgen-20210630.xsd#Disclosure-SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <roleRef roleURI="http://cgen.com/role/cgen-set" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-set"/>
  <roleRef roleURI="http://cgen.com/role/cgen-fint" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-fint"/>
  <roleRef roleURI="http://cgen.com/role/RelatedPartyBalancesAndTransactionsTables" xlink:type="simple" xlink:href="cgen-20210630.xsd#RelatedPartyBalancesAndTransactionsTables"/>
  <roleRef roleURI="http://cgen.com/role/cgen-gd1" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-gd1"/>
  <roleRef roleURI="http://cgen.com/role/CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="cgen-20210630.xsd#CommitmentsAndContingenciesDetails"/>
  <roleRef roleURI="http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails" xlink:type="simple" xlink:href="cgen-20210630.xsd#ShareholdersEquityIssuanceOfSharesDetails"/>
  <roleRef roleURI="http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails" xlink:type="simple" xlink:href="cgen-20210630.xsd#ShareholdersEquityScheduleOfStock-basedCompensationDetails"/>
  <roleRef roleURI="http://cgen.com/role/cgen-find" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-find"/>
  <roleRef roleURI="http://cgen.com/role/cgen-rpbatd" xlink:type="simple" xlink:href="cgen-20210630.xsd#cgen-rpbatd"/>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-daei1">
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_DocumentAndEntityInformationAbstract" xlink:label="locator_cgen_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="locator_dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityRegistrantName" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="locator_dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityCentralIndexKey" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="locator_dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_CurrentFiscalYearEndDate" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="locator_dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_DocumentType" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="locator_dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_AmendmentFlag" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="locator_dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_DocumentPeriodEndDate" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="locator_dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_DocumentFiscalPeriodFocus" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="locator_dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_DocumentFiscalYearFocus" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="locator_dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityFileNumber" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="locator_dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityIncorporationStateCountryCode" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="locator_dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityAddressAddressLine1" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="locator_dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityAddressAddressLine2" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="locator_dei_EntityAddressAddressLine3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityAddressAddressLine3" use="optional" priority="0" order="120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="locator_dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityAddressCityOrTown" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="locator_dei_EntityAddressCountry"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityAddressCountry" use="optional" priority="0" order="140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="locator_dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityAddressPostalZipCode" use="optional" priority="0" order="150"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-cbs">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="locator_us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="locator_us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_AssetsAbstract" use="optional" priority="0" order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="locator_us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_AssetsCurrentAbstract" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermInvestments" xlink:label="locator_us-gaap_OtherShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_OtherShortTermInvestments" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="locator_us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_AccountsReceivableNetCurrent" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="locator_us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_AssetsCurrent" use="optional" priority="0" order="70" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="locator_us-gaap_AssetsNoncurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_AssetsNoncurrentAbstract" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="locator_us-gaap_PrepaidExpenseNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="locator_us-gaap_PrepaidExpenseNoncurrent" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_SeverancePayFundNoncurrent" xlink:label="locator_cgen_SeverancePayFundNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="locator_cgen_SeverancePayFundNoncurrent" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="locator_us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="locator_us-gaap_OperatingLeaseRightOfUseAsset" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentNet" use="optional" priority="0" order="120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="locator_us-gaap_AssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="locator_us-gaap_AssetsNoncurrent" use="optional" priority="0" order="130" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="locator_us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_Assets" use="optional" priority="0" order="140" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" use="optional" priority="0" order="150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="locator_us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_LiabilitiesCurrentAbstract" use="optional" priority="0" order="160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="locator_us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_AccountsPayableCurrent" use="optional" priority="0" order="170"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" xlink:label="locator_cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses" use="optional" priority="0" order="180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_OperatingLeaseLiabilityCurrent" use="optional" priority="0" order="190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="locator_us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_OtherAccountsPayableAndAccruedLiabilities" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="locator_us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_LiabilitiesCurrent" use="optional" priority="0" order="210" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="locator_us-gaap_LiabilitiesNoncurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_LiabilitiesNoncurrentAbstract" use="optional" priority="0" order="220"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses" xlink:label="locator_cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="locator_cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses" use="optional" priority="0" order="230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="locator_us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" priority="0" order="240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="locator_us-gaap_PostemploymentBenefitsLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="locator_us-gaap_PostemploymentBenefitsLiabilityNoncurrent" use="optional" priority="0" order="250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="locator_us-gaap_LiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="locator_us-gaap_LiabilitiesNoncurrent" use="optional" priority="0" order="260" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="locator_us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_CommitmentsAndContingencies" use="optional" priority="0" order="270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="locator_us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_StockholdersEquityAbstract" use="optional" priority="0" order="280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="locator_us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityAbstract" xlink:to="locator_us-gaap_CommonStockValue" use="optional" priority="0" order="290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="locator_us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityAbstract" xlink:to="locator_us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" priority="0" order="300"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityAbstract" xlink:to="locator_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" priority="0" order="310"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="locator_us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityAbstract" xlink:to="locator_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" priority="0" order="320"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityAbstract" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="330" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_LiabilitiesAndStockholdersEquity" use="optional" priority="0" order="340" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-cbsp">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="locator_us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_CommonStockParOrStatedValuePerShare" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="locator_us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_CommonStockSharesAuthorized" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="locator_us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_CommonStockSharesIssued" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_CommonStockSharesOutstanding" use="optional" priority="0" order="30"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-csocl">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="locator_us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="locator_us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_OperatingExpensesAbstract" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OperatingExpensesAbstract" xlink:to="locator_us-gaap_ResearchAndDevelopmentExpense" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDevelopment" xlink:label="locator_us-gaap_BusinessDevelopment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OperatingExpensesAbstract" xlink:to="locator_us-gaap_BusinessDevelopment" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OperatingExpensesAbstract" xlink:to="locator_us-gaap_GeneralAndAdministrativeExpense" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="locator_us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OperatingExpensesAbstract" xlink:to="locator_us-gaap_OperatingExpenses" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_FinancialAndOtherIncomeNet" xlink:label="locator_cgen_FinancialAndOtherIncomeNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_cgen_FinancialAndOtherIncomeNet" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" use="optional" priority="0" order="60" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="locator_us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_IncomeTaxExpenseBenefit" use="optional" priority="0" order="70" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="80" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="locator_us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_EarningsPerShareBasicAndDiluted" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="locator_us-gaap_ComprehensiveIncomeNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_ComprehensiveIncomeNetOfTax" use="optional" priority="0" order="100" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" use="optional" priority="0" order="110"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-socise1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="locator_us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="locator_us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementEquityComponentsAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="locator_us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_CommonStockMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="locator_us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_AdditionalPaidInCapitalMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="locator_us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_RetainedEarningsMember" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="locator_us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_EquityComponentDomain" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesOutstanding" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="locator_cgen_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_StockIssuedDuringPeriodValueWarrantsExercised" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_NumberOfWarrantsExercised" xlink:label="locator_cgen_NumberOfWarrantsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_NumberOfWarrantsExercised" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity_3756f562-5c13-f2aa-ca89-b17f61b6fa10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockholdersEquity_3756f562-5c13-f2aa-ca89-b17f61b6fa10" use="optional" priority="0" order="130" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding_5cfa01c4-c70d-e6dc-9c83-23b76c7e26e2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesOutstanding_5cfa01c4-c70d-e6dc-9c83-23b76c7e26e2" use="optional" priority="0" order="140" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/ConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="locator_us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="locator_us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_ShareBasedCompensation" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="locator_us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_Depreciation" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_SeverancePayNet" xlink:label="locator_cgen_SeverancePayNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_cgen_SeverancePayNet" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="locator_us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" use="optional" priority="0" order="60" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:label="locator_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" use="optional" priority="0" order="70" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="locator_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" use="optional" priority="0" order="80" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsReceivable" use="optional" priority="0" order="90" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" priority="0" order="100" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInPrepaidExpense" use="optional" priority="0" order="110" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade" use="optional" priority="0" order="120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" use="optional" priority="0" order="140"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" xlink:label="locator_cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses" use="optional" priority="0" order="150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" priority="0" order="160" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" use="optional" priority="0" order="170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:label="locator_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="locator_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" use="optional" priority="0" order="180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="locator_us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="locator_us-gaap_PaymentsToAcquireShortTermInvestments" use="optional" priority="0" order="190" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" priority="0" order="200" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="locator_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="locator_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" use="optional" priority="0" order="210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" priority="0" order="220" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" use="optional" priority="0" order="230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="locator_us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="locator_us-gaap_ProceedsFromIssuanceOfCommonStock" use="optional" priority="0" order="240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="locator_us-gaap_ProceedsFromWarrantExercises"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="locator_us-gaap_ProceedsFromWarrantExercises" use="optional" priority="0" order="250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="locator_us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="locator_us-gaap_ProceedsFromStockOptionsExercised" use="optional" priority="0" order="260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" priority="0" order="270" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" use="optional" priority="0" order="280" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" use="optional" priority="0" order="290" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19fb325e-092f-e23a-3a74-11fbee83bd9d"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19fb325e-092f-e23a-3a74-11fbee83bd9d" use="optional" priority="0" order="300" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="locator_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" use="optional" priority="0" order="310"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="locator_us-gaap_FairValueOfAssetsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="locator_us-gaap_FairValueOfAssetsAcquired" use="optional" priority="0" order="320"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ReceivablesOnAccountOfShares" xlink:label="locator_cgen_ReceivablesOnAccountOfShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="locator_cgen_ReceivablesOnAccountOfShares" use="optional" priority="0" order="330"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-g">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" use="optional" priority="0" order="10"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-sap1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="locator_us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_SignificantAccountingPoliciesTextBlock" use="optional" priority="0" order="10"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/UnauditedInterimConsolidatedFinancialStatements">
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract" xlink:label="locator_cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock" xlink:label="locator_cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract" xlink:to="locator_cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock" use="optional" priority="0" order="0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-cac">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="locator_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="locator_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" use="optional" priority="0" order="10"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-se1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="locator_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" use="optional" priority="0" order="10"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/TaxesOnIncome">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="locator_us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="locator_us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_us-gaap_IncomeTaxDisclosureTextBlock" use="optional" priority="0" order="10"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-fin">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="locator_us-gaap_OtherIncomeAndExpensesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:label="locator_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="locator_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-rpbat">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="locator_us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" use="optional" priority="0" order="10"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="locator_us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_ConcentrationRiskCreditRisk" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="locator_us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_RevenueRecognitionPolicyTextBlock" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="locator_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="locator_cgen_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_cgen_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="locator_us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_EarningsPerSharePolicyTextBlock" use="optional" priority="0" order="50"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-set">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="locator_us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_SubsidiarySaleOfStockAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="locator_us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="locator_us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="locator_us-gaap_EmployeeStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="locator_us-gaap_EmployeeStockMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-fint">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="locator_us-gaap_OtherIncomeAndExpensesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncomeTableTextBlock" xlink:label="locator_us-gaap_InterestAndOtherIncomeTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="locator_us-gaap_InterestAndOtherIncomeTableTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/RelatedPartyBalancesAndTransactionsTables">
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RelatedPartyBalancesAndTransactionsTablesAbstract" xlink:label="locator_cgen_RelatedPartyBalancesAndTransactionsTablesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_RelatedPartyBalancesAndTransactionsTablesAbstract" xlink:to="locator_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" use="optional" priority="0" order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-gd1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:label="locator_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="locator_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:label="locator_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="locator_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation" xlink:label="locator_cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="locator_cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ResearchAndDevelopmentArrangementPaymentsReceivable" xlink:label="locator_cgen_ResearchAndDevelopmentArrangementPaymentsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="locator_cgen_ResearchAndDevelopmentArrangementPaymentsReceivable" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable" xlink:label="locator_cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="locator_cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable" xlink:label="locator_cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="locator_cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram" xlink:label="locator_cgen_ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="locator_cgen_ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue" xlink:label="locator_us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="locator_us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue" use="optional" priority="0" order="70"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/CommitmentsAndContingenciesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsTable" xlink:label="locator_cgen_GovernmentAndOtherGrantsTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="locator_cgen_GovernmentAndOtherGrantsTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:label="locator_us-gaap_GuaranteeObligationsByNatureAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_us-gaap_GuaranteeObligationsByNatureAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:label="locator_us-gaap_GuaranteeObligationsNatureDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="locator_us-gaap_GuaranteeObligationsNatureDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyLeaseGuaranteeMember" xlink:label="locator_us-gaap_PropertyLeaseGuaranteeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GuaranteeObligationsNatureDomain" xlink:to="locator_us-gaap_PropertyLeaseGuaranteeMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="locator_srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_srt_StatementGeographicalAxis" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="locator_srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_StatementGeographicalAxis" xlink:to="locator_srt_SegmentGeographicalDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:label="locator_country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_SegmentGeographicalDomain" xlink:to="locator_country_IL" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesByNatureAxis" xlink:label="locator_us-gaap_GainContingenciesByNatureAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_us-gaap_GainContingenciesByNatureAxis" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingencyNatureDomain" xlink:label="locator_us-gaap_GainContingencyNatureDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GainContingenciesByNatureAxis" xlink:to="locator_us-gaap_GainContingencyNatureDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsMember" xlink:label="locator_cgen_GovernmentAndOtherGrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GainContingencyNatureDomain" xlink:to="locator_cgen_GovernmentAndOtherGrantsMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="locator_srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_srt_RangeAxis" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="locator_srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_RangeAxis" xlink:to="locator_srt_RangeMember" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="locator_srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MinimumMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="locator_srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MaximumMember" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsAxis" xlink:label="locator_cgen_GovernmentAndOtherGrantsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_cgen_GovernmentAndOtherGrantsAxis" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsDomain" xlink:label="locator_cgen_GovernmentAndOtherGrantsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsAxis" xlink:to="locator_cgen_GovernmentAndOtherGrantsDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_May2012AgreementMember" xlink:label="locator_cgen_May2012AgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsDomain" xlink:to="locator_cgen_May2012AgreementMember" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_CommercialLicenseAgreementMember" xlink:label="locator_cgen_CommercialLicenseAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsDomain" xlink:to="locator_cgen_CommercialLicenseAgreementMember" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentAxis" xlink:label="locator_us-gaap_SupplyCommitmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_us-gaap_SupplyCommitmentAxis" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember" xlink:label="locator_us-gaap_SupplyCommitmentArrangementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SupplyCommitmentAxis" xlink:to="locator_us-gaap_SupplyCommitmentArrangementMember" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_CollaborationAgreementWithUSAntibodyCompanyMember" xlink:label="locator_cgen_CollaborationAgreementWithUSAntibodyCompanyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SupplyCommitmentArrangementMember" xlink:to="locator_cgen_CollaborationAgreementWithUSAntibodyCompanyMember" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_GovernmentAndOtherGrantsLineItems" xlink:label="locator_cgen_GovernmentAndOtherGrantsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsTable" xlink:to="locator_cgen_GovernmentAndOtherGrantsLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure" xlink:label="locator_us-gaap_GuaranteeObligationsMaximumExposure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_us-gaap_GuaranteeObligationsMaximumExposure" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RoyaltyPercentageBasedOnFutureRevenues" xlink:label="locator_cgen_RoyaltyPercentageBasedOnFutureRevenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_RoyaltyPercentageBasedOnFutureRevenues" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived" xlink:label="locator_cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RoyaltyContingentObligations" xlink:label="locator_cgen_RoyaltyContingentObligations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_RoyaltyContingentObligations" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ContingentFees" xlink:label="locator_cgen_ContingentFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_ContingentFees" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ParticipationRights" xlink:label="locator_cgen_ParticipationRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_ParticipationRights" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RetainerFee" xlink:label="locator_cgen_RetainerFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_RetainerFee" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="locator_us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_us-gaap_PaymentsOfStockIssuanceCosts" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AgreementStartDate" xlink:label="locator_cgen_AgreementStartDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_AgreementStartDate" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AgreementTerminationDescription" xlink:label="locator_cgen_AgreementTerminationDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_AgreementTerminationDescription" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_PercentageOfRoyaltiesOnNetSales" xlink:label="locator_cgen_PercentageOfRoyaltiesOnNetSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_PercentageOfRoyaltiesOnNetSales" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AmountIncurredMilestonePayments" xlink:label="locator_cgen_AmountIncurredMilestonePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cgen_GovernmentAndOtherGrantsLineItems" xlink:to="locator_cgen_AmountIncurredMilestonePayments" use="optional" priority="0" order="110"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="locator_srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_srt_StatementScenarioAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="locator_srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_StatementScenarioAxis" xlink:to="locator_srt_ScenarioUnspecifiedDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AtTheMarketOfferingProgramMember" xlink:label="locator_cgen_AtTheMarketOfferingProgramMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_cgen_AtTheMarketOfferingProgramMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_AgreementMember" xlink:label="locator_cgen_AgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_cgen_AgreementMember" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_MasterClinicalAgreementMember" xlink:label="locator_cgen_MasterClinicalAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_cgen_MasterClinicalAgreementMember" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_CollaborativeArrangementsMember" xlink:label="locator_cgen_CollaborativeArrangementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_cgen_CollaborativeArrangementsMember" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" xlink:label="locator_cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="locator_us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_AwardTypeAxis" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AwardTypeAxis" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_RegisteredDirectOfferingMember" xlink:label="locator_cgen_RegisteredDirectOfferingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="locator_cgen_RegisteredDirectOfferingMember" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_UnderwritersMember" xlink:label="locator_cgen_UnderwritersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="locator_cgen_UnderwritersMember" use="optional" priority="0" order="150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockParOrStatedValuePerShare" use="optional" priority="0" order="0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock" xlink:label="locator_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="locator_us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_PaymentsOfStockIssuanceCosts" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="locator_us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesAuthorized" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="locator_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="locator_us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_SharesIssuedPricePerShare" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="locator_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable" xlink:label="locator_cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="locator_us-gaap_EquityMethodInvestmentAggregateCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_EquityMethodInvestmentAggregateCost" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_PercentageOfClosingPrice" xlink:label="locator_cgen_PercentageOfClosingPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_PercentageOfClosingPrice" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_DeferredParticipationOfBmsInRdExpenses" xlink:label="locator_cgen_DeferredParticipationOfBmsInRdExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cgen_DeferredParticipationOfBmsInRdExpenses" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="locator_us-gaap_ProceedsFromWarrantExercises"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ProceedsFromWarrantExercises" use="optional" priority="0" order="120" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="locator_us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ClassOfWarrantOrRightOutstanding" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="locator_us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_ProceedsFromIssuanceInitialPublicOffering" use="optional" priority="0" order="140"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="locator_srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="locator_srt_RangeAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="locator_srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_RangeAxis" xlink:to="locator_srt_RangeMember" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="locator_srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MinimumMember" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="locator_srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MaximumMember" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="locator_us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="locator_us-gaap_SubsidiarySaleOfStockAxis" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="locator_us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="locator_us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="locator_us-gaap_EmployeeStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="locator_us-gaap_EmployeeStockMember" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" use="optional" priority="0" order="120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="locator_us-gaap_StockOptionPlanExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_StockOptionPlanExpense" use="optional" priority="0" order="140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="locator_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" use="optional" priority="0" order="150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" use="optional" priority="0" order="160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" use="optional" priority="0" order="170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" use="optional" priority="0" order="180"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-find">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="locator_us-gaap_OtherIncomeAndExpensesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:label="locator_us-gaap_InterestIncomeDepositsWithFinancialInstitutions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="locator_us-gaap_InterestIncomeDepositsWithFinancialInstitutions" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="locator_us-gaap_GainLossOnInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="locator_us-gaap_GainLossOnInvestments" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="locator_us-gaap_OtherNonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="locator_us-gaap_OtherNonoperatingIncomeExpense" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:href="cgen-20210630.xsd#cgen_FinancialAndOtherIncomeNet" xlink:label="locator_cgen_FinancialAndOtherIncomeNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="locator_cgen_FinancialAndOtherIncomeNet" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cgen.com/role/cgen-rpbatd">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="locator_us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="locator_us-gaap_CostsAndExpensesRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_us-gaap_CostsAndExpensesRelatedParty" use="optional" priority="0" order="10"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ =P!2  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !O 1L# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8 %/HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQEC7MU% 'Q3_ ,*V\:_]"OJG_@.U?8F@:>ND>'=-TY5VBUM8X< =U4 UI44
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>cgen6k0621_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cgen="http://cgen.com/20210630"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cgen-20210630.xsd" xlink:type="simple"/>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2018-05-25_custom_AtTheMarketOfferingProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:AtTheMarketOfferingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-25</instant>
        </period>
    </context>
    <context id="AsOf2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:AgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cgen:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-14</instant>
        </period>
    </context>
    <context id="From2020-01-01to2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-01-01to2019-12-31_custom_AtTheMarketOfferingProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:AtTheMarketOfferingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-03-01to2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:SvbLeerinkLlcAndStifelNicolausAndCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-16</endDate>
        </period>
    </context>
    <context id="From2020-04-01to2020-04-14_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:SvbLeerinkLlcAndStifelNicolausAndCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cgen:UnderwritersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-14</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:SvbLeerinkLlcAndStifelNicolausAndCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2018-03-01to2018-03-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-30</endDate>
        </period>
    </context>
    <context id="From2013-08-01to2013-08-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
        </entity>
        <period>
            <startDate>2013-08-01</startDate>
            <endDate>2013-08-05</endDate>
        </period>
    </context>
    <context id="AsOf2013-08-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
        </entity>
        <period>
            <instant>2013-08-05</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_PropertyLeaseGuaranteeMember_country_IL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:PropertyLeaseGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">cgen:GovernmentAndOtherGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">cgen:GovernmentAndOtherGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">cgen:GovernmentAndOtherGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_GovernmentAndOtherGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">cgen:GovernmentAndOtherGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_custom_May2012AgreementMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cgen:GovernmentAndOtherGrantsAxis">cgen:May2012AgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_custom_May2012AgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cgen:GovernmentAndOtherGrantsAxis">cgen:May2012AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2018-01-01to2018-01-05_custom_CommercialLicenseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cgen:GovernmentAndOtherGrantsAxis">cgen:CommercialLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-01-05</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_custom_CollaborationAgreementWithUSAntibodyCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">cgen:CollaborationAgreementWithUSAntibodyCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2018-05-01to2018-05-25_custom_AtTheMarketOfferingProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:AtTheMarketOfferingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-25</endDate>
        </period>
    </context>
    <context id="From2018-06-01to2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:AgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cgen:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-01</startDate>
            <endDate>2018-06-14</endDate>
        </period>
    </context>
    <context id="From2018-10-01to2018-10-10_custom_MasterClinicalAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:MasterClinicalAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-10</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_custom_CollaborativeArrangementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:CollaborativeArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2018-10-10_custom_MasterClinicalAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:MasterClinicalAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-10</instant>
        </period>
    </context>
    <context id="AsOf2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:SvbLeerinkLlcAndStifelNicolausAndCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-16</instant>
        </period>
    </context>
    <context id="AsOf2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cgen:SvbLeerinkLlcAndStifelNicolausAndCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cgen:UnderwritersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-16</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_EmployeeStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-01-01to2020-06-30_us-gaap_EmployeeStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-06-30_us-gaap_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-06-30_us-gaap_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2018-03-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001119774</identifier>
        </entity>
        <period>
            <instant>2018-03-30</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="ILSPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="USDPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568467">0001119774</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568468">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568469">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568460">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568470">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568471">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentType
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568459">6-K</dei:DocumentType>
    <dei:EntityFileNumber
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568461">000-30902</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568462">COMPUGEN LTD</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568463">26 Harokmim Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568464">Holon</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568465">5885849</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_1627436568466">IL</dei:EntityAddressCountry>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2020-12-31"
      id="Fact_304"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2021-06-30"
      id="Fact_305"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-06-30" id="Fact_306">0001119774</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-01-01to2021-06-30" id="Fact_307">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2021-01-01to2021-06-30" id="Fact_308">6-K</dei:DocumentType>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-06-30" id="Fact_309">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="From2021-01-01to2021-06-30" id="Fact_310">2021-06-30</dei:DocumentPeriodEndDate>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_1"
      unitRef="usd">7847000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_2"
      unitRef="usd">7143000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_3"
      unitRef="usd">681000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_4"
      unitRef="usd">667000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OtherShortTermInvestments
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_5"
      unitRef="usd">102564000</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_6"
      unitRef="usd">116622000</us-gaap:OtherShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2021-06-30"
      id="Fact_7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_8"
      unitRef="usd">2000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_9"
      unitRef="usd">2662000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_10"
      unitRef="usd">2658000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_11"
      unitRef="usd">113754000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_12"
      unitRef="usd">129090000</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_13"
      unitRef="usd">1906000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_14"
      unitRef="usd">1880000</us-gaap:PrepaidExpenseNoncurrent>
    <cgen:SeverancePayFundNoncurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_15"
      unitRef="usd">3017000</cgen:SeverancePayFundNoncurrent>
    <cgen:SeverancePayFundNoncurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_16"
      unitRef="usd">2863000</cgen:SeverancePayFundNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_17"
      unitRef="usd">2415000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_18"
      unitRef="usd">2772000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_19"
      unitRef="usd">1724000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_20"
      unitRef="usd">1711000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_21"
      unitRef="usd">9062000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_22"
      unitRef="usd">9226000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_23"
      unitRef="usd">122816000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_24"
      unitRef="usd">138316000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_25"
      unitRef="usd">1809000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_26"
      unitRef="usd">1413000</us-gaap:AccountsPayableCurrent>
    <cgen:ShortTermDeferredParticipationInResearchAndDevelopmentExpenses
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_27"
      unitRef="usd">660000</cgen:ShortTermDeferredParticipationInResearchAndDevelopmentExpenses>
    <cgen:ShortTermDeferredParticipationInResearchAndDevelopmentExpenses
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_28"
      unitRef="usd">668000</cgen:ShortTermDeferredParticipationInResearchAndDevelopmentExpenses>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_29"
      unitRef="usd">706000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_30"
      unitRef="usd">639000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_31"
      unitRef="usd">8675000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_32"
      unitRef="usd">7803000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_33"
      unitRef="usd">11850000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_34"
      unitRef="usd">10523000</us-gaap:LiabilitiesCurrent>
    <cgen:LongTermDeferredParticipationInResearchAndDevelopmentExpenses
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_35"
      unitRef="usd">1798000</cgen:LongTermDeferredParticipationInResearchAndDevelopmentExpenses>
    <cgen:LongTermDeferredParticipationInResearchAndDevelopmentExpenses
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_36"
      unitRef="usd">1968000</cgen:LongTermDeferredParticipationInResearchAndDevelopmentExpenses>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_37"
      unitRef="usd">2141000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_38"
      unitRef="usd">2527000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_39"
      unitRef="usd">3606000</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_40"
      unitRef="usd">3516000</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_41"
      unitRef="usd">7545000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_42"
      unitRef="usd">8011000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      id="Fact_44"
      unitRef="ILSPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30"
      decimals="INF"
      id="Fact_43"
      unitRef="ILSPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2020-12-31"
      decimals="INF"
      id="Fact_46"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-06-30"
      decimals="INF"
      id="Fact_45"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-06-30"
      decimals="INF"
      id="Fact_48"
      unitRef="Shares">83917929</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-06-30"
      decimals="INF"
      id="Fact_47"
      unitRef="Shares">83917929</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2020-12-31"
      decimals="INF"
      id="Fact_50"
      unitRef="Shares">83675856</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2020-12-31"
      decimals="INF"
      id="Fact_49"
      unitRef="Shares">83675856</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_51"
      unitRef="usd">231000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_52"
      unitRef="usd">231000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_53"
      unitRef="usd">510468000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_54"
      unitRef="usd">507427000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_55"
      unitRef="usd">-407278000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_56"
      unitRef="usd">-387876000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_57"
      unitRef="usd">103421000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_58"
      unitRef="usd">119782000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_59"
      unitRef="usd">122816000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_60"
      unitRef="usd">138316000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_61"
      unitRef="usd">14123000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_62"
      unitRef="usd">9159000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:BusinessDevelopment
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_63"
      unitRef="usd">465000</us-gaap:BusinessDevelopment>
    <us-gaap:BusinessDevelopment
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_64"
      unitRef="usd">414000</us-gaap:BusinessDevelopment>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_65"
      unitRef="usd">5373000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_66"
      unitRef="usd">4607000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_67"
      unitRef="usd">19961000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_68"
      unitRef="usd">14180000</us-gaap:OperatingExpenses>
    <cgen:FinancialAndOtherIncomeNet
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_69"
      unitRef="usd">559000</cgen:FinancialAndOtherIncomeNet>
    <cgen:FinancialAndOtherIncomeNet
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_70"
      unitRef="usd">806000</cgen:FinancialAndOtherIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_71"
      unitRef="usd">-19402000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_72"
      unitRef="usd">-13374000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-06-30"
      id="Fact_73"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-01to2020-06-30"
      id="Fact_74"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_75"
      unitRef="usd">-19402000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_76"
      unitRef="usd">-13374000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_77"
      unitRef="USDPerShare">0.23</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-01-01to2020-06-30"
      decimals="INF"
      id="Fact_78"
      unitRef="USDPerShare">0.18</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_79"
      unitRef="usd">-19402000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_80"
      unitRef="usd">-13374000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_81"
      unitRef="Shares">83739983</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-01-01to2020-06-30"
      decimals="INF"
      id="Fact_82"
      unitRef="Shares">75774881</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_83"
      unitRef="Shares">67922836</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact_84"
      unitRef="usd">187000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_85"
      unitRef="usd">396312000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_86"
      unitRef="usd">-358178000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31"
      decimals="-3"
      id="Fact_87"
      unitRef="usd">38321000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_88"
      unitRef="Shares">2450973</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact_89"
      unitRef="usd">6000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_90"
      unitRef="usd">12790000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_91"
      unitRef="usd">12796000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cgen:NumberOfWarrantsExercised
      contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_92"
      unitRef="Shares">3504061</cgen:NumberOfWarrantsExercised>
    <cgen:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact_93"
      unitRef="usd">10000</cgen:StockIssuedDuringPeriodValueWarrantsExercised>
    <cgen:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_94"
      unitRef="usd">16599000</cgen:StockIssuedDuringPeriodValueWarrantsExercised>
    <cgen:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_95"
      unitRef="usd">16609000</cgen:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_96"
      unitRef="Shares">8816339</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact_97"
      unitRef="usd">24000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_98"
      unitRef="usd">74123000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_99"
      unitRef="usd">74147000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_100"
      unitRef="usd">968000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_101"
      unitRef="usd">968000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_102"
      unitRef="usd">-13374000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_103"
      unitRef="usd">-13374000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_104"
      unitRef="Shares">82694209</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact_105"
      unitRef="usd">227000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_106"
      unitRef="usd">500792000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_107"
      unitRef="usd">-371552000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30"
      decimals="-3"
      id="Fact_108"
      unitRef="usd">129467000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_109"
      unitRef="Shares">83675856</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact_110"
      unitRef="usd">231000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_111"
      unitRef="usd">507427000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_112"
      unitRef="usd">-387876000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_113"
      unitRef="usd">119782000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_114"
      unitRef="Shares">115877</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember"
      id="Fact_115"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-01to2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_116"
      unitRef="usd">461000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_117"
      unitRef="usd">461000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cgen:NumberOfWarrantsExercised
      contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_118"
      unitRef="Shares">89557</cgen:NumberOfWarrantsExercised>
    <cgen:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember"
      id="Fact_119"
      unitRef="usd"
      xsi:nil="true"/>
    <cgen:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2021-01-01to2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_120"
      unitRef="usd">425000</cgen:StockIssuedDuringPeriodValueWarrantsExercised>
    <cgen:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_121"
      unitRef="usd">425000</cgen:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_122"
      unitRef="Shares">36639</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="From2021-01-01to2021-06-30_us-gaap_CommonStockMember"
      id="Fact_123"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="From2021-01-01to2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_124"
      unitRef="usd">239000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_125"
      unitRef="usd">239000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-01-01to2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_126"
      unitRef="usd">1916000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_127"
      unitRef="usd">1916000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_128"
      unitRef="usd">-19402000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_129"
      unitRef="usd">-19402000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_130"
      unitRef="Shares">83917929</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact_131"
      unitRef="usd">231000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_132"
      unitRef="usd">510468000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_133"
      unitRef="usd">-407278000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_134"
      unitRef="usd">103421000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_135"
      unitRef="usd">-19402000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_136"
      unitRef="usd">-13374000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_137"
      unitRef="usd">1916000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_138"
      unitRef="usd">968000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_139"
      unitRef="usd">240000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_140"
      unitRef="usd">377000</us-gaap:Depreciation>
    <cgen:SeverancePayNet
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_141"
      unitRef="usd">-64000</cgen:SeverancePayNet>
    <cgen:SeverancePayNet
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_142"
      unitRef="usd">200000</cgen:SeverancePayNet>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_143"
      unitRef="usd">1000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2020-01-01to2020-06-30"
      id="Fact_144"
      unitRef="usd"
      xsi:nil="true"/>
    <cgen:IncreaseDecreaseInOperatingLeaseRightOfUseAsset
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_145"
      unitRef="usd">-357000</cgen:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <cgen:IncreaseDecreaseInOperatingLeaseRightOfUseAsset
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_146"
      unitRef="usd">-235000</cgen:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_147"
      unitRef="usd">-403000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_148"
      unitRef="usd">316000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_149"
      unitRef="usd">-2000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2020-01-01to2020-06-30"
      id="Fact_150"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_151"
      unitRef="usd">-212000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_152"
      unitRef="usd">-40000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_153"
      unitRef="usd">26000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_154"
      unitRef="usd">526000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_155"
      unitRef="usd">361000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_156"
      unitRef="usd">70000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_157"
      unitRef="usd">872000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_158"
      unitRef="usd">1325000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_159"
      unitRef="usd">-319000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_160"
      unitRef="usd">-271000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <cgen:IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_161"
      unitRef="usd">-178000</cgen:IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses>
    <cgen:IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_162"
      unitRef="usd">-294000</cgen:IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_163"
      unitRef="usd">-13629000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_164"
      unitRef="usd">-11566000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_165"
      unitRef="usd">71100000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_166"
      unitRef="usd">15500000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_167"
      unitRef="usd">57445000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_168"
      unitRef="usd">104100000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_169"
      unitRef="usd">218000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_170"
      unitRef="usd">108000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_171"
      unitRef="usd">1000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2020-01-01to2020-06-30"
      id="Fact_172"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_173"
      unitRef="usd">13438000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_174"
      unitRef="usd">-88708000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_175"
      unitRef="usd">239000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_176"
      unitRef="usd">74147000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_177"
      unitRef="usd">425000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_178"
      unitRef="usd">16609000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_179"
      unitRef="usd">245000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_180"
      unitRef="usd">12789000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_181"
      unitRef="usd">909000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_182"
      unitRef="usd">103545000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_183"
      unitRef="usd">718000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_184"
      unitRef="usd">3271000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_185"
      unitRef="usd">7810000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2019-12-31"
      decimals="-3"
      id="Fact_186"
      unitRef="usd">9839000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_187"
      unitRef="usd">8528000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2020-06-30"
      decimals="-3"
      id="Fact_188"
      unitRef="usd">13110000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_189"
      unitRef="usd">35000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_190"
      unitRef="usd">47000</us-gaap:FairValueOfAssetsAcquired>
    <cgen:ReceivablesOnAccountOfShares
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_191"
      unitRef="usd">216000</cgen:ReceivablesOnAccountOfShares>
    <cgen:ReceivablesOnAccountOfShares
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_192"
      unitRef="usd">7000</cgen:ReceivablesOnAccountOfShares>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_200">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;NOTE 1:-&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:16.68pt; "&gt;GENERAL&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; "&gt;a.&lt;span style="padding-left:13.06pt; "&gt;Compugen Ltd. (the "Company" or &#x201c;Compugen&#x201d;) is a clinical-stage, therapeutic discovery and development company &lt;/span&gt;utilizing its proprietary computational discovery platforms to identify novel drug targets and develop first-in-class therapeutics in the field of cancer immunotherapy. The Company&#x2019;s innovative immuno-oncology pipeline consists of three clinical stage programs, targeting immune checkpoints the Company discovered computationally, COM701, COM902 and BAY 1905254. The Company&#x2019;s therapeutic pipeline also includes early-stage immuno-oncology programs focused largely on myeloid targets. The innovative immuno-oncology pipeline, the strategic collaborations and the Company&#x2019;s computational discovery engine serve as the three key corporate building blocks. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; "&gt;b.&lt;span style="padding-left:12.5pt; "&gt;The Company is headquartered in Holon, Israel. Its clinical development activities operate through its U.S. subsidiary &lt;/span&gt;in South San Francisco, California. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; "&gt;c.&lt;span style="padding-left:13.06pt; "&gt;On August 5, 2013, the Company entered into a Research and Development Collaboration and License Agreement &lt;/span&gt;("Bayer Agreement") with Bayer Pharma AG ("Bayer") for the research, development, and commercialization of antibody-based therapeutics against two novel Compugen-discovered immune checkpoint regulators. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;Under the terms of the Bayer Agreement, the Company received an upfront payment of $10,000, and, following the return of the CGEN 15022 program in 2017, the Company is eligible to receive an aggregate of over $250,000 in potential milestone payments, not including aggregate milestone payments of approximately $23,000 received to date. Additionally, the Company is eligible to receive mid to high single digit royalties on global net sales of any approved products under the collaboration.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;Pursuant to the terms of Bayer Agreement, BAY 1905254 program (formerly CGEN-15001T) was transferred to Bayer&#x2019;s full control for further preclinical and clinical development activities, and worldwide commercialization under milestone and royalty bearing licenses from Compugen.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; "&gt;d.&lt;span style="padding-left:12.5pt; "&gt;Effective March 30, 2018, the Company entered into an exclusive license agreement with MedImmune Limited, the &lt;/span&gt;global biologics research and development arm of AstraZeneca ("AstraZeneca") to enable the development of bi-specific and multi-specific immuno-oncology antibody products. Under the terms of the agreement, Compugen provided an exclusive license to AstraZeneca for the development of bi-specific and multi-specific antibody products derived from a Compugen pipeline program. AstraZeneca has the right to create multiple products under this license and will be solely responsible for all research, development and commercial activities under the agreement. Compugen received a $10,000 upfront payment and an additional $2,000 milestone payment out of up to an aggregate milestone amount of $200,000 that the Company is eligible to receive in development, regulatory and commercial milestones for the first product as well as tiered royalties on future product sales. If additional products are developed, additional milestones and royalties would be due to Compugen for each product. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;7&lt;/p&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;COMPUGEN LTD. AND ITS SUBSIDIARY&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/span&gt;&lt;/p&gt; &lt;hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;U.S. dollars in thousands (except share and per share data)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;NOTE 1:-&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:16.68pt; "&gt;GENERAL (Cont.)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; "&gt;e.&lt;span style="padding-left:13.06pt; "&gt;On October 10, 2018, the Company entered into a Master Clinical Trial Collaboration Agreement (the "Master &lt;/span&gt;Clinical Agreement") with the Bristol-Myers Squibb Company ("Bristol-Myers Squibb") to evaluate the safety and tolerability of Compugen&#x2019;s COM701 in combination with Bristol-Myers Squibb&#x2019;s programmed death-1 (PD-1) immune checkpoint inhibitor Opdivo&#xae; (nivolumab), in patients with advanced solid tumors. Pursuant to the Master Clinical Agreement, Compugen is responsible for and will continue sponsoring the ongoing two-part Phase 1 trial, which includes the evaluation of the combination of COM701 and Opdivo&#xae;. The collaboration was also designed to address potential future combinations, including trials sponsored by Bristol-Myers Squibb to investigate combined inhibition of checkpoint mechanisms, such as PVRIG and TIGIT. Bristol-Myers Squibb and Compugen each supplies the other company with its own compound(s) for the studies. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;In conjunction with the signing of the Master Clinical Agreement, Bristol-Myers Squibb made a $12,000 investment in Compugen, see Note 5a.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;On February 14, 2020, the Master Clinical Agreement with Bristol-Myers Squibb was amended to include a triple combination clinical trial to evaluate the safety, tolerability and antitumor activity of COM701 in combination with Opdivo&#xae; (nivolumab), and Bristol-Myers Squibb&#x2019;s antibody targeting TIGIT known as BMS-986207, in patients with advanced solid tumors, instead of the planned expansion of the combined therapy study designed to evaluate the dual combination of COM701 and Opdivo&#xae;. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;Pursuant to the Master Clinical Agreement, as amended, the Company sponsors the two-part Phase 1/2 trial, which includes the evaluation of the triple combination of COM701, Opdivo&#xae; and BMS-986207, in patients with advanced solid tumors where Bristol-Myers Squibb provides Opdivo&#xae; and BMS-986207 at no cost to the Company. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;As part of the said amendment, it was agreed that the Company will complete the dose escalation arm of the dual combination of COM701 with Opdivo&#xae; under the Phase 1 study and will not continue the expansion cohorts of the dual combination.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;On February 19, 2021, the Master Clinical Agreement was further amended to include an expansion of the Phase 1 combination study designed to evaluate the dual combination of COM701 and Opdivo&#xae; in patients with advanced solid tumors, where Compugen is responsible for and sponsors the expansion cohort and Bristol-Myers Squibb provides Opdivo&#xae; at no cost to us for this study. The amendment also revises the exclusivity period granted to Bristol-Myers Squibb to include a specific date for termination of the exclusivity period, so that it ends at the earlier of (i) six months after the study completion of the triple combination and the dual combination; or (ii) December 31, 2023. &lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="From2013-08-01to2013-08-05"
      decimals="-3"
      id="Fact_193"
      unitRef="usd">10000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <cgen:ResearchAndDevelopmentArrangementPaymentsReceivable
      contextRef="AsOf2013-08-05"
      decimals="-3"
      id="Fact_194"
      unitRef="usd">250000000</cgen:ResearchAndDevelopmentArrangementPaymentsReceivable>
    <cgen:ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable
      contextRef="AsOf2013-08-05"
      decimals="-3"
      id="Fact_195"
      unitRef="usd">23000000</cgen:ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="From2018-03-01to2018-03-30"
      decimals="-3"
      id="Fact_196"
      unitRef="usd">10000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <cgen:ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable
      contextRef="AsOf2018-03-30"
      decimals="-3"
      id="Fact_197"
      unitRef="usd">2000000</cgen:ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable>
    <cgen:DevelopmentRegulatoryAndCommercialMilestonesCompensation
      contextRef="From2018-03-01to2018-03-30"
      decimals="-3"
      id="Fact_198"
      unitRef="usd">200000000</cgen:DevelopmentRegulatoryAndCommercialMilestonesCompensation>
    <us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_199"
      unitRef="usd">12000000</us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_201">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;NOTE 2:-&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:16.68pt; "&gt;SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:60pt; margin-bottom:0pt; "&gt;These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes for the year ended December 31, 2020. The significant accounting policies applied in the annual financial statements of the Company as of December 31, 2020, are applied consistently in these interim consolidated financial statements. &lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <cgen:UnauditedInterimConsolidatedFinancialStatementsTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_202">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;NOTE 3:-&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:16.68pt; "&gt;UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:60pt; margin-bottom:0pt; "&gt;The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:60pt; margin-bottom:0pt; "&gt;Operating results for the six-month period ended June 30, 2021 are not necessarily indicative of the results that may be expected for the year ended December 31, 2021. &lt;/p&gt;</cgen:UnauditedInterimConsolidatedFinancialStatementsTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_217">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;NOTE 4:-&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:16.68pt; "&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; "&gt;a.&lt;span style="padding-left:13.06pt; "&gt;The Company provided bank guarantees in the amount of $&lt;/span&gt;672 in favor of its offices in Israel, car leases in Israel and credit card security for its U.S. subsidiary. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; "&gt;b.&lt;span style="padding-left:12.5pt; "&gt;The Company received in the past grants from the office of the Israel Innovation Authority of the Israeli Ministry of &lt;/span&gt;Industry, Trade and Labor, formerly known as the Office of the Chief Scientist, ("IIA"). The Company is not obligated to repay any amounts received from the IIA if it does not generate any income from products which incorporate technologies which were funded by such research program(s). &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;If income is generated from products which incorporate technologies which were funded by a research program, the Company is committed to pay royalties at a rate of between 3% to 5% of future revenue generated from products that incorporate technologies that were funded by such research program(s), up to a maximum of 100% of the amount received, linked to the U.S. dollar (for grants received under programs approved subsequent to January 1, 1999, the maximum amount to be repaid is 100% plus interest at LIBOR).&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;As of June 30, 2021, the Company's aggregate contingent obligations for payments to IIA, based on royalty-bearing participation received or accrued, net of royalties paid or accrued, totaled $9,540. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;9&lt;/p&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;COMPUGEN LTD. AND ITS SUBSIDIARY&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/span&gt;&lt;/p&gt; &lt;hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;U.S. dollars in thousands (except share and per share data)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;NOTE 4:-&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:16.68pt; "&gt;COMMITMENTS AND CONTINGENCIES (Cont.)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; "&gt;c.&lt;span style="padding-left:13.06pt; "&gt;On June 25, 2012, the Company entered into an Antibodies Discovery Collaboration Agreement (the "Antibodies &lt;/span&gt;Discovery Agreement") with a U.S. antibody technology company ("mAb Technology Company"), providing an established source for fully human mAbs. Under the Antibodies Discovery Agreement, the mAb Technology Company will be entitled to certain royalties that could be eliminated upon payment of certain one-time fees (all milestone and royalties payments referred together as "Contingent Fees"). For the six-month periods ended June 30, 2021 and 2020, the Company incurred Contingent Fees in the amounts of $0 and $500, respectively. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; "&gt;d.&lt;span style="padding-left:12.5pt; "&gt;On &lt;/span&gt;May 9, 2012, the Company entered into agreement (the "May 2012 Agreement") with a U.S. Business Development Strategic Advisor ("Advisor") for the purpose of entering into transactions with Pharma companies related to selected Pipeline Program Candidates. Under the agreement the Advisor shall be entitled to 4% of the cash considerations that may be received under such transactions. In 2014, the May 2012 Agreement was terminated, except with respect to certain payments arising from the Bayer Agreement which survive termination until August 5, 2025. For the six months ended June 30, 2021 and 2020, the Company had not paid or accrued expenses related to the May 2012 Agreement. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; "&gt;e.&lt;span style="padding-left:13.06pt; "&gt;Effective as of January 5, 2018, the Company entered into a Commercial License Agreement (&#x201c;CLA&#x201d;) with a &lt;/span&gt;European cell line development company. Under the agreement the Company is required to pay an annual maintenance fee, certain amounts upon the occurrence of specified milestones events, and 1% royalties on annual net sales with respect to each commercialized product manufactured using the company&#x2019;s cell line. Royalties due under the CLA are creditable against the annual maintenance fee. In addition, the Company may at any time prior to the occurrence of a specific milestone event buy-out the royalty payment obligations in a single fixed amount. For the six-month periods ended June 30, 2021 and 2020, the Company incurred milestone payments in the amounts of $0 and $52, respectively. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; "&gt;f.&lt;span style="padding-left:14.17pt; "&gt;Effective as of October 28, 2020, the Company entered into a collaboration agreement with a U.S. antibody &lt;/span&gt;discovery and optimization company for generation and optimization of therapeutic antibodies for the Company. Under the agreement the Company is required to pay service fees per services performed and certain amounts upon the occurrence of specified milestones events, and single-digit percent royalties on annual net sales with respect to each product sold that comprises or contains one or more antibodies so generated or optimized. The royalty rate is dependent upon the product type and any third-party contribution. For the six-month period ended June 30, 2021, the Company incurred milestone payments in the amounts of $150. &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="AsOf2021-06-30_us-gaap_PropertyLeaseGuaranteeMember_country_IL"
      decimals="-3"
      id="Fact_203"
      unitRef="usd">672000</us-gaap:GuaranteeObligationsMaximumExposure>
    <cgen:RoyaltyPercentageBasedOnFutureRevenues
      contextRef="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember_srt_MinimumMember"
      decimals="INF"
      id="Fact_204"
      unitRef="Pure">0.03</cgen:RoyaltyPercentageBasedOnFutureRevenues>
    <cgen:RoyaltyPercentageBasedOnFutureRevenues
      contextRef="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember_srt_MaximumMember"
      decimals="INF"
      id="Fact_205"
      unitRef="Pure">0.05</cgen:RoyaltyPercentageBasedOnFutureRevenues>
    <cgen:MaximumRoyaltyRepaidAsPercentageOfGrantReceived
      contextRef="From2021-01-01to2021-06-30_custom_GovernmentAndOtherGrantsMember"
      decimals="INF"
      id="Fact_206"
      unitRef="Pure">1</cgen:MaximumRoyaltyRepaidAsPercentageOfGrantReceived>
    <cgen:RoyaltyContingentObligations
      contextRef="AsOf2021-06-30_custom_GovernmentAndOtherGrantsMember"
      decimals="-3"
      id="Fact_207"
      unitRef="usd">9540000</cgen:RoyaltyContingentObligations>
    <cgen:ContingentFees
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_208"
      unitRef="usd">0</cgen:ContingentFees>
    <cgen:ContingentFees
      contextRef="AsOf2020-06-30"
      decimals="-3"
      id="Fact_209"
      unitRef="usd">500000</cgen:ContingentFees>
    <cgen:AgreementStartDate
      contextRef="From2021-01-01to2021-06-30_custom_May2012AgreementMember"
      id="Fact_210">2012-05-09</cgen:AgreementStartDate>
    <cgen:ParticipationRights
      contextRef="From2021-01-01to2021-06-30_custom_May2012AgreementMember_srt_MinimumMember"
      decimals="INF"
      id="Fact_211"
      unitRef="Pure">0.04</cgen:ParticipationRights>
    <cgen:AgreementTerminationDescription
      contextRef="From2021-01-01to2021-06-30_custom_May2012AgreementMember"
      id="Fact_212">In 2014, the May 2012 Agreement was terminated, except with respect to certain payments arising from the Bayer Agreement which survive termination until August 5, 2025.</cgen:AgreementTerminationDescription>
    <cgen:PercentageOfRoyaltiesOnNetSales
      contextRef="From2018-01-01to2018-01-05_custom_CommercialLicenseAgreementMember"
      decimals="INF"
      id="Fact_213"
      unitRef="Pure">0.01</cgen:PercentageOfRoyaltiesOnNetSales>
    <cgen:AmountIncurredMilestonePayments
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_214"
      unitRef="usd">0</cgen:AmountIncurredMilestonePayments>
    <cgen:AmountIncurredMilestonePayments
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_215"
      unitRef="usd">52000</cgen:AmountIncurredMilestonePayments>
    <cgen:AmountIncurredMilestonePayments
      contextRef="From2021-01-01to2021-06-30_custom_CollaborationAgreementWithUSAntibodyCompanyMember"
      decimals="-3"
      id="Fact_216"
      unitRef="usd">150000</cgen:AmountIncurredMilestonePayments>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_289">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;NOTE 5:-&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:16.68pt; "&gt;SHAREHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; "&gt;a.&lt;span style="padding-left:13.06pt; "&gt;Issuance of Shares:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;On May 25, 2018, the Company entered into a sales agreement with Cantor Fitzgerald &amp;amp; Co. ("Cantor"), as sales agent, pursuant to which the Company was entitled to offer and sell, from time to time through Cantor, ordinary shares, par value NIS 0.01 per share, of the Company (the "Ordinary Shares"), under an At-the-Market ("ATM") program, having an aggregate offering price of up to $25,000 (the "ATM Shares"). Any ATM Shares offered and sold were issued pursuant to the Company&#x2019;s shelf registration statement on Form F-3 (Registration No. 333-213007) and the related prospectus previously declared effective by the Securities and Exchange Commission on October 11, 2016 (the "Registration Statement"), as supplemented by a prospectus supplement, dated May 25, 2018. As of December 31, 2019, 7,245,268 ATM Shares were issued and sold under the ATM, with proceeds of approximately $22,914 (net of $781 issuance expenses). The program was terminated in 2019. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;On June 14, 2018, the Company entered into agreements in connection with a registered direct offering (the "Offering") of an aggregate of 5,316,457 Ordinary Shares (the "RD Shares") of the Company at a purchase price of $3.95 per RD Share. In connection with the issuance of the RD Shares, the Company also issued warrants to purchase an aggregate of up to 4,253,165 additional Ordinary Shares (the "Warrants"). The Warrants are exercisable at a price of $4.74 per Ordinary Share and have a term of five years from the date of issuance. The Offering was made pursuant to the Company&#x2019;s Registration Statement. Proceeds from the Offering were $19,767 (net of $1,233 issuance expenses). &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;During the six-month periods ended June 30, 2021 and 2020, Warrants to purchase an aggregate of 89,557 and 3,504,061 Ordinary Shares were exercised with proceeds of approximately $425 and $16,609, respectively, and Warrants to purchase up to 297,469 Ordinary Shares remain outstanding as of June 30, 2021.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;On October 10, 2018, the Company entered into a Master Clinical Trial Collaboration Agreement with Bristol-Myers Squibb to evaluate the safety and tolerability of the Company&#x2019;s COM701 in combination with Bristol-Myers Squibb&#x2019;s programmed death-1 (PD-1) immune checkpoint inhibitor Opdivo&#xae; (nivolumab), in patients with advanced solid tumors. In conjunction with the Master Clinical Agreement, Bristol-Myers Squibb made a $12,000 equity investment in the Company. Under the terms of the securities purchase agreement, Bristol-Myers Squibb purchased 2,424,243 Ordinary Shares of the Company at a purchase price of $4.95 per share. The share price represents a 33% premium over the average closing price of Compugen&#x2019;s Ordinary Shares for twenty (20) Nasdaq trading days prior to the execution of the securities purchase agreement. The investment closed on October 12, 2018.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;The premium over the fair market value in the amount of $4,121 represents the relative fair value of deferred participation of Bristol-Myers Squibb in R&amp;amp;D expenses which will be amortized over the period of the clinical trial based on the progress in the R&amp;amp;D, in accordance with ASC 808 "Collaborative Arrangements" and $7,788 (net of $91 issuance expenses) were considered equity investment. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;11&lt;/p&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;COMPUGEN LTD. AND ITS SUBSIDIARY&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/span&gt;&lt;/p&gt; &lt;hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;U.S. dollars in thousands (except share and per share data)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;NOTE 5:-&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:16.68pt; "&gt;SHAREHOLDERS&#x2019; EQUITY (Cont.)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;In March 2020, the Company entered into an underwriting agreement with SVB Leerink LLC and Stifel, Nicolaus &amp;amp; Company, Incorporated, as representatives of the several underwriters relating to the issuance and sale in a public offering of 8,333,334 of the Company's Ordinary Shares at a price to the public of $9.00 per share (and a price of $8.46 per share to the underwriters). Such shares were issued on March 16, 2020. In addition, the Company granted the underwriters a 30-day option to purchase additional Ordinary Shares at the price set forth above. On April 14, 2020, the Company issued and sold, pursuant to that underwriting agreement an additional 483,005 Ordinary Shares pursuant to the underwriters&#x2019; option specified above. The Company sold a total of 8,816,339 Ordinary Shares in the offering with proceeds of $74,147 (net of $5,200 issuance expenses). &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; "&gt;b.&lt;span style="padding-left:12.5pt; "&gt;Stock option plan:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;During the six-month period ended June 30, 2021, the Company's Board of Directors granted 66,500 options to purchase Ordinary Shares of the Company to employees. The exercise prices for such options range from $7.59 to $13.32 per Ordinary Share, with vesting to occur in up to four years.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt; The following table presents the assumptions used to estimate the fair value of the options granted in the periods presented: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:80pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Six months ended&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;June 30,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Unaudited&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Volatility &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;66%-67% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;55%-59% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Risk-free interest rate &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0.5%-0.8% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0.5%-1.6% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Dividend yield &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Expected life (years) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;5.1 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;5.0-5.1 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:100%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;Weighted average fair value of options granted during the six-month periods ended June 30, 2021 and 2020 were $5.54 and $3.10, respectively.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;During the six-month periods ended June 30, 2021 and 2020, the Company recorded share based compensation in a total amount of $1,805 and $968, respectively.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;As of June 30, 2021, the total unrecognized estimated compensation cost related to non-vested stock options granted prior to that date was $9,596 which is expected to be recognized over a weighted average period of approximately 3.00 years.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;For the six months ended June 30, 2021 and 2020, the total weighted average number of shares related to outstanding options and warrants excluded from the calculations of diluted net loss per share were 6,242,283 and 7,984,232, respectively. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;12&lt;/p&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;COMPUGEN LTD. AND ITS SUBSIDIARY&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/span&gt;&lt;/p&gt; &lt;hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;U.S. dollars in thousands (except share and per share data)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;NOTE 5:-&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:16.68pt; "&gt;SHAREHOLDERS' EQUITY (Cont.)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; "&gt;c.&lt;span style="padding-left:13.06pt; "&gt;Employee Stock Purchase Plan:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;The Company selected the Black-Scholes-Merton option-pricing model as the most appropriate fair value method for its stock-option awards and Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;). &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;As of June 30, 2021, 36,639 Ordinary Shares had been purchased under the ESPP and 563,361 Ordinary Shares were available for future issuance under the ESPP. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:80pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Six months ended&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;June 30,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Unaudited&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Volatility &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;64%-70% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Risk-free interest rate &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0.0%-0.1% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Dividend yield &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Expected life (years) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0.4-0.5 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:100%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt;During the six-month period ended June 30, 2021, the Company recorded ESPP compensation in a total amount of $111. &lt;/p&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2018-05-25_custom_AtTheMarketOfferingProgramMember"
      decimals="INF"
      id="Fact_218"
      unitRef="ILSPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock
      contextRef="From2018-05-01to2018-05-25_custom_AtTheMarketOfferingProgramMember"
      decimals="-3"
      id="Fact_219"
      unitRef="usd">25000000</cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-01-01to2019-12-31_custom_AtTheMarketOfferingProgramMember"
      decimals="INF"
      id="Fact_220"
      unitRef="Shares">7245268</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock
      contextRef="From2019-01-01to2019-12-31_custom_AtTheMarketOfferingProgramMember"
      decimals="-3"
      id="Fact_221"
      unitRef="usd">22914000</cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2019-01-01to2019-12-31_custom_AtTheMarketOfferingProgramMember"
      decimals="-3"
      id="Fact_222"
      unitRef="usd">781000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember"
      decimals="INF"
      id="Fact_223"
      unitRef="Shares">5316457</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember"
      decimals="INF"
      id="Fact_224"
      unitRef="USDPerShare">3.95</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember"
      decimals="INF"
      id="Fact_225"
      unitRef="Shares">4253165</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember"
      decimals="INF"
      id="Fact_226"
      unitRef="USDPerShare">4.74</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cgen:ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable
      contextRef="From2018-06-01to2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember"
      id="Fact_227">P5Y</cgen:ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable>
    <cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock
      contextRef="From2018-06-01to2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember"
      decimals="-3"
      id="Fact_228"
      unitRef="usd">19767000</cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2018-06-01to2018-06-14_custom_AgreementMember_custom_RegisteredDirectOfferingMember"
      decimals="-3"
      id="Fact_229"
      unitRef="usd">1233000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2021-06-30"
      decimals="INF"
      id="Fact_230"
      unitRef="Shares">89557</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-06-30"
      decimals="INF"
      id="Fact_231"
      unitRef="Shares">3504061</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_232"
      unitRef="usd">425000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_233"
      unitRef="usd">16609000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2021-06-30"
      decimals="INF"
      id="Fact_234"
      unitRef="Shares">297469</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="AsOf2018-10-10_custom_MasterClinicalAgreementMember"
      decimals="-3"
      id="Fact_235"
      unitRef="usd">12000000</us-gaap:EquityMethodInvestmentAggregateCost>
    <cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock
      contextRef="From2018-10-01to2018-10-10_custom_MasterClinicalAgreementMember"
      decimals="-3"
      id="Fact_236"
      unitRef="usd">2424243000</cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2018-10-10_custom_MasterClinicalAgreementMember"
      decimals="INF"
      id="Fact_237"
      unitRef="USDPerShare">4.95</us-gaap:SharesIssuedPricePerShare>
    <cgen:PercentageOfClosingPrice
      contextRef="From2018-10-01to2018-10-10_custom_MasterClinicalAgreementMember"
      decimals="INF"
      id="Fact_238"
      unitRef="Pure">0.33</cgen:PercentageOfClosingPrice>
    <cgen:DeferredParticipationOfBmsInRdExpenses
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_239"
      unitRef="usd">4121000</cgen:DeferredParticipationOfBmsInRdExpenses>
    <cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-01to2021-06-30_custom_CollaborativeArrangementsMember"
      decimals="-3"
      id="Fact_240"
      unitRef="usd">7788000</cgen:MaximumAuthorizedProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2021-01-01to2021-06-30_custom_CollaborativeArrangementsMember"
      decimals="-3"
      id="Fact_241"
      unitRef="usd">91000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-03-01to2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember"
      decimals="INF"
      id="Fact_242"
      unitRef="Shares">8333334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember"
      decimals="INF"
      id="Fact_243"
      unitRef="USDPerShare">9.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-03-16_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember_custom_UnderwritersMember"
      decimals="INF"
      id="Fact_244"
      unitRef="USDPerShare">8.46</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-04-01to2020-04-14_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember_custom_UnderwritersMember"
      decimals="INF"
      id="Fact_245"
      unitRef="Shares">483005</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-01-01to2021-06-30_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember"
      decimals="INF"
      id="Fact_246"
      unitRef="Shares">8816339</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2021-01-01to2021-06-30_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember"
      decimals="-3"
      id="Fact_247"
      unitRef="usd">74147000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2021-01-01to2021-06-30_custom_SvbLeerinkLlcAndStifelNicolausAndCompanyMember"
      decimals="-3"
      id="Fact_248"
      unitRef="usd">5200000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_249"
      unitRef="Shares">66500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_250"
      unitRef="USDPerShare">7.59</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_251"
      unitRef="USDPerShare">13.32</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2021-01-01to2021-06-30" id="Fact_252">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_266">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "&gt; The following table presents the assumptions used to estimate the fair value of the options granted in the periods presented: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:80pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Six months ended&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;June 30,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Unaudited&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Volatility &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;66%-67% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;55%-59% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Risk-free interest rate &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0.5%-0.8% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0.5%-1.6% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Dividend yield &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Expected life (years) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;5.1 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;5.0-5.1 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:100%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_253"
      unitRef="Pure">0.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_254"
      unitRef="Pure">0.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2020-01-01to2020-06-30"
      decimals="INF"
      id="Fact_255"
      unitRef="Pure">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2020-01-01to2020-06-30"
      decimals="INF"
      id="Fact_256"
      unitRef="Pure">0.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_257"
      unitRef="Pure">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_258"
      unitRef="Pure">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2020-01-01to2020-06-30"
      decimals="INF"
      id="Fact_259"
      unitRef="Pure">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2020-01-01to2020-06-30"
      decimals="INF"
      id="Fact_260"
      unitRef="Pure">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_261"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2020-01-01to2020-06-30"
      decimals="INF"
      id="Fact_262"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-01to2021-06-30" id="Fact_263">P5Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2020-01-01to2020-06-30_us-gaap_MinimumMember"
      id="Fact_264">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2020-01-01to2020-06-30_us-gaap_MaximumMember"
      id="Fact_265">P5Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_267"
      unitRef="USDPerShare">5.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2020-01-01to2020-06-30"
      decimals="INF"
      id="Fact_268"
      unitRef="USDPerShare">3.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_269"
      unitRef="usd">1805000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_270"
      unitRef="usd">968000</us-gaap:StockOptionPlanExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_271"
      unitRef="usd">9596000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2021-01-01to2021-06-30" id="Fact_272">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      id="Fact_273"
      unitRef="Shares">6242283</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-01to2020-06-30"
      decimals="INF"
      id="Fact_274"
      unitRef="Shares">7984232</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember"
      decimals="INF"
      id="Fact_275"
      unitRef="Shares">36639</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-06-30_us-gaap_EmployeeStockMember"
      decimals="INF"
      id="Fact_276"
      unitRef="Shares">563361</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember"
      id="Fact_287">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:80pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Six months ended&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;June 30,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Unaudited&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Volatility &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;64%-70% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Risk-free interest rate &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0.0%-0.1% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Dividend yield &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0% &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Expected life (years) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;0.4-0.5 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:100%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember"
      decimals="INF"
      id="Fact_277"
      unitRef="Pure">0.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember"
      decimals="INF"
      id="Fact_278"
      unitRef="Pure">0.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2020-01-01to2020-06-30_us-gaap_EmployeeStockMember"
      id="Fact_279"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember"
      decimals="INF"
      id="Fact_280"
      unitRef="Pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember"
      decimals="INF"
      id="Fact_281"
      unitRef="Pure">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2020-01-01to2020-06-30_us-gaap_EmployeeStockMember"
      id="Fact_282"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember"
      decimals="INF"
      id="Fact_283"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2020-01-01to2020-06-30_us-gaap_EmployeeStockMember"
      id="Fact_284"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember_srt_MinimumMember"
      id="Fact_285">P0Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember_srt_MaximumMember"
      id="Fact_286">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="From2021-01-01to2021-06-30_us-gaap_EmployeeStockMember"
      decimals="-3"
      id="Fact_288"
      unitRef="usd">111000</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_297">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;NOTE 6:-&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:16.68pt; "&gt;FINANCIAL AND OTHER INCOME, NET&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:60pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Six months ended&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;June 30,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Unaudited&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Interest income &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;528 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;878 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Exchange rate differences and other &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;31 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(72 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:1.5pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Financial and other income, net &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;559 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;806 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:100%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:InterestAndOtherIncomeTableTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_296">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:60pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Six months ended&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;June 30,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Unaudited&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Interest income &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;528 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;878 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Exchange rate differences and other &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;31 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(72 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:1.5pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Financial and other income, net &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;559 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;806 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:100%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InterestAndOtherIncomeTableTextBlock>
    <us-gaap:InterestIncomeDepositsWithFinancialInstitutions
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_290"
      unitRef="usd">528000</us-gaap:InterestIncomeDepositsWithFinancialInstitutions>
    <us-gaap:InterestIncomeDepositsWithFinancialInstitutions
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_291"
      unitRef="usd">878000</us-gaap:InterestIncomeDepositsWithFinancialInstitutions>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_292"
      unitRef="usd">31000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_293"
      unitRef="usd">-72000</us-gaap:OtherNonoperatingIncomeExpense>
    <cgen:FinancialAndOtherIncomeNet
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_294"
      unitRef="usd">559000</cgen:FinancialAndOtherIncomeNet>
    <cgen:FinancialAndOtherIncomeNet
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_295"
      unitRef="usd">806000</cgen:FinancialAndOtherIncomeNet>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_303">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;NOTE 7:-&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:16.68pt; "&gt;RELATED PARTY BALANCES AND TRANSACTIONS&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; "&gt; Balances with related parties: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:60pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;June 30,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;31, 2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Unaudited&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Trade and other payables (a) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;62 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;83 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:100%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; "&gt;Related parties' expenses: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:60pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Six months ended&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;June 30,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Unaudited&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Amounts charged to: &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Research and development expenses (a) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;110 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;146 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:100%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;div style="margin-left:60pt; "&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:4%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;(a) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:96%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;The Company incurred expenses for research and development services provided by related party for cancer studies in animal models, and breeding and maintenance of animals (mice) to support such studies. &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_302">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; "&gt; Balances with related parties: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:60pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;June 30,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;31, 2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Unaudited&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Trade and other payables (a) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;62 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;83 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:100%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; "&gt;Related parties' expenses: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:60pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Six months ended&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;June 30,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Unaudited&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:26%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Amounts charged to: &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:71%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Research and development expenses (a) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;110 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;$ &lt;/p&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;146 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:100%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;div style="margin-left:60pt; "&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:4%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;(a) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:96%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;The Company incurred expenses for research and development services provided by related party for cancer studies in animal models, and breeding and maintenance of animals (mice) to support such studies. &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2021-06-30"
      decimals="-3"
      id="Fact_298"
      unitRef="usd">62000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact_299"
      unitRef="usd">83000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="From2021-01-01to2021-06-30"
      decimals="-3"
      id="Fact_300"
      unitRef="usd">110000</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="From2020-01-01to2020-06-30"
      decimals="-3"
      id="Fact_301"
      unitRef="usd">146000</us-gaap:CostsAndExpensesRelatedParty>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact_115"
          xlink:label="Fact_115"
          xlink:type="locator"/>
        <link:footnote id="FN_5f067295be4d443bcdbba938" xlink:label="FN_5f067295be4d443bcdbba938" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents an amount lower than $1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_115"
          xlink:to="FN_5f067295be4d443bcdbba938"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_119"
          xlink:label="Fact_119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_119"
          xlink:to="FN_5f067295be4d443bcdbba938"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_299"
          xlink:label="Fact_299"
          xlink:type="locator"/>
        <link:footnote id="FN_60e66b41df40f60778298cb2" xlink:label="FN_60e66b41df40f60778298cb2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company incurred expenses for research and development services provided by related party for cancer studies in animal models, and breeding and maintenance of animals (mice) to support such studies.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_299"
          xlink:to="FN_60e66b41df40f60778298cb2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_298"
          xlink:label="Fact_298"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_298"
          xlink:to="FN_60e66b41df40f60778298cb2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_301"
          xlink:label="Fact_301"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_301"
          xlink:to="FN_60e66b41df40f60778298cb2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_300"
          xlink:label="Fact_300"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_300"
          xlink:to="FN_60e66b41df40f60778298cb2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_123"
          xlink:label="Fact_123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_123"
          xlink:to="FN_5f067295be4d443bcdbba938"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522732244600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COMPUGEN LTD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001119774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">6-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">26 Harokmim Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Holon<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">5885849<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document And Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522644981880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,847<span></span>
</td>
<td class="nump">$ 7,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">681<span></span>
</td>
<td class="nump">667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">Short-term bank deposits</a></td>
<td class="nump">102,564<span></span>
</td>
<td class="nump">116,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other accounts receivable and prepaid expenses</a></td>
<td class="nump">2,662<span></span>
</td>
<td class="nump">2,658<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">113,754<span></span>
</td>
<td class="nump">129,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>NON-CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Long-term prepaid expenses</a></td>
<td class="nump">1,906<span></span>
</td>
<td class="nump">1,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_SeverancePayFundNoncurrent', window );">Severance pay fund</a></td>
<td class="nump">3,017<span></span>
</td>
<td class="nump">2,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right to use asset</a></td>
<td class="nump">2,415<span></span>
</td>
<td class="nump">2,772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,724<span></span>
</td>
<td class="nump">1,711<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">9,062<span></span>
</td>
<td class="nump">9,226<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">122,816<span></span>
</td>
<td class="nump">138,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Trade payables</a></td>
<td class="nump">1,809<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses', window );">Short-term deferred participation in R&amp;D expenses</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturity of operating lease liability</a></td>
<td class="nump">706<span></span>
</td>
<td class="nump">639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities', window );">Other accounts payable and accrued expenses</a></td>
<td class="nump">8,675<span></span>
</td>
<td class="nump">7,803<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">11,850<span></span>
</td>
<td class="nump">10,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>NON- CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses', window );">Long-term deferred participation in R&amp;D expenses</a></td>
<td class="nump">1,798<span></span>
</td>
<td class="nump">1,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long term operating lease liability</a></td>
<td class="nump">2,141<span></span>
</td>
<td class="nump">2,527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsLiabilityNoncurrent', window );">Accrued severance pay</a></td>
<td class="nump">3,606<span></span>
</td>
<td class="nump">3,516<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">7,545<span></span>
</td>
<td class="nump">8,011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENT LIABILITIES (NOTE 4)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares of NIS 0.01 par value per share: 200,000,000 shares authorized on June 30, 2021 and December 31, 2020; 83,917,929 and 83,675,856 shares issued and outstanding on June 30, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">510,468<span></span>
</td>
<td class="nump">507,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(407,278)<span></span>
</td>
<td class="num">(387,876)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">103,421<span></span>
</td>
<td class="nump">119,782<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 122,816<span></span>
</td>
<td class="nump">$ 138,316<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term deferred participation in R&amp;amp;amp;amp;D expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_SeverancePayFundNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly deposits in externally managed funds which primarily cover Israeli law severance pay liability of one month's salary for each year of employment upon the retirement or death of an employee or termination of employment without a valid legal reason.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_SeverancePayFundNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short term deferred participation in R&amp;amp;amp;amp;D expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable after one year (or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6410138&amp;loc=d3e79708-111665<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -SubTopic 10<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6410138&amp;loc=d3e79691-111665<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522731486376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value per share</a></td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued</a></td>
<td class="nump">83,917,929<span></span>
</td>
<td class="nump">83,675,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">83,917,929<span></span>
</td>
<td class="nump">83,675,856<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522644952696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses, net</a></td>
<td class="nump">$ 14,123<span></span>
</td>
<td class="nump">$ 9,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDevelopment', window );">Marketing and business development expenses</a></td>
<td class="nump">465<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">5,373<span></span>
</td>
<td class="nump">4,607<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">19,961<span></span>
</td>
<td class="nump">14,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_FinancialAndOtherIncomeNet', window );">Financial and other income, net</a></td>
<td class="nump">559<span></span>
</td>
<td class="nump">806<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before taxes on income</a></td>
<td class="nump">19,402<span></span>
</td>
<td class="nump">13,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Taxes on income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 19,402<span></span>
</td>
<td class="nump">$ 13,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share</a></td>
<td class="nump">$ 0.23<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="nump">$ 19,402<span></span>
</td>
<td class="nump">$ 13,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of ordinary shares used in computing basic and diluted net loss per share</a></td>
<td class="nump">83,739,983<span></span>
</td>
<td class="nump">75,774,881<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_FinancialAndOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate of financial and other income net of expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_FinancialAndOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522645110696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Ordinary shares [Member]</div></th>
<th class="th"><div>Additional paid-in capital [Member]</div></th>
<th class="th"><div>Accumulated deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 187<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 396,312<span></span>
</td>
<td class="num">$ (358,178)<span></span>
</td>
<td class="nump">$ 38,321<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="nump">67,922,836<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised, shares</a></td>
<td class="nump">2,450,973<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_StockIssuedDuringPeriodValueWarrantsExercised', window );">Warrants exercised</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_NumberOfWarrantsExercised', window );">Warrants exercised, shares</a></td>
<td class="nump">3,504,061<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares, net</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">74,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, net, shares</a></td>
<td class="nump">8,816,339<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation issued to employees, directors and non-employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,374)<span></span>
</td>
<td class="num">(13,374)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2020</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">500,792<span></span>
</td>
<td class="num">(371,552)<span></span>
</td>
<td class="nump">129,467<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2020</a></td>
<td class="nump">82,694,209<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">507,427<span></span>
</td>
<td class="num">(387,876)<span></span>
</td>
<td class="nump">$ 119,782<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="nump">83,675,856<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,675,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised, shares</a></td>
<td class="nump">115,877<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_StockIssuedDuringPeriodValueWarrantsExercised', window );">Warrants exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_NumberOfWarrantsExercised', window );">Warrants exercised, shares</a></td>
<td class="nump">89,557<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of ordinary shares pursuant to the ESPP</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of ordinary shares pursuant to the ESPP, shares</a></td>
<td class="nump">36,639<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation issued to employees, directors and non-employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,402)<span></span>
</td>
<td class="num">(19,402)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">$ 231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 510,468<span></span>
</td>
<td class="num">$ (407,278)<span></span>
</td>
<td class="nump">$ 103,421<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2021</a></td>
<td class="nump">83,917,929<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,917,929<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents an amount lower than $1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_NumberOfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_NumberOfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522649174408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (19,402)<span></span>
</td>
<td class="num">$ (13,374)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,916<span></span>
</td>
<td class="nump">968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_SeverancePayNet', window );">Increase (decrease) in severance pay, net</a></td>
<td class="num">(64)<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain from property and equipment disposal</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset', window );">Decrease in operating lease right of use asset</a></td>
<td class="nump">357<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Decrease (increase) in interest receivables from short-term bank deposits</a></td>
<td class="nump">403<span></span>
</td>
<td class="num">(316)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Decrease in trade receivables</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Decrease in other accounts receivable and prepaid expenses</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Increase in long-term prepaid expenses</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(526)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Increase in trade payables</a></td>
<td class="nump">361<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase in other accounts payable and accrued expenses</a></td>
<td class="nump">872<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Decrease in operating lease liability</a></td>
<td class="num">(319)<span></span>
</td>
<td class="num">(271)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses', window );">Decrease in deferred participation in R&amp;D expenses</a></td>
<td class="num">(178)<span></span>
</td>
<td class="num">(294)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(13,629)<span></span>
</td>
<td class="num">(11,566)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities', window );">Proceeds from maturity of short-term bank deposits</a></td>
<td class="nump">71,100<span></span>
</td>
<td class="nump">15,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Investment in short-term bank deposits</a></td>
<td class="num">(57,445)<span></span>
</td>
<td class="num">(104,100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(218)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sales of property and equipment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">13,438<span></span>
</td>
<td class="num">(88,708)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of ordinary shares, net</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">74,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="nump">425<span></span>
</td>
<td class="nump">16,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of options</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">12,789<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">909<span></span>
</td>
<td class="nump">103,545<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">718<span></span>
</td>
<td class="nump">3,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">7,810<span></span>
</td>
<td class="nump">9,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">8,528<span></span>
</td>
<td class="nump">13,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Purchase of property and equipment</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_ReceivablesOnAccountOfShares', window );">Receivables on account of shares</a></td>
<td class="nump">$ 216<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in deferred participation in R&amp;amp;amp;amp;D expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in operating lease right of use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_ReceivablesOnAccountOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables on account of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_ReceivablesOnAccountOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_SeverancePayNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Severance pay, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_SeverancePayNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522646741624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>GENERAL [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 1:-</span><span style="font-weight:bold; padding-left:16.68pt; ">GENERAL</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">a.<span style="padding-left:13.06pt; ">Compugen Ltd. (the "Company" or &#8220;Compugen&#8221;) is a clinical-stage, therapeutic discovery and development company </span>utilizing its proprietary computational discovery platforms to identify novel drug targets and develop first-in-class therapeutics in the field of cancer immunotherapy. The Company&#8217;s innovative immuno-oncology pipeline consists of three clinical stage programs, targeting immune checkpoints the Company discovered computationally, COM701, COM902 and BAY 1905254. The Company&#8217;s therapeutic pipeline also includes early-stage immuno-oncology programs focused largely on myeloid targets. The innovative immuno-oncology pipeline, the strategic collaborations and the Company&#8217;s computational discovery engine serve as the three key corporate building blocks. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">b.<span style="padding-left:12.5pt; ">The Company is headquartered in Holon, Israel. Its clinical development activities operate through its U.S. subsidiary </span>in South San Francisco, California. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">c.<span style="padding-left:13.06pt; ">On August 5, 2013, the Company entered into a Research and Development Collaboration and License Agreement </span>("Bayer Agreement") with Bayer Pharma AG ("Bayer") for the research, development, and commercialization of antibody-based therapeutics against two novel Compugen-discovered immune checkpoint regulators. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">Under the terms of the Bayer Agreement, the Company received an upfront payment of $10,000, and, following the return of the CGEN 15022 program in 2017, the Company is eligible to receive an aggregate of over $250,000 in potential milestone payments, not including aggregate milestone payments of approximately $23,000 received to date. Additionally, the Company is eligible to receive mid to high single digit royalties on global net sales of any approved products under the collaboration.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">Pursuant to the terms of Bayer Agreement, BAY 1905254 program (formerly CGEN-15001T) was transferred to Bayer&#8217;s full control for further preclinical and clinical development activities, and worldwide commercialization under milestone and royalty bearing licenses from Compugen.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">d.<span style="padding-left:12.5pt; ">Effective March 30, 2018, the Company entered into an exclusive license agreement with MedImmune Limited, the </span>global biologics research and development arm of AstraZeneca ("AstraZeneca") to enable the development of bi-specific and multi-specific immuno-oncology antibody products. Under the terms of the agreement, Compugen provided an exclusive license to AstraZeneca for the development of bi-specific and multi-specific antibody products derived from a Compugen pipeline program. AstraZeneca has the right to create multiple products under this license and will be solely responsible for all research, development and commercial activities under the agreement. Compugen received a $10,000 upfront payment and an additional $2,000 milestone payment out of up to an aggregate milestone amount of $200,000 that the Company is eligible to receive in development, regulatory and commercial milestones for the first product as well as tiered royalties on future product sales. If additional products are developed, additional milestones and royalties would be due to Compugen for each product. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;7</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 1:-</span><span style="font-weight:bold; padding-left:16.68pt; ">GENERAL (Cont.)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">e.<span style="padding-left:13.06pt; ">On October 10, 2018, the Company entered into a Master Clinical Trial Collaboration Agreement (the "Master </span>Clinical Agreement") with the Bristol-Myers Squibb Company ("Bristol-Myers Squibb") to evaluate the safety and tolerability of Compugen&#8217;s COM701 in combination with Bristol-Myers Squibb&#8217;s programmed death-1 (PD-1) immune checkpoint inhibitor Opdivo&#174; (nivolumab), in patients with advanced solid tumors. Pursuant to the Master Clinical Agreement, Compugen is responsible for and will continue sponsoring the ongoing two-part Phase 1 trial, which includes the evaluation of the combination of COM701 and Opdivo&#174;. The collaboration was also designed to address potential future combinations, including trials sponsored by Bristol-Myers Squibb to investigate combined inhibition of checkpoint mechanisms, such as PVRIG and TIGIT. Bristol-Myers Squibb and Compugen each supplies the other company with its own compound(s) for the studies. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">In conjunction with the signing of the Master Clinical Agreement, Bristol-Myers Squibb made a $12,000 investment in Compugen, see Note 5a.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">On February 14, 2020, the Master Clinical Agreement with Bristol-Myers Squibb was amended to include a triple combination clinical trial to evaluate the safety, tolerability and antitumor activity of COM701 in combination with Opdivo&#174; (nivolumab), and Bristol-Myers Squibb&#8217;s antibody targeting TIGIT known as BMS-986207, in patients with advanced solid tumors, instead of the planned expansion of the combined therapy study designed to evaluate the dual combination of COM701 and Opdivo&#174;. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">Pursuant to the Master Clinical Agreement, as amended, the Company sponsors the two-part Phase 1/2 trial, which includes the evaluation of the triple combination of COM701, Opdivo&#174; and BMS-986207, in patients with advanced solid tumors where Bristol-Myers Squibb provides Opdivo&#174; and BMS-986207 at no cost to the Company. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">As part of the said amendment, it was agreed that the Company will complete the dose escalation arm of the dual combination of COM701 with Opdivo&#174; under the Phase 1 study and will not continue the expansion cohorts of the dual combination.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">On February 19, 2021, the Master Clinical Agreement was further amended to include an expansion of the Phase 1 combination study designed to evaluate the dual combination of COM701 and Opdivo&#174; in patients with advanced solid tumors, where Compugen is responsible for and sponsors the expansion cohort and Bristol-Myers Squibb provides Opdivo&#174; at no cost to us for this study. The amendment also revises the exclusivity period granted to Bristol-Myers Squibb to include a specific date for termination of the exclusivity period, so that it ends at the earlier of (i) six months after the study completion of the triple combination and the dual combination; or (ii) December 31, 2023. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522646880360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 2:-</span><span style="font-weight:bold; padding-left:16.68pt; ">SIGNIFICANT ACCOUNTING POLICIES</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:60pt; margin-bottom:0pt; ">These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes for the year ended December 31, 2020. The significant accounting policies applied in the annual financial statements of the Company as of December 31, 2020, are applied consistently in these interim consolidated financial statements. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522646814488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract', window );"><strong>Unaudited Interim Consolidated Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock', window );">UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 3:-</span><span style="font-weight:bold; padding-left:16.68pt; ">UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:60pt; margin-bottom:0pt; ">The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:60pt; margin-bottom:0pt; ">Operating results for the six-month period ended June 30, 2021 are not necessarily indicative of the results that may be expected for the year ended December 31, 2021. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of unaudited interim consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522738729032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 4:-</span><span style="font-weight:bold; padding-left:16.68pt; ">COMMITMENTS AND CONTINGENCIES</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">a.<span style="padding-left:13.06pt; ">The Company provided bank guarantees in the amount of $</span>672 in favor of its offices in Israel, car leases in Israel and credit card security for its U.S. subsidiary. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">b.<span style="padding-left:12.5pt; ">The Company received in the past grants from the office of the Israel Innovation Authority of the Israeli Ministry of </span>Industry, Trade and Labor, formerly known as the Office of the Chief Scientist, ("IIA"). The Company is not obligated to repay any amounts received from the IIA if it does not generate any income from products which incorporate technologies which were funded by such research program(s). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">If income is generated from products which incorporate technologies which were funded by a research program, the Company is committed to pay royalties at a rate of between 3% to 5% of future revenue generated from products that incorporate technologies that were funded by such research program(s), up to a maximum of 100% of the amount received, linked to the U.S. dollar (for grants received under programs approved subsequent to January 1, 1999, the maximum amount to be repaid is 100% plus interest at LIBOR).</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">As of June 30, 2021, the Company's aggregate contingent obligations for payments to IIA, based on royalty-bearing participation received or accrued, net of royalties paid or accrued, totaled $9,540. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;9</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 4:-</span><span style="font-weight:bold; padding-left:16.68pt; ">COMMITMENTS AND CONTINGENCIES (Cont.)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">c.<span style="padding-left:13.06pt; ">On June 25, 2012, the Company entered into an Antibodies Discovery Collaboration Agreement (the "Antibodies </span>Discovery Agreement") with a U.S. antibody technology company ("mAb Technology Company"), providing an established source for fully human mAbs. Under the Antibodies Discovery Agreement, the mAb Technology Company will be entitled to certain royalties that could be eliminated upon payment of certain one-time fees (all milestone and royalties payments referred together as "Contingent Fees"). For the six-month periods ended June 30, 2021 and 2020, the Company incurred Contingent Fees in the amounts of $0 and $500, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">d.<span style="padding-left:12.5pt; ">On </span>May 9, 2012, the Company entered into agreement (the "May 2012 Agreement") with a U.S. Business Development Strategic Advisor ("Advisor") for the purpose of entering into transactions with Pharma companies related to selected Pipeline Program Candidates. Under the agreement the Advisor shall be entitled to 4% of the cash considerations that may be received under such transactions. In 2014, the May 2012 Agreement was terminated, except with respect to certain payments arising from the Bayer Agreement which survive termination until August 5, 2025. For the six months ended June 30, 2021 and 2020, the Company had not paid or accrued expenses related to the May 2012 Agreement. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">e.<span style="padding-left:13.06pt; ">Effective as of January 5, 2018, the Company entered into a Commercial License Agreement (&#8220;CLA&#8221;) with a </span>European cell line development company. Under the agreement the Company is required to pay an annual maintenance fee, certain amounts upon the occurrence of specified milestones events, and 1% royalties on annual net sales with respect to each commercialized product manufactured using the company&#8217;s cell line. Royalties due under the CLA are creditable against the annual maintenance fee. In addition, the Company may at any time prior to the occurrence of a specific milestone event buy-out the royalty payment obligations in a single fixed amount. For the six-month periods ended June 30, 2021 and 2020, the Company incurred milestone payments in the amounts of $0 and $52, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:80pt !important; margin-bottom:0pt; ">f.<span style="padding-left:14.17pt; ">Effective as of October 28, 2020, the Company entered into a collaboration agreement with a U.S. antibody </span>discovery and optimization company for generation and optimization of therapeutic antibodies for the Company. Under the agreement the Company is required to pay service fees per services performed and certain amounts upon the occurrence of specified milestones events, and single-digit percent royalties on annual net sales with respect to each product sold that comprises or contains one or more antibodies so generated or optimized. The royalty rate is dependent upon the product type and any third-party contribution. For the six-month period ended June 30, 2021, the Company incurred milestone payments in the amounts of $150. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522646788536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>SHAREHOLDERS' EQUITY [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">SHAREHOLDERS' EQUITY</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 5:-</span><span style="font-weight:bold; padding-left:16.68pt; ">SHAREHOLDERS&#8217; EQUITY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; ">a.<span style="padding-left:13.06pt; ">Issuance of Shares:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">On May 25, 2018, the Company entered into a sales agreement with Cantor Fitzgerald &amp; Co. ("Cantor"), as sales agent, pursuant to which the Company was entitled to offer and sell, from time to time through Cantor, ordinary shares, par value NIS 0.01 per share, of the Company (the "Ordinary Shares"), under an At-the-Market ("ATM") program, having an aggregate offering price of up to $25,000 (the "ATM Shares"). Any ATM Shares offered and sold were issued pursuant to the Company&#8217;s shelf registration statement on Form F-3 (Registration No. 333-213007) and the related prospectus previously declared effective by the Securities and Exchange Commission on October 11, 2016 (the "Registration Statement"), as supplemented by a prospectus supplement, dated May 25, 2018. As of December 31, 2019, 7,245,268 ATM Shares were issued and sold under the ATM, with proceeds of approximately $22,914 (net of $781 issuance expenses). The program was terminated in 2019. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">On June 14, 2018, the Company entered into agreements in connection with a registered direct offering (the "Offering") of an aggregate of 5,316,457 Ordinary Shares (the "RD Shares") of the Company at a purchase price of $3.95 per RD Share. In connection with the issuance of the RD Shares, the Company also issued warrants to purchase an aggregate of up to 4,253,165 additional Ordinary Shares (the "Warrants"). The Warrants are exercisable at a price of $4.74 per Ordinary Share and have a term of five years from the date of issuance. The Offering was made pursuant to the Company&#8217;s Registration Statement. Proceeds from the Offering were $19,767 (net of $1,233 issuance expenses). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">During the six-month periods ended June 30, 2021 and 2020, Warrants to purchase an aggregate of 89,557 and 3,504,061 Ordinary Shares were exercised with proceeds of approximately $425 and $16,609, respectively, and Warrants to purchase up to 297,469 Ordinary Shares remain outstanding as of June 30, 2021.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">On October 10, 2018, the Company entered into a Master Clinical Trial Collaboration Agreement with Bristol-Myers Squibb to evaluate the safety and tolerability of the Company&#8217;s COM701 in combination with Bristol-Myers Squibb&#8217;s programmed death-1 (PD-1) immune checkpoint inhibitor Opdivo&#174; (nivolumab), in patients with advanced solid tumors. In conjunction with the Master Clinical Agreement, Bristol-Myers Squibb made a $12,000 equity investment in the Company. Under the terms of the securities purchase agreement, Bristol-Myers Squibb purchased 2,424,243 Ordinary Shares of the Company at a purchase price of $4.95 per share. The share price represents a 33% premium over the average closing price of Compugen&#8217;s Ordinary Shares for twenty (20) Nasdaq trading days prior to the execution of the securities purchase agreement. The investment closed on October 12, 2018.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">The premium over the fair market value in the amount of $4,121 represents the relative fair value of deferred participation of Bristol-Myers Squibb in R&amp;D expenses which will be amortized over the period of the clinical trial based on the progress in the R&amp;D, in accordance with ASC 808 "Collaborative Arrangements" and $7,788 (net of $91 issuance expenses) were considered equity investment. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;11</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 5:-</span><span style="font-weight:bold; padding-left:16.68pt; ">SHAREHOLDERS&#8217; EQUITY (Cont.)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">In March 2020, the Company entered into an underwriting agreement with SVB Leerink LLC and Stifel, Nicolaus &amp; Company, Incorporated, as representatives of the several underwriters relating to the issuance and sale in a public offering of 8,333,334 of the Company's Ordinary Shares at a price to the public of $9.00 per share (and a price of $8.46 per share to the underwriters). Such shares were issued on March 16, 2020. In addition, the Company granted the underwriters a 30-day option to purchase additional Ordinary Shares at the price set forth above. On April 14, 2020, the Company issued and sold, pursuant to that underwriting agreement an additional 483,005 Ordinary Shares pursuant to the underwriters&#8217; option specified above. The Company sold a total of 8,816,339 Ordinary Shares in the offering with proceeds of $74,147 (net of $5,200 issuance expenses). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; ">b.<span style="padding-left:12.5pt; ">Stock option plan:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">During the six-month period ended June 30, 2021, the Company's Board of Directors granted 66,500 options to purchase Ordinary Shares of the Company to employees. The exercise prices for such options range from $7.59 to $13.32 per Ordinary Share, with vesting to occur in up to four years.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "> The following table presents the assumptions used to estimate the fair value of the options granted in the periods presented: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:80pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Volatility </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">66%-67% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">55%-59% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Risk-free interest rate </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0.5%-0.8% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0.5%-1.6% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Dividend yield </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected life (years) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">5.1 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">5.0-5.1 </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">Weighted average fair value of options granted during the six-month periods ended June 30, 2021 and 2020 were $5.54 and $3.10, respectively.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">During the six-month periods ended June 30, 2021 and 2020, the Company recorded share based compensation in a total amount of $1,805 and $968, respectively.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">As of June 30, 2021, the total unrecognized estimated compensation cost related to non-vested stock options granted prior to that date was $9,596 which is expected to be recognized over a weighted average period of approximately 3.00 years.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">For the six months ended June 30, 2021 and 2020, the total weighted average number of shares related to outstanding options and warrants excluded from the calculations of diluted net loss per share were 6,242,283 and 7,984,232, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;12</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">COMPUGEN LTD. AND ITS SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <hr style="border-top:1.5pt solid #000000; width:100%; margin-top:3pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-6pt; margin-bottom:0pt; "><span style="font-weight:bold; ">U.S. dollars in thousands (except share and per share data)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 5:-</span><span style="font-weight:bold; padding-left:16.68pt; ">SHAREHOLDERS' EQUITY (Cont.)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; ">c.<span style="padding-left:13.06pt; ">Employee Stock Purchase Plan:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">The Company selected the Black-Scholes-Merton option-pricing model as the most appropriate fair value method for its stock-option awards and Employee Stock Purchase Plan (&#8220;ESPP&#8221;). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">As of June 30, 2021, 36,639 Ordinary Shares had been purchased under the ESPP and 563,361 Ordinary Shares were available for future issuance under the ESPP. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:80pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Volatility </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">64%-70% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Risk-free interest rate </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0.0%-0.1% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Dividend yield </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected life (years) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0.4-0.5 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; ">During the six-month period ended June 30, 2021, the Company recorded ESPP compensation in a total amount of $111. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522731255416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL AND OTHER INCOME, NET<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>FINANCIAL AND OTHER INCOME, NET [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">FINANCIAL AND OTHER INCOME, NET</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 6:-</span><span style="font-weight:bold; padding-left:16.68pt; ">FINANCIAL AND OTHER INCOME, NET</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:60pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Interest income </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">528 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">878 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exchange rate differences and other </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">31 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(72 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Financial and other income, net </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">559 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">806 </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI http://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI http://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522646943896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>RELATED PARTY BALANCES AND TRANSACTIONS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY BALANCES AND TRANSACTIONS</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 7:-</span><span style="font-weight:bold; padding-left:16.68pt; ">RELATED PARTY BALANCES AND TRANSACTIONS</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; "> Balances with related parties: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:60pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">31, 2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Trade and other payables (a) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">83 </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; ">Related parties' expenses: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:60pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Amounts charged to: </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development expenses (a) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">110 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">146 </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> <div style="margin-left:60pt; ">
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:4%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">(a) </p> </td> <td style="width:96%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">The Company incurred expenses for research and development services provided by related party for cancer studies in animal models, and breeding and maintenance of animals (mice) to support such studies. </p></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522650282472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-average Assumptions Used to Estimate Fair Value of Options Granted</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:80pt; margin-bottom:0pt; "> The following table presents the assumptions used to estimate the fair value of the options granted in the periods presented: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:80pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Volatility </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">66%-67% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">55%-59% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Risk-free interest rate </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0.5%-0.8% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0.5%-1.6% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Dividend yield </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected life (years) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">5.1 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">5.0-5.1 </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-average Assumptions Used to Estimate Fair Value of Options Granted</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:80pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Volatility </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">64%-70% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Risk-free interest rate </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0.0%-0.1% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Dividend yield </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0% </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected life (years) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">0.4-0.5 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522646943896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL AND OTHER INCOME, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>FINANCIAL AND OTHER INCOME, NET [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncomeTableTextBlock', window );">Schedule of Financial And Other Income, Net</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:60pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Interest income </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">528 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">878 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exchange rate differences and other </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">31 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:1pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(72 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Financial and other income, net </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">559 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">806 </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522646808552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_RelatedPartyBalancesAndTransactionsTablesAbstract', window );"><strong>Related Party Balances And Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Related Party Balances and Transactions</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; "> Balances with related parties: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:60pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">31, 2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Trade and other payables (a) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">83 </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:60pt; margin-bottom:0pt; ">Related parties' expenses: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:60pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Six months ended</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">June 30,</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td colspan="2" style="width:12%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Unaudited</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Amounts charged to: </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:71%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development expenses (a) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">110 </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">146 </p> </td> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> <div style="margin-left:60pt; ">
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:4%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">(a) </p> </td> <td style="width:96%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">The Company incurred expenses for research and development services provided by related party for cancer studies in animal models, and breeding and maintenance of animals (mice) to support such studies. </p></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_RelatedPartyBalancesAndTransactionsTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_RelatedPartyBalancesAndTransactionsTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522731149688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 05, 2013</div></th>
<th class="th"><div>Mar. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>GENERAL [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Upfront payment received</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation', window );">Development, regulatory and commercial milestones compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_ResearchAndDevelopmentArrangementPaymentsReceivable', window );">Potential milestone compensation</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable', window );">Additional milestone compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable', window );">Preclinical milestone compensation</a></td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue', window );">Amount of investment in Compugen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Development, regulatory and commercial milestones compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Addition Potential milestone revenue from arrangements for research and development, including collaboration and licenses agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_ResearchAndDevelopmentArrangementPaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential milestone revenue from arrangements for research and development, including collaboration and licenses agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_ResearchAndDevelopmentArrangementPaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential milestone revenue for preclinical stages of research from arrangements for research and development, including collaboration and licenses agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount on the investment owned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 10<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6438156&amp;loc=d3e57880-113973<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 10<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6431724&amp;loc=d3e32938-113948<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23221-108380<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522641989992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 05, 2018</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_GovernmentAndOtherGrantsLineItems', window );"><strong>Government and Other Grants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_ContingentFees', window );">Contingent fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_AmountIncurredMilestonePayments', window );">Amount incurred milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplyCommitmentAxis=cgen_CollaborationAgreementWithUSAntibodyCompanyMember', window );">Collaboration Agreement With U.S. Antibody Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_GovernmentAndOtherGrantsLineItems', window );"><strong>Government and Other Grants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_AmountIncurredMilestonePayments', window );">Amount incurred milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_GovernmentAndOtherGrantsAxis=cgen_May2012AgreementMember', window );">May 2012 Agreement With Advisor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_GovernmentAndOtherGrantsLineItems', window );"><strong>Government and Other Grants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_AgreementStartDate', window );">Agreement, start date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  09,  2012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_AgreementTerminationDescription', window );">Agreement termination description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In 2014, the May 2012 Agreement was terminated, except with respect to certain payments arising from the Bayer Agreement which survive termination until August 5, 2025.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_GovernmentAndOtherGrantsAxis=cgen_CommercialLicenseAgreementMember', window );">Commercial License Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_GovernmentAndOtherGrantsLineItems', window );"><strong>Government and Other Grants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_PercentageOfRoyaltiesOnNetSales', window );">Percentage of royalties on net sales</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | May 2012 Agreement With Advisor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_GovernmentAndOtherGrantsLineItems', window );"><strong>Government and Other Grants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_ParticipationRights', window );">Participation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesByNatureAxis=cgen_GovernmentAndOtherGrantsMember', window );">Government and Other Grants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_GovernmentAndOtherGrantsLineItems', window );"><strong>Government and Other Grants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived', window );">Maximum royalty repaid as percentage of grant received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_RoyaltyContingentObligations', window );">Contingent royalty obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesByNatureAxis=cgen_GovernmentAndOtherGrantsMember', window );">Government and Other Grants [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_GovernmentAndOtherGrantsLineItems', window );"><strong>Government and Other Grants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_RoyaltyPercentageBasedOnFutureRevenues', window );">Royalty percentage based on future revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesByNatureAxis=cgen_GovernmentAndOtherGrantsMember', window );">Government and Other Grants [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_GovernmentAndOtherGrantsLineItems', window );"><strong>Government and Other Grants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_RoyaltyPercentageBasedOnFutureRevenues', window );">Royalty percentage based on future revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_PropertyLeaseGuaranteeMember', window );">Office leases [Member] | Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_GovernmentAndOtherGrantsLineItems', window );"><strong>Government and Other Grants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Bank guarantees in favor of lessor, foreign currency derivative contracts and credit card security</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_AgreementStartDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Start date of the agreement, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_AgreementStartDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_AgreementTerminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreement termination description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_AgreementTerminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_AmountIncurredMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount incurred milestone payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_AmountIncurredMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_ContingentFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_ContingentFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_GovernmentAndOtherGrantsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Government And Other Grants [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_GovernmentAndOtherGrantsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Royalty Repaid As Percentage Of Grant Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_ParticipationRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the cash consideration received by the Company or its affiliates from third parties to be paid back to advisor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_ParticipationRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_PercentageOfRoyaltiesOnNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalties on net sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_PercentageOfRoyaltiesOnNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_RoyaltyContingentObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The contingent obligations for payments based on royalty-bearing participation received or accrued, net of royalties paid or accrued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_RoyaltyContingentObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_RoyaltyPercentageBasedOnFutureRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty Percentage Based On Future Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_RoyaltyPercentageBasedOnFutureRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplyCommitmentAxis=cgen_CollaborationAgreementWithUSAntibodyCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplyCommitmentAxis=cgen_CollaborationAgreementWithUSAntibodyCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_GovernmentAndOtherGrantsAxis=cgen_May2012AgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_GovernmentAndOtherGrantsAxis=cgen_May2012AgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_GovernmentAndOtherGrantsAxis=cgen_CommercialLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_GovernmentAndOtherGrantsAxis=cgen_CommercialLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesByNatureAxis=cgen_GovernmentAndOtherGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesByNatureAxis=cgen_GovernmentAndOtherGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_PropertyLeaseGuaranteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_PropertyLeaseGuaranteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522640718312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Issuance of Shares) (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 14, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 10, 2018 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 14, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 16, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 25, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 25, 2018 </div>
<div>&#8362; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants purchase to ordinary shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,504,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_DeferredParticipationOfBmsInRdExpenses', window );">Deferred participation of BMS in R&amp;D expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425<span></span>
</td>
<td class="nump">$ 16,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants purchase to ordinary shares remain outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=cgen_AtTheMarketOfferingProgramMember', window );">At The Market Offering Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, net, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,245,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=cgen_AgreementMember', window );">Agreement [Member] | Registered direct offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,316,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants purchase to ordinary shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,253,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable', window );">Expiration period of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=cgen_MasterClinicalAgreementMember', window );">Master Clinical Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,424,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_PercentageOfClosingPrice', window );">Percentage of closing price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=cgen_CollaborativeArrangementsMember', window );">Collaborative Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember', window );">SVB Leerink LLC and Stifel, Nicolaus &amp; Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, net, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,333,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,816,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from ordinary shares in offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember', window );">SVB Leerink LLC and Stifel, Nicolaus &amp; Company [Member] | Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, net, shares | shares</a></td>
<td class="nump">483,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration period of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_DeferredParticipationOfBmsInRdExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred participation of BMS in R&amp;amp;amp;amp;D expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_DeferredParticipationOfBmsInRdExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum authorized proceeds from issuance of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_PercentageOfClosingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of closing price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_PercentageOfClosingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cgen_AtTheMarketOfferingProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cgen_AtTheMarketOfferingProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cgen_AgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cgen_AgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cgen_RegisteredDirectOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cgen_RegisteredDirectOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cgen_MasterClinicalAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cgen_MasterClinicalAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cgen_CollaborativeArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cgen_CollaborativeArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cgen_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cgen_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522640595688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Schedule of Stock-Based Compensation) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted</a></td>
<td class="nump">66,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Stock options granted, exercise price, minimum</a></td>
<td class="nump">$ 7.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock options granted, exercise price, maximum</a></td>
<td class="nump">$ 13.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">66.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Expected risk free interest rates range, minimum</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Expected risk free interest rate range, maximum</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options granted during period</a></td>
<td class="nump">$ 5.54<span></span>
</td>
<td class="nump">$ 3.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Share based compensation stock options</a></td>
<td class="nump">$ 1,805<span></span>
</td>
<td class="nump">$ 968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 9,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period over which compensation expense will be recognized</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total weighted average number of shares related to outstanding options and warrants excluded from the calculations of diluted net loss per share</a></td>
<td class="nump">6,242,283<span></span>
</td>
<td class="nump">7,984,232<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted</a></td>
<td class="nump">36,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Ordinary shares available for issuance | shares</a></td>
<td class="nump">563,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">64.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Expected risk free interest rates range, minimum</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Expected risk free interest rate range, maximum</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense', window );">Share based compensation ESPP</a></td>
<td class="nump">$ 111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of plan compensation cost recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522731461768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL AND OTHER INCOME, NET (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>FINANCIAL AND OTHER INCOME, NET [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeDepositsWithFinancialInstitutions', window );">Interest income</a></td>
<td class="nump">$ 528<span></span>
</td>
<td class="nump">$ 878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Exchange rate differences and other</a></td>
<td class="nump">31<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cgen_FinancialAndOtherIncomeNet', window );">Financial and other income, net</a></td>
<td class="nump">$ 559<span></span>
</td>
<td class="nump">$ 806<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cgen_FinancialAndOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate of financial and other income net of expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cgen_FinancialAndOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeDepositsWithFinancialInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest income derived from funds deposited with both domestic and foreign financial institutions including funds in money market and other accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (a)<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (b)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeDepositsWithFinancialInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140522650905832">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>RELATED PARTY BALANCES AND TRANSACTIONS [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Trade and other payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesRelatedParty', window );">Related parties' expenses amounts charged to research and development expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company incurred expenses for research and development services provided by related party for cancer studies in animal models, and breeding and maintenance of animals (mice) to support such studies.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs of sales and operating expenses for the period incurred from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>34
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M'2]O)$^+ ^8'+B6/B\L]@^Y"* -XO^-<OMZH,^OC_RB&_P)02P,$%     @
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MU>%2=:-%7I[// JMQ:J\7#)H]*41@/<+(?3;C5E@>\0W^Q]02P,$%     @
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M)[T3RHG'FLXP%=BY''!2)%?]+Q9X=/PU>[P^QA#MC [A+.O8 (!E3=[P2X=
M+]?3J0QCD6Y#-T7Z38ZW]5Y!\@4%Y%BJ5HU"6O760ODYW<ILF.<5\-RH7'F9
M!7W_^,P!ZB4G>_7_$5W>WSX\<4/<C*]01G=7-!R/:/1T,1I>#0>/?Q SY(C&
M]UAY-[J_&5X-QM=7]'EX-[B['((P1V,\N+V^@U3@E(S3;QTW@I^;RB$>CG8
M6)8HHKFP,42@I/H.!2QVZ0T1[UPB>YU=DH&8[E-O)A!)?B \B*3#/5VN4CNV
MW(R;O/3*19'@:YEAP57SWZJ(.Y802W[OU*S@3-84\JV%]2JV"H6@]VY1CHY&
M7RLUF6"[@-H1X*A^31+/J)9@'6%:U4.;G)1T!_:@0Q&\_BPGMF)V3@["4.ZU
MMUN/>-]%P!TCL":+W1(9B#%YJTH="GNBBAB;IB=\"!R6RV>AJSA"$ LQE9Y9
MQFC,E8G2RL>)ABY7OLK1;74#+3E>J+"C7L*.KML(2._+3#V;7WY*C@Y.:*?
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M%K5+H/>9H@_2;%R!]G]B_!-02P,$%     @ M3C\4B+\</M= P  J0<  !@
M  !X;"]W;W)K<VAE971S+W-H965T.2YX;6RU55%OXC@0_BNC/-U*+:&AW5U5
M@$2!ZCAM:57HW;.)!^*K8V=MIY1_OS-.2%EIVX?5W0O$XYGO^V;L&0_WUCW[
M C' :ZF-'R5%"-5UFOJ\P%+XGJW0T,[6NE($6KI=ZBN'0L:@4J=9O_\Y+84R
MR7@8;0]N/+1UT,K@@P-?EZ5PAQO4=C]*+I*CX5'MBL"&=#RLQ Y7&)ZJ!T>K
MM$.1JD3CE37@<#M*)A?7-Y?L'QW^5KCW)]_ F6RL?>;%0HZ2/@M"C7E@!$%_
M+SA%K1F(9'QO,9..D@-/OX_HMS%WRF4C/$ZM_D?)4(R2KPE(W(I:AT>[_Q/;
M?*X8+[?:QU_8-[Y760)Y[8,MVV!24"K3_(O7M@XG 5_[[P1D;4 6=3=$4>5,
M!#$>.KL'Q]Z$QA\QU1A-XI3A0UD%1[N*XL+X:3EYFBW6\QDLENOYX^(.IO?+
MU?VWQ6S"QMO%<K*<+B;?8+4FP]U\N5X-TT#$')[F+<E-0Y*]0_(9[JP)A8>Y
MD2A_CD])<*<Z.ZJ^R3X$_*LV/1CTSR#K9Q<?X VZ*@PBWN"]*AA12Q50PL($
M=*J$J37>:B4%&V^5$2970L,JD('N9/ ?L%YVK)>1]?+_K?V')-S4U[X2.8X2
MZEJ/[@63\?)^/8?!]3G\A@18%TC-E-NR$N:@S [JKGJJK5Y^6KUM5SW?50\*
M\8*P031 JBKA8G"$=9*\D=H@%'%=F\ DE5,$4FGTL$.#3FA]X'VL&F(().O)
M1!GQE#S0R.H4O8E0IAEE-!-Z,(F$A*\/9XQP &G!V$!>N:XE):IU1#Z) F$H
M*6L#^1&+P^^U8OV;PW^@E\NJ,> OJ]:CZQGC;*4,*[%;F@6&AB=OGT6Q0OY+
M4Z,I\A]\#LI'/>1J. --@O/:.;:1'%<+[3_% U,2.0V#.7I/ SKJ$; 5RD&\
M.B8T^;^=75LEV8/[BE*,1.1)$[')AK5Z]7I><OL#N2@K 7D( +4P=BT,= %B
MV8_DBHJEC%2YX*'-XAGJ"!T*$2CQ XD ?*UHP/,U:_D.*%S+,2.T<H,.!A<-
M3P]^U;;IR?@LT>WB(^$A'F4S23MK]PY-FO'[YMX\8G?"[93QH'%+H?W>EZL$
M7/,P-(M@JSB,-S;0:(^?!;VEZ-B!]OE>'1=,T+W.XQ]02P,$%     @ M3C\
M4CU+,!FQ!   /@H  !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULK59M
M;^)&$/[>7S&B=VTB$3 .N>85B0#7^I1 %$BKJNJ'Q1[;J]B[OMUU./Y]9];
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MKOP+8:D=O3?\9TX//#0L0.>IUFZ[8(#=DW'P%U!+ P04    " "U./Q2":\
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M+<#SF5)Y=4,*ZM?&7_X#4$L#!!0    ( +4X_%(YVSW170(  #0%   9
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;*U438_:,!"]YU>,HAY::;L)X;,K
M0 *6U5(56.U'>ZAZ,,F$6)O8U)X4^N]K.R%+I2Z5JEYLCSWOS9NQQ\.]5,\Z
M0R0X%+G0(S\CVET%@8XS+)B^E#L4YB25JF!D3+4-]$XA2QRHR(,H#'M!P;CP
MQT.W=Z?&0UE2S@7>*=!E43#U<XJYW(_\EG_<N.?;C.Q&,![NV!8?D)YV=\I8
M0<.2\ *%YE* PG3D3UI7TX[U=PZ?.>[UR1IL)ALIGZVQ2$9^: 5ACC%9!F:F
M'SC#/+=$1L;WFM-O0EK@Z?K(?N-R-[ELF,:9S+_PA+*1/_ AP925.=W+_2W6
M^70M7RQS[4;85[Z=M@]QJ4D6-=@H*+BH9G:HZW "&(2O *(:$#G=52"G\IH1
M&P^5W(.RWH;-+ERJ#FW$<6$OY8&4.>4&1^.;Q6JRFBTFGV"RNH;UX^W\'A:K
MV7HYOX#5_'$8D EB78.X)IQ6A-$KA#U82D&9AKE(,/D='QAQC<+HJ' :G27\
M6(I+:(<7$(51ZPQ?N\FX[?C:_Y8Q?)UL-"GS6KZ="=9I@G5<L,[_*^]YPM7Z
M<0Z]J_?P%V;O@1^@J&X"[4V J2/:.GJVCG8(O2?!RH03)MY"$"K4!%S$LD#O
MC=>-!F8<] ?>_!!G3&P1%".$A*>I<14Q:F B 4D9*J_=\M[V(^^==\,%$S%G
M^<MAS7D! LD2=S]8XK#WI_(&)R^Y0+5U_:HAEJ6@ZE$WN\V7,*DZX<6]^D^6
M3&VYT)!C:J#A9;_K@ZIZM#)([EQ?;"29+G/+S'QKJ*R#.4^EI*-A S0?Y?@7
M4$L#!!0    ( +4X_%)887?'_0(  )4&   9    >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;*U5[V_:,!#]GK_"BB9ME3H2 OTA!$B!,JU32RN@FZ9I'YSD
M(%9C.[,=*/_]SDZ:T6E%D[8O2<ZY]][=V7D9[J1ZU#F (4^\$'KDY\:4@R#0
M:0Z<ZHXL0>";M52<&@S5)M"E IHY$"^"* S/ TZ9\,=#MW:OQD-9F8()N%=$
M5YQ3M9] (7<CO^L_+RS8)C=V(1@/2[J!)9B'\EYA%+0L&>,@-)."*%B/_+@[
MF/1MODOXS&"G#YZ)[221\M$&U]G(#VU!4$!J+ /%VQ:F4!26",OXT7#ZK:0%
M'CX_LW]PO6,O"=4PE<47EIE\Y%_Z)(,UK0JSD+N/T/1S9OE266AW);LZ]PP5
MTTH;R1LPQIR)^DZ?FCD< "[#5P!1 XA<W;60J_**&CH>*KDCRF8CFWUPK3HT
M%L>$W92E4?B6(<Z,%[.;>#6[(O?Q8O653.*;>#Z=+4D\OR*K13Q?QM/5]=U\
M.0P,BEE(D#;$DYHX>H7XG-Q*87)-9B*#["4^P"+;2J/G2B?14<)/E>B07GA*
MHC#J'N'KM9WW'%_OWSHGW^)$&X6GY_L1T7XKVG>B_?\_[J/$]ML=Z)*F,/+Q
MX]2@MN"/YW>K&;D8O"=_V^N$%E2DH/$0FAR_N8(:R$A)E6&@!QYN =@M\*X@
M!9Z \NQ>>+VNVY30>Q"TRAA"O)6B&1 J,B)-#@HI]C0ID/@=/?'>>.<17BY[
MWN*EPEL"3^@VVFHMV1/A]0D">X)(*^XT?].+N:R$T23-J=I@LI$#)-= 59J[
M,C+8H@&5:">F%6F*Z79#>^V?>S9>Y4"FDI=4[ D3::44TK4(=$&B7N.U4V=V
M>J626V9K3O8OAKAW^-2.&'W18.V8S-":!..TP'8S*/2IXTT40,;$Q@767 T(
MBR-RW:1C^1S53K!7M-2RE HKJ+"LAKA#_G1>@P.KX("SLH:(<[/CJUVC76T]
M-ZZMYE=Z;=BW.&HF-"E@C="P<W'F$U6;8!T863KC2:1!&W./.?XW0-D$?+^6
MTCP'5J#]$XU_ E!+ P04    " "U./Q2H> KYPH#   I!P  &0   'AL+W=O
M<FMS:&5E=',O<VAE970Q-"YX;6S-5=MNVS@0?==7# 08FP*5)3NVTPUL TGC
M;K)H4-?.!8NB#[0ULHA0I$I2<?SW'5*RFNYNW*)/!6R1',[ES!QR.-XJ_6!R
M1 M/A9!F$N;6EJ=Q;-8Y%LQT58F2=C*E"V9IJ3>Q*36RU!L5(NXGR2@N&)?A
M=.QE<ST=J\H*+G&NP51%P?3N'(7:3L)>N!<L^":W3A!/QR7;X!+M;3G7M(I;
M+RDO4!JN)&C,)N%9[_1\Z/2]PAW'K7DV!Y?)2JD'M[A*)V'B *' M74>& V/
M^!:%<(X(QI?&9]B&=(;/YWOO[WSNE,N*&7RKQ#U/;3X)WX208L8J81=J>XE-
M/A[@6@GCO[!M=),0UI6QJFB,"4'!93VRIZ8./V/0;PSZ'G<=R*.\8)9-QUIM
M03MM\N8F/E5O3>"X=*0LK:9=3G9VNKP\6\PN/[R_F"V6?\#LX^W5S3]P=,-6
M LVK<6PIA%.,UXV[\]I=_P5W([A6TN8&9C+%]'O[F*"U^/I[?.?]@P[_KF07
MCI/7T$_ZO0/^CMM\C[V_P4OYTJE.*X&@,KCWE&$:L4?4= +AS-#9+-UI,7!K
M, 6K8&8L)_(1WC&NX8Z)RMM^:-3^TDS:?V=:)W88R$V.D"E!EX++#5A7<*!K
M95!: Y8VV3,P50,&]V"<0N8 />X!.8EJU#<U*.#2BTO47*5F[Q[3TV#)GZ"H
MF4+'%%"=T=4Y<'5VGR2XE:Q*.:D'=THPRP6WNV TZD2CDTXP'':BX9^=8,'-
M0Y1I1 IFD0)8T 0P2+JDD'3?=.I9KSOJ!!?\D:<4#G8<11HD'?>;/95T00F!
MX!G"T0Z9-J^"8;='_R2B\0#I@Y;TP<%:SXI2J!UA7%JU?H!YI=<YW628"R;A
MTS46*]2?#\09MG&&O\OA^@&07Z9WT(E.B)7H +&)([;G=/Y+:/0"GTEW0$;#
M(/J_*L?/VE>!>N.;M(&UJJ2M.UDK;=^!L[K]?5.O'Y%KIC><*B<P(].D>T)U
MTG5CKA=6E;X9KI2EUNJG.;UEJ)T"[6=*V?W"!6A?Q^E74$L#!!0    ( +4X
M_%*Y/*X-;@(  " %   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;)U4
MW6_:,!!_SU]QBO;02E43 K2L B2@5*5::=6/[6':@TDNQ*IC,_LRV'\_VPDI
MD]I.VHOCC_M]W,7GX5;I%U,@$NQ*(<TH+(@V%U%DT@)+9D[5!J4]R94N&=FE
M7D=FHY%E'E2**(GCLZAD7(;CH=^[U^.AJDAPB?<:3%663/^>HE#;4=@)]QL/
M?%V0VXC&PPU;XR/2\^9>VU74LF2\1&FXDJ Q'X63SL6TY^)]P%>.6W,P!Y?)
M2JD7MUADHS!VAE!@2HZ!V<\OG*$0CLC:^-EPAJVD Q[.]^Q7/G>;RXH9G"GQ
MC6=4C,)!"!GFK!+TH+;7V.33=WRI$L:/L*UC>[T0TLJ0*ANP=5!R67_9KJG#
M 6 0OP-(&D#B?=="WN4E(S8>:K4%[:(MFYOX5#W:FN/2_91'TO:46QR-KQ;+
MR7*VF'R!R?(2[IZNYP^P6,[N;N<GL)P_P=$36PDTQ\.(K)K#1&G#/*V9DW>8
MS^!622H,S&6&V=_XR+ILK29[J]/D0\*;2IY"-SZ!)$XZ'_!UV]2[GJ_[GZE_
MGZP,:7MM?GP@UFO%>EZL]X[8H^VFK!((*H<K+IE,.1,PD1G<48$:%C)5)5IA
MI+=*_0]ROH.R+C:Z8H,M%;I2!:Y4;HB#9\FJC!-FP4(2:C0$W&L&GX)^,K#C
MX'P0S'=IP>0:03-"R'B>VU"9H@%FK2IG->AV@J/S)#@.7O-H#QO.$Y!(CKC_
MV1''9V]5,#JXM27JM>]- ZFJ)-47N-UMVW]2W_K7\/KMN&5ZS:4!@;F%QJ?G
M_1!TW8_U@M3&]\!*D>TH/RWL$X;:!=CS7"G:+YQ ^RB._P!02P,$%     @
MM3C\4ET9;#,( P  ;@8  !D   !X;"]W;W)K<VAE971S+W-H965T,38N>&UL
M?55=;]HP%'W/K[B*)FV5IB8$VE4(D +MM$UMAX!MVJ-)+L2:/S+;@?+O=^W0
MK)T&+\%V[CWG^&"?C/;:_+(5HH,G*90=QY5S]3!);%&A9/92UZCHS48;R1Q-
MS3:QM4%6AB8IDBQ-KQ/)N(HGH[ V-Y.1;IS@"N<&;",E,X<I"KT?Q[WX>6'!
MMY7S"\ED5+,M+M%]J^>&9DF'4G*)RG*MP.!F'.>]X73@ZT/!=XY[^V(,?B=K
MK7_YR>=R'*=>$ HLG$=@]+/#&0KA@4C&[R-FW%'ZQI?C9_2/8>^TES6S.-/B
M!R]=-8YO8BAQPQKA%GK_"8_[N?)XA18V/&'?UEYE,12-=5H>FTF!Y*K]94]'
M'UXTW*0G&K)C0Q9TMT1!Y2US;#(R>@_&5Q.:'X2MAFX2QY7_4Y;.T%M.?6ZR
MN+O/5W>W,,\7JY\PS>_SQ]G=$O+'6U@M\L=E/EM]_OJXA'<KMA9H+T:)(U;?
MFQ1'AFG+D)U@N(8'K5QEX4Z56+[N3TAM)SE[ECS-S@)^:=0E]-/WD*59[PQ>
MO[.@'_#ZIRQ P1R6,&?&'6#*!%,%6LA5"2O#E&7A_-@S3(..:1"8!B>8EG2E
MRD8@Z V<8&5G65M[SI+X6SRT-2MP'-,UM6AV&$\Z_#UW%5VFEKLF;HYV&)&E
MZ"V-;K% N483>6^C?B^8G$;?%&M*3BT1:2LQJ-2N0D,0AW PX!V[B-Y$UQD]
M;OK1XC7#6\ GBA'KN9;\"61[(M"?".C( ^<_?+G4C7(6BHJ9+14[/21PB\P4
M59!1XHZ2I::<<!W)44ROE_KGX#KR\U6%,-.R9NH 7!6-,037=5"\@3F%ZTWD
MWKW:Z!WWFM>'5R8>0G_A+:; <Z2=BCEECN*2"=INB<*^#[AK@UARM0T3GYH.
ME>_S9Z(M)_F2V"YHKY25=:T-*6A(UA'X$OYW%),7&2"1O/))1[YY^]HXZ%:[
M,,W;#/E;WB;Q UG-E06!&VI-+S]<Q6#:=&LG3M<A4=;:43Z%844?!#2^@-YO
MM';/$T_0?6(F?P!02P,$%     @ M3C\4K-WKS*L @  D@<  !D   !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&ULE95=;YLP%(;_BH5ZT4I=(!"2J$J0TM!]
M:9NB=MTNIETX8,"JL9EMDO;?[]A0E"J!MKD(MO'[^O'A^'BQ%_)!%81H]%@R
MKI9.H75UY;HJ*4B)U4A4A,.;3,@2:^C*W%65)#BUHI*YON=-W1)3[D0+.[:1
MT4+4FE%.-A*INBRQ?+HF3.R7SMAY'KBE>:'-@!LM*IR3.Z+OJXV$GMNYI+0D
M7%'!D239TEF-K^*YF6\G_*)DKP[:R.QD*\2#Z7Q)EXYG@ @CB38.&!X[LB:,
M&2/ ^-=Z.MV21GC8?G;_:/<.>]EB1=:"_::I+I;.W$$IR7#-]*W8?R;M?D+C
MEPBF[#_:-W.G@8.26FE1MF(@*"EOGOBQC<.!8#SI$?BMP'^K(&@%P5L%DU8P
ML9%IMF+C$&.-HX44>R3-;' S#1M,JX;M4VX^^YV6\):"3D>?;G[<W*Z^H?.8
M:$R9ND ?T/U=C,[/+M 9HAS]+$2M,$_5PM6PGE&Y2>M]W7C[/=ZK.A\A+[Q$
MOC<.3LC7P_+O6(Y0X%GY_(0\'I9_K?FSW!^_E+L0I"Y2?A<IW_H%KT3JSVJK
MM(1\_3M@&G2F@36=])C>5YD47*,*/\%9TG"0$@+G(#T5[,8IM$[F-.^BL0>_
MA;L[C.EKLUY@3CK,R2!F3'90("J#> F,><VP%O()05Z@1)0ED0G%#/*3$<A8
M3I09A<JDL#G<ISY]L][T -/W^CG#CC,<Y-P(#8@O4%XCN0Z/2<)^DFE',ATD
M6:4I-2N^!V4]/?IV?B_(K .9#8<$4@K&:/*NH,R.28)>E'F',A^.22EJR'&1
M05W9 8C->"@Q:X"I<W(*))X?I_.)F+@'!=#<5E Z<LH58B0#G3>:@8%L;H"F
MHT5E:^)6:*BPMEG I4FDF0#O,P&9U'9,F>VNX>@_4$L#!!0    ( +4X_%*3
M&1[B] 0  ( 3   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;+58;6_B
M.!#^O/<K1FA/VI4X2 ST9=4B4;K7X[2T55]N/ZSN@TDF8#6QL[8#1;H??^-
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MT\L%)6I]D@'J^QGG<G.3O) HWA\>_PM02P,$%     @ M3C\4DBYA>0;!@
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M0&$"]/V4<[79F 3-5R;Z"U!+ P04    " "U./Q2DNZ7 D$#  "8"   &0
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6RE5FV/VS8,_BN$4:!W0'=^R=LU
M2 (X<89U:&^')-TP%/V@V$QLU)8\24XN_WZ4['-S5R<HMB^V1/,A^5 4Z<E1
MR&\J1=3P5.1<39U4ZW+LNBI.L6#J3I3(Z<M.R()IVLJ]JTJ)++&@(G<#SQNZ
M!<NX,YM8V:.<342E\XSCHP15%063ISGFXCAU?.=9L,KVJ38"=S8IV1[7J#^7
MCY)V;FLER0KD*A,<).ZF3NB/ER.C;Q7^S/"HSM9@F&R%^&8V'Y*IXYF ,,=8
M&PN,7@=<8)X;0Q3&/XU-IW5I@.?K9^N_6N[$9<L4+D3^5Y;H=.K<.Y#@CE6Y
M7HGC;]CP&1A[L<B5?<*QUAV]=R"NE!9% Z8(BHS7;_;4Y.$,<.]=  0-('@%
M(,?=@%X#Z+T&]"\ ^@V@_[. 00.PU-V:NTU<Q#2;3:0X@C3:9,TL;/8MFO*5
M<5,G:RWI:T8X/5LM/X:;902/X6KS-\S#C^'#8KF&\"&"S2I\6(>+S8<_'M9P
M$Z%F6:YNX1?XO([@YLTMO(&,PR85E6(\41-74SS&JALWOA>U[^""[R%\$ERG
M"I8\P>0EWB4>+9G@F<PBN&KP]XK?0<][!X$7^!WQ1#\/]SK@R^OP"&."^UWP
M%VQZ[='TK+W>_SR:+^%6:4DW[NL5I_W6:=\Z[5]PNI$L0:#S!*%3E%"R$]OF
MV'6Z\^N6OOA?NTJB!@TLR#2QPVP83-S#>9I_5+GOM2HO6 U:5H.KL:PP9QH3
M8B-UANHMX!,U6H4*6"$JKA7$*9-[TM""NI]")N/49B'! _72DCJC;D%=N;CN
M_T(N!C\0]7WO93*B#IW^L#L;0^>58-2F9_0?PIM?!VU2A(4H2L9/U ?B2DI*
M7YM7FF"7$ZE0'K*8M$HI#AG=?=B>2/O[&9TL/F8\IA)4NDKHT$RS83PK6 Z%
M2#!7[ZS=K41,,KZW&S,8-7*# [%KU!7<%.3MUIRMJLI22(J@HK :PW==U\8]
M:ZD%4FF8649E8JJEODVMM!V7<SLE7LD7_CCR.^3A<!P-.^3ST3BR8]?][K:>
MV9^H0C.N(,<=A>#=C:@H9#T'ZXT6I6WT6Z%I;-AE2K\.*(T"?=\)H9\WQD'[
M,S+[%U!+ P04    " "U./Q2PSA@9QL#  "-$   #0   'AL+W-T>6QE<RYX
M;6S=6%%KVS 0_BO&+:.%42?QZL5K$M@"A<$V"NW#WHH2RXY ECQ9[I(^[N?T
M9^V73&?9CI/J2M>'+9M#8^D^W7>?[LZ1Z:34&TZO5Y1J;YUS44[]E=;%NR H
MERN:D_),%E08))4J)]I,51:4A:(D*<$IY\%H,(B"G##ASR:BRB]S77I+60D]
M]</.Y-G;QV3J#Z,WOF?IYC*A4__VY-6W2NJ+8\_>CUX?'0UN3R_V[2<U<.H'
M3M)S-^G/'P]]VK-!GWD+GK0H1A\]0_,N^;&3.FA2-)ND4NQF"@PF-LFI=T?X
MU)\3SA:*@5=*<L8WUCP"PU)RJ3QM2F3$#,%2WEMX:&=0O88G9T*J.K:-8+\7
MS?(]H)V!0,9Y)W#D6\-L4A"MJ1*79E(OKHV/(*\9WVP*HS!39#,<G?M;A_IF
M@BRD2JCJP@S]UC2;<)J"',6R%=RU+ ( M9:Y&22,9%*06D/KT0P,[9)R?@VM
M_37=X5ZGO:H.H*:B&QI!S=#2V GP]]DL=X\V?A&M5[ [J3]49C>BGD.OT"M%
M4[:NY^NTBX^Q#W%V4A1\\YZS3.34[OW9 6<3TOIY*ZG8O8D&G;(T!JI\[XXJ
MS99]RW=%BANZUFTWK5-<\^@?U/QG\YQ1017A?=&F]0\YRR]6W!P%?T-S_:NR
MK]@I,GQ[^!J;X^_0148'*3)H?M![I\;.F=%9/3B;I_X7> _@VZ#>HF)<,]',
M5BQ)J'AT=!AZ31;F76N'WZQ/:$HJKF\Z<.IOQY]IPJH\[E9=02*:5=OQ)]C>
M,.I>#$PL)A*ZILF\F:IL40\],S!1FPL<]I'+^G(CF(_%W A@6!Q, >9CO; X
M_]-^QNA^+(9I&SN1,>HS1GVLEPN9UQ\LCMLG-I=[IW$<AE&$970^=RJ88WF+
M(OASLV':P .+ Y%^+]=XM?$.>;H/L)H^U2'83O%.Q':*YQH0=][ (X[=U<;B
M@ =6!:QW(+X[#O24VR<,H:J8-NP)QI$XQA#H17>/1A&2G0@^[OI@3TD8QK$;
M <RM( PQ!)Y&',$4@ 8,"</Z'-P[CX+VG JV_X"8_0)02P,$%     @ M3C\
M4I>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(
M,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5
MN %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;
M+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%
MR=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
M    " "U./Q2\4?V9\X"  "F#P  #P   'AL+W=O<FMB;V]K+GAM;,6776_;
M(!1 _PKRRS)IFN.T33_45/)LDB E.+.=2GV:B$T:5!LB3-JMOW[85C2R56@O
MM$^$#^'#O< )MR]"/FV$> (_ZXHW$V^GU/[&]YMB1VO2?!5[RG7/5LB:*%V5
MCWZSEY24S8Y255?^:#@<^S5AW+N[/<ZUDKY9$8H6B@FN&]N&>T9?FC_];14\
MLX9M6,74KXG7_:ZH!VK&6<U>:3GQAAYH=N)E+B1[%5R1*BNDJ*J)%_0=]U0J
M5OS3G+60.=DT78LBFY1HD(DW'NH)MTPVJAO1S4\TXS/5@_O:08DIJQ25,5%T
M)L5AS_AC.XU>A6\LHXO#L>R#>"/_)XQBNV4%C45QJ"E7?1PEK5I WNS8OO$
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M3DNL/]'H=OU&+582M$7OK_.+=@MM#U45Z;:$+P0IC\_,XQ/Y[C=02P,$%
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MQ_8[]?;AT9*?>YYK?OX[J0[CLS0?/RV?FXOW,N$,[$_O] M02P,$%     @
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M;W!S+V%P<"YX;6Q02P$"% ,4    " "U./Q2+YE&2N\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "U./Q2
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( +4X_%*O*#<:/@,  '4+   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "U./Q2
MRCL%FED&  "O&   &               @(&""P  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @ M3C\4F0GE2^% @  K08  !@
M     ("!$1(  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M +4X_%*1@D^\Y0,  &H,   8              " @<P4  !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6Q02P$"% ,4    " "U./Q2+8;9^*4%  !&&   &
M            @('G&   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#
M%     @ M3C\4J;@O$O)!@  [AL  !@              ("!PAX  'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( +4X_%)48+\Q9 <  , 1
M   8              " @<$E  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"% ,4    " "U./Q2WM,BO*H"   S!@  &               @(%;+0
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ M3C\4B+\</M=
M P  J0<  !@              ("!.S   'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;%!+ 0(4 Q0    ( +4X_%(]2S 9L00  #X*   9              "
M@<XS  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ M3C\
M4@FO "ZP"P  0AX  !D              ("!MC@  'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"% ,4    " "U./Q2.=L]T5T"   T!0  &0
M        @(&=1   >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0
M   ( +4X_%)887?'_0(  )4&   9              " @3%'  !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ M3C\4J'@*^<* P  *0<
M !D              ("!94H  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q0
M2P$"% ,4    " "U./Q2N3RN#6X"   @!0  &0              @(&F30
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( +4X_%)=&6PS
M" ,  &X&   9              " @4M0  !X;"]W;W)K<VAE971S+W-H965T
M,38N>&UL4$L! A0#%     @ M3C\4K-WKS*L @  D@<  !D
M ("!BE,  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " "U
M./Q2DQD>XO0$  " $P  &0              @(%M5@  >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( +4X_%(9M;AY7@8  $L<   9
M          " @9A;  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#
M%     @ M3C\4DBYA>0;!@  C1P  !D              ("!+6(  'AL+W=O
M<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "U./Q2M\DLK90"  !Q
M!@  &0              @(%_:   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM
M;%!+ 0(4 Q0    ( +4X_%*2[I<"00,  )@(   9              " @4IK
M  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ M3C\4L,X
M8&<; P  C1    T              ( !PFX  'AL+W-T>6QE<RYX;6Q02P$"
M% ,4    " "U./Q2EXJ[',     3 @  "P              @ $(<@  7W)E
M;',O+G)E;'-02P$"% ,4    " "U./Q2\4?V9\X"  "F#P  #P
M    @ 'Q<@  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ M3C\4N 71U@M
M 0  ^0T  !H              ( !['4  'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ M3C\4J\1:3!H 0  ! \  !,
M ( !47<  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     !X '@ )"   ZG@
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>57</ContextCount>
  <ElementCount>232</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>19</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-daei1</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00020 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-cbs</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-cbsp</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00040 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-csocl</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00050 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-socise1</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00070 - Disclosure - GENERAL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-g</Role>
      <ShortName>GENERAL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00080 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-sap1</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00090 - Disclosure - UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/UnauditedInterimConsolidatedFinancialStatements</Role>
      <ShortName>UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00100 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-cac</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00110 - Disclosure - SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-se1</Role>
      <ShortName>SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00130 - Disclosure - FINANCIAL AND OTHER INCOME, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-fin</Role>
      <ShortName>FINANCIAL AND OTHER INCOME, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00140 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-rpbat</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00160 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-set</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cgen.com/role/cgen-se1</ParentRole>
      <Position>14</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00170 - Disclosure - FINANCIAL AND OTHER INCOME, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-fint</Role>
      <ShortName>FINANCIAL AND OTHER INCOME, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cgen.com/role/cgen-fin</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00180 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/RelatedPartyBalancesAndTransactionsTables</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cgen.com/role/cgen-rpbat</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00190 - Disclosure - GENERAL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-gd1</Role>
      <ShortName>GENERAL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cgen.com/role/cgen-g</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00200 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cgen.com/role/cgen-cac</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00210 - Disclosure - SHAREHOLDERS' EQUITY (Issuance of Shares) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Issuance of Shares) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cgen.com/role/cgen-set</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00220 - Disclosure - SHAREHOLDERS' EQUITY (Schedule of Stock-Based Compensation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Schedule of Stock-Based Compensation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cgen.com/role/cgen-set</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00230 - Disclosure - FINANCIAL AND OTHER INCOME, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-find</Role>
      <ShortName>FINANCIAL AND OTHER INCOME, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cgen.com/role/cgen-fint</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="cgen6k0621.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00240 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cgen.com/role/cgen-rpbatd</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cgen.com/role/RelatedPartyBalancesAndTransactionsTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="6-K" original="cgen6k0621.htm">cgen6k0621.htm</File>
    <File doctype="6-K" original="exhibit_99-2.htm">exhibit_99-2.htm</File>
    <File>cgen-20210630.xsd</File>
    <File>cgen-20210630_cal.xml</File>
    <File>cgen-20210630_def.xml</File>
    <File>cgen-20210630_lab.xml</File>
    <File>cgen-20210630_pre.xml</File>
    <File>exhibit_99-1.htm</File>
    <File>exhibit_99-3.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>40
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cgen6k0621.htm exhibit_99-2.htm": {
   "axisCustom": 1,
   "axisStandard": 9,
   "contextCount": 57,
   "dts": {
    "calculationLink": {
     "local": [
      "cgen-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cgen-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cgen6k0621.htm",
      "exhibit_99-2.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cgen-20210630_lab.xml",
      "us-gaap-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cgen-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "local": [
      "us-gaap-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cgen-20210630.xsd",
      "xbrl-linkbase-2003-12-31.xsd",
      "xl-2003-12-31.xsd",
      "xlink-2003-12-31.xsd",
      "us-gaap-2021-01-31.xsd",
      "xbrl-instance-2003-12-31.xsd",
      "types.xsd",
      "extensible-enumerations-2.0.xsd",
      "xbrldt-2005.xsd",
      "ref-2006-02-27.xsd",
      "us-types-2021-01-31.xsd",
      "srt-types-2021-01-31.xsd",
      "srt-2021-01-31.xsd",
      "country-2021.xsd",
      "srt-roles-2021-01-31.xsd",
      "us-roles-2021-01-31.xsd",
      "net-2009-12-16.xsd",
      "negated-2009-12-16.xsd",
      "dei-2021.xsd",
      "currency-2021.xsd",
      "exch-2021.xsd",
      "naics-2021.xsd",
      "sic-2021.xsd",
      "stpr-2021.xsd",
      "dei-2021_doc.xsd",
      "dei-2021_ref.xsd",
      "reference-2009-12-16.xsd",
      "us-parts-codification-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 237,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 2,
    "http://xbrl.sec.gov/dei/2021": 11,
    "total": 13
   },
   "keyCustom": 28,
   "keyStandard": 204,
   "memberCustom": 11,
   "memberStandard": 8,
   "nsprefix": "cgen",
   "nsuri": "http://cgen.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cgen6k0621.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00010 - Document - Document and Entity Information",
     "role": "http://cgen.com/role/cgen-daei1",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cgen6k0621.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00100 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://cgen.com/role/cgen-cac",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00110 - Disclosure - SHAREHOLDERS' EQUITY",
     "role": "http://cgen.com/role/cgen-se1",
     "shortName": "SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00130 - Disclosure - FINANCIAL AND OTHER INCOME, NET",
     "role": "http://cgen.com/role/cgen-fin",
     "shortName": "FINANCIAL AND OTHER INCOME, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00140 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS",
     "role": "http://cgen.com/role/cgen-rpbat",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00160 - Disclosure - SHAREHOLDERS' EQUITY (Tables)",
     "role": "http://cgen.com/role/cgen-set",
     "shortName": "SHAREHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestAndOtherIncomeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00170 - Disclosure - FINANCIAL AND OTHER INCOME, NET (Tables)",
     "role": "http://cgen.com/role/cgen-fint",
     "shortName": "FINANCIAL AND OTHER INCOME, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestAndOtherIncomeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00180 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)",
     "role": "http://cgen.com/role/RelatedPartyBalancesAndTransactionsTables",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2013-08-01to2013-08-05",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00190 - Disclosure - GENERAL (Details)",
     "role": "http://cgen.com/role/cgen-gd1",
     "shortName": "GENERAL (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2013-08-01to2013-08-05",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cgen:ContingentFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00200 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://cgen.com/role/CommitmentsAndContingenciesDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cgen:ContingentFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "ILSPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00210 - Disclosure - SHAREHOLDERS' EQUITY (Issuance of Shares) (Details)",
     "role": "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails",
     "shortName": "SHAREHOLDERS' EQUITY (Issuance of Shares) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2020-06-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00020 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://cgen.com/role/cgen-cbs",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00220 - Disclosure - SHAREHOLDERS' EQUITY (Schedule of Stock-Based Compensation) (Details)",
     "role": "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails",
     "shortName": "SHAREHOLDERS' EQUITY (Schedule of Stock-Based Compensation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:InterestAndOtherIncomeTableTextBlock",
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestIncomeDepositsWithFinancialInstitutions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00230 - Disclosure - FINANCIAL AND OTHER INCOME, NET (Details)",
     "role": "http://cgen.com/role/cgen-find",
     "shortName": "FINANCIAL AND OTHER INCOME, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:InterestAndOtherIncomeTableTextBlock",
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestIncomeDepositsWithFinancialInstitutions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00240 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details)",
     "role": "http://cgen.com/role/cgen-rpbatd",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "ILSPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://cgen.com/role/cgen-cbsp",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00040 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)",
     "role": "http://cgen.com/role/cgen-csocl",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00050 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "role": "http://cgen.com/role/cgen-socise1",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "role": "http://cgen.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00070 - Disclosure - GENERAL",
     "role": "http://cgen.com/role/cgen-g",
     "shortName": "GENERAL",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00080 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://cgen.com/role/cgen-sap1",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cgen:UnauditedInterimConsolidatedFinancialStatementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00090 - Disclosure - UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS",
     "role": "http://cgen.com/role/UnauditedInterimConsolidatedFinancialStatements",
     "shortName": "UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cgen:UnauditedInterimConsolidatedFinancialStatementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 19,
   "tag": {
    "cgen_AgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement [Member]",
        "label": "Agreement [Member]"
       }
      }
     },
     "localname": "AgreementMember",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cgen_AgreementStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of the agreement, in CCYY-MM-DD format.",
        "label": "Agreement, start date"
       }
      }
     },
     "localname": "AgreementStartDate",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "cgen_AgreementTerminationDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement termination description.",
        "label": "Agreement termination description"
       }
      }
     },
     "localname": "AgreementTerminationDescription",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cgen_AmountIncurredMilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount incurred milestone payments.",
        "label": "Amount incurred milestone payments"
       }
      }
     },
     "localname": "AmountIncurredMilestonePayments",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_AtTheMarketOfferingProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At The Market Offering Program [Member]",
        "label": "At The Market Offering Program [Member]"
       }
      }
     },
     "localname": "AtTheMarketOfferingProgramMember",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cgen_ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration period of warrants.",
        "label": "Expiration period of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRighstPeriodFromWhichWarrantsOrRightsExercisable",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cgen_CollaborationAgreementWithUSAntibodyCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Agreement With U.S. Antibody Company [Member]",
        "label": "Collaboration Agreement With U.S. Antibody Company [Member]"
       }
      }
     },
     "localname": "CollaborationAgreementWithUSAntibodyCompanyMember",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cgen_CollaborativeArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangements [Member]",
        "label": "Collaborative Arrangements [Member]"
       }
      }
     },
     "localname": "CollaborativeArrangementsMember",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cgen_CommercialLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License Agreement [Member]",
        "label": "Commercial License Agreement [Member]"
       }
      }
     },
     "localname": "CommercialLicenseAgreementMember",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cgen_ContingentFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent fees.",
        "label": "Contingent fees"
       }
      }
     },
     "localname": "ContingentFees",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_DeferredParticipationOfBmsInRdExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred participation of BMS in R&amp;amp;amp;amp;D expenses.",
        "label": "Deferred participation of BMS in R&amp;D expenses"
       }
      }
     },
     "localname": "DeferredParticipationOfBmsInRdExpenses",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_DevelopmentRegulatoryAndCommercialMilestonesCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development, regulatory and commercial milestones compensation.",
        "label": "Development, regulatory and commercial milestones compensation"
       }
      }
     },
     "localname": "DevelopmentRegulatoryAndCommercialMilestonesCompensation",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/cgen-gd1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document And Entity Information [Abstract]",
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://cgen.com/20210630",
     "xbrltype": "stringItemType"
    },
    "cgen_FinancialAndOtherIncomeNet": {
     "auth_ref": [],
     "calculation": {
      "http://cgen.com/role/cgen-csocl": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://cgen.com/role/cgen-find": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate of financial and other income net of expense.",
        "label": "Financial and other income, net",
        "totalLabel": "Financial and other income, net"
       }
      }
     },
     "localname": "FinancialAndOtherIncomeNet",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/cgen-csocl",
      "http://cgen.com/role/cgen-find"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_GovernmentAndOtherGrantsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government and Other Grants [Axis]",
        "label": "Government and Other Grants [Axis]"
       }
      }
     },
     "localname": "GovernmentAndOtherGrantsAxis",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cgen_GovernmentAndOtherGrantsDomain": {
     "auth_ref": [],
     "localname": "GovernmentAndOtherGrantsDomain",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cgen_GovernmentAndOtherGrantsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government And Other Grants [Line Items]",
        "label": "Government and Other Grants [Line Items]"
       }
      }
     },
     "localname": "GovernmentAndOtherGrantsLineItems",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cgen_GovernmentAndOtherGrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government and Other Grants [Member]",
        "label": "Government and Other Grants [Member]"
       }
      }
     },
     "localname": "GovernmentAndOtherGrantsMember",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cgen_GovernmentAndOtherGrantsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government And Other Grants [Table]",
        "label": "Government and Other Grants [Table]"
       }
      }
     },
     "localname": "GovernmentAndOtherGrantsTable",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cgen_IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in deferred participation in R&amp;amp;amp;amp;D expenses.",
        "label": "Decrease in deferred participation in R&amp;D expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredParticipationInResearchAndDevelopmentExpenses",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_IncreaseDecreaseInOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in operating lease right of use asset.",
        "label": "Operating Leases, Future Minimum Payments Due After Year Four",
        "negatedLabel": "Decrease in operating lease right of use asset"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAsset",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_LongTermDeferredParticipationInResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term deferred participation in R&amp;amp;amp;amp;D expenses.",
        "label": "Long-term deferred participation in R&amp;D expenses"
       }
      }
     },
     "localname": "LongTermDeferredParticipationInResearchAndDevelopmentExpenses",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_MasterClinicalAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Master Clinical Agreement [Member]",
        "label": "Master Clinical Agreement [Member]"
       }
      }
     },
     "localname": "MasterClinicalAgreementMember",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cgen_MaximumAuthorizedProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum authorized proceeds from issuance of common stock.",
        "label": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "MaximumAuthorizedProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_MaximumRoyaltyRepaidAsPercentageOfGrantReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Royalty Repaid As Percentage Of Grant Received",
        "label": "Maximum royalty repaid as percentage of grant received"
       }
      }
     },
     "localname": "MaximumRoyaltyRepaidAsPercentageOfGrantReceived",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cgen_May2012AgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the May 2012 Agreement.",
        "label": "May 2012 Agreement With Advisor [Member]"
       }
      }
     },
     "localname": "May2012AgreementMember",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cgen_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements not yet adopted, that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recently issued accounting pronouncements, not yet adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cgen_NumberOfWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants exercised.",
        "label": "Warrants exercised, shares"
       }
      }
     },
     "localname": "NumberOfWarrantsExercised",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "sharesItemType"
    },
    "cgen_ParticipationRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the cash consideration received by the Company or its affiliates from third parties to be paid back to advisor.",
        "label": "Participation Rights"
       }
      }
     },
     "localname": "ParticipationRights",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cgen_PercentageOfClosingPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of closing price.",
        "label": "Percentage of closing price"
       }
      }
     },
     "localname": "PercentageOfClosingPrice",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cgen_PercentageOfRoyaltiesOnNetSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of royalties on net sales.",
        "label": "Percentage of royalties on net sales"
       }
      }
     },
     "localname": "PercentageOfRoyaltiesOnNetSales",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cgen_ReceivablesOnAccountOfShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables on account of shares.",
        "label": "Receivables on account of shares"
       }
      }
     },
     "localname": "ReceivablesOnAccountOfShares",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_RegisteredDirectOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Registered direct offering [Member]",
        "label": "Registered direct offering [Member]"
       }
      }
     },
     "localname": "RegisteredDirectOfferingMember",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cgen_RelatedPartyBalancesAndTransactionsTablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Balances And Transactions"
       }
      }
     },
     "localname": "RelatedPartyBalancesAndTransactionsTablesAbstract",
     "nsuri": "http://cgen.com/20210630",
     "xbrltype": "stringItemType"
    },
    "cgen_ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Addition Potential milestone revenue from arrangements for research and development, including collaboration and licenses agreements.",
        "label": "Additional milestone compensation"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementAdditionalPaymentsReceivable",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/cgen-gd1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_ResearchAndDevelopmentArrangementPaymentsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential milestone revenue from arrangements for research and development, including collaboration and licenses agreements.",
        "label": "Retainer Fee [Default Label]",
        "terseLabel": "Potential milestone compensation"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementPaymentsReceivable",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/cgen-gd1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential milestone compensation company is now eligible for.",
        "label": "Potential milestone compensation company is now eligible for"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementPaymentsReceivableOnRemainingProgram",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/cgen-gd1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential milestone revenue for preclinical stages of research from arrangements for research and development, including collaboration and licenses agreements.",
        "label": "Preclinical milestone compensation"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/cgen-gd1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_RetainerFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retainer fee per month.",
        "label": "Retainer Fee"
       }
      }
     },
     "localname": "RetainerFee",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_RoyaltyContingentObligations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The contingent obligations for payments based on royalty-bearing participation received or accrued, net of royalties paid or accrued.",
        "label": "Contingent royalty obligations"
       }
      }
     },
     "localname": "RoyaltyContingentObligations",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_RoyaltyPercentageBasedOnFutureRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Percentage Based On Future Revenues",
        "label": "Royalty percentage based on future revenues"
       }
      }
     },
     "localname": "RoyaltyPercentageBasedOnFutureRevenues",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cgen_SeverancePayFundNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly deposits in externally managed funds which primarily cover Israeli law severance pay liability of one month's salary for each year of employment upon the retirement or death of an employee or termination of employment without a valid legal reason.",
        "label": "Severance pay fund"
       }
      }
     },
     "localname": "SeverancePayFundNoncurrent",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_SeverancePayNet": {
     "auth_ref": [],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Severance pay, net.",
        "label": "Increase (decrease) in severance pay, net"
       }
      }
     },
     "localname": "SeverancePayNet",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_ShortTermDeferredParticipationInResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short term deferred participation in R&amp;amp;amp;amp;D expenses.",
        "label": "Short-term deferred participation in R&amp;D expenses"
       }
      }
     },
     "localname": "ShortTermDeferredParticipationInResearchAndDevelopmentExpenses",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_StockIssuedDuringPeriodValueWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of warrants.",
        "label": "Warrants exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cgen_SvbLeerinkLlcAndStifelNicolausAndCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SVB Leerink LLC and Stifel, Nicolaus &amp;amp; Company [Member]",
        "label": "SVB Leerink LLC and Stifel, Nicolaus &amp; Company [Member]"
       }
      }
     },
     "localname": "SvbLeerinkLlcAndStifelNicolausAndCompanyMember",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cgen_UnauditedInterimConsolidatedFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unaudited Interim Consolidated Financial Statements"
       }
      }
     },
     "localname": "UnauditedInterimConsolidatedFinancialStatementsAbstract",
     "nsuri": "http://cgen.com/20210630",
     "xbrltype": "stringItemType"
    },
    "cgen_UnauditedInterimConsolidatedFinancialStatementsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of unaudited interim consolidated financial statements.",
        "label": "Unaudited Interim Consolidated Financial Statements Text Block",
        "verboseLabel": "UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS"
       }
      }
     },
     "localname": "UnauditedInterimConsolidatedFinancialStatementsTextBlock",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/UnauditedInterimConsolidatedFinancialStatements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cgen_UnderwritersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriters [Member]",
        "label": "Underwriters [Member]"
       }
      }
     },
     "localname": "UnderwritersMember",
     "nsuri": "http://cgen.com/20210630",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel [Member]"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cgen.com/role/cgen-daei1"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r158",
      "r160",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r268",
      "r270",
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails",
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r158",
      "r160",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r268",
      "r270",
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails",
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r146",
      "r147",
      "r157",
      "r158",
      "r160",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r268",
      "r270",
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]",
        "verboseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails",
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r157",
      "r158",
      "r160",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r268",
      "r270",
      "r288",
      "r289"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails",
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r93",
      "r97",
      "r159"
     ],
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r112",
      "r113",
      "r152",
      "r153",
      "r269",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287"
     ],
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r112",
      "r113",
      "r152",
      "r153",
      "r269",
      "r277",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Geographical [Axis]",
        "verboseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r93",
      "r97",
      "r127",
      "r159",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES [Abstract]",
        "verboseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r36",
      "r230"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Trade payables"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r24",
      "r114",
      "r115"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Trade receivables"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r42",
      "r43",
      "r44",
      "r257",
      "r275",
      "r276"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r178",
      "r179",
      "r180",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional paid-in capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r161",
      "r163",
      "r183",
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Stock-based compensation issued to employees, directors and non-employees"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments required to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Total weighted average number of shares related to outstanding options and warrants excluded from the calculations of diluted net loss per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r80",
      "r105",
      "r107",
      "r110",
      "r119",
      "r133",
      "r134",
      "r135",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r144",
      "r145",
      "r204",
      "r206",
      "r213",
      "r228",
      "r230",
      "r242",
      "r255"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r41",
      "r80",
      "r119",
      "r133",
      "r134",
      "r135",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r144",
      "r145",
      "r204",
      "r206",
      "r213",
      "r228",
      "r230"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT ASSETS:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r80",
      "r119",
      "r133",
      "r134",
      "r135",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r144",
      "r145",
      "r204",
      "r206",
      "r213",
      "r228"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NON-CURRENT ASSETS:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r164",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessDevelopment": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-csocl": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service.",
        "label": "Marketing and business development expenses"
       }
      }
     },
     "localname": "BusinessDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-csocl"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r33",
      "r72"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r67",
      "r72",
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r67",
      "r214"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Exercise price of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Warrants purchase to ordinary shares"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Warrants purchase to ordinary shares remain outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r38",
      "r126",
      "r246",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "COMMITMENTS AND CONTINGENT LIABILITIES (NOTE 4)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r129",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cac"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r85",
      "r86",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Ordinary shares [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Ordinary shares, par value per share",
        "verboseLabel": "Ordinary shares, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails",
      "http://cgen.com/role/cgen-cbsp"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Ordinary shares, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails",
      "http://cgen.com/role/cgen-cbsp"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Ordinary shares, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbsp"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Ordinary shares, shares outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbsp",
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23",
      "r230"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Ordinary shares of NIS 0.01 par value per share: 200,000,000 shares authorized on June 30, 2021 and December 31, 2020; 83,917,929 and 83,675,856 shares issued and outstanding on June 30, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r46",
      "r48",
      "r49",
      "r55",
      "r250",
      "r265"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-csocl": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "negatedTotalLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-csocl"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r103",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration of credit risks"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpensesRelatedParty": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties.",
        "label": "Related parties' expenses amounts charged to research and development expenses"
       }
      }
     },
     "localname": "CostsAndExpensesRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-rpbatd"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r70",
      "r121"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r83",
      "r136",
      "r138",
      "r139",
      "r143",
      "r144",
      "r145",
      "r225",
      "r245",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Trade and other payables"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-rpbatd"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Basic and diluted net loss per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-csocl"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r100",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Basic and diluted loss per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r175"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Period over which compensation expense will be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails",
      "http://cgen.com/role/cgen-set"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": {
     "auth_ref": [
      "r185"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of plan compensation cost recognized during the period.",
        "label": "Share based compensation ESPP"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r50",
      "r51",
      "r52",
      "r85",
      "r86",
      "r87",
      "r89",
      "r94",
      "r96",
      "r102",
      "r120",
      "r148",
      "r150",
      "r178",
      "r179",
      "r180",
      "r195",
      "r196",
      "r211",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r271",
      "r272",
      "r273",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r73",
      "r74",
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Purchase of property and equipment"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainContingenciesByNatureAxis": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of gain contingency.",
        "label": "Gain Contingencies, Nature [Axis]"
       }
      }
     },
     "localname": "GainContingenciesByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingencyNatureDomain": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization."
       }
      }
     },
     "localname": "GainContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r59",
      "r70",
      "r118"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-find": {
       "order": 2.0,
       "parentTag": "cgen_FinancialAndOtherIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Income from sales of marketable securities"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-find"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Gain from property and equipment disposal"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-csocl": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-csocl"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsByNatureAxis": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of guarantee.",
        "label": "Guarantor Obligations, Nature [Axis]"
       }
      }
     },
     "localname": "GuaranteeObligationsByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Bank guarantees in favor of lessor, foreign currency derivative contracts and credit card security"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsNatureDomain": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees."
       }
      }
     },
     "localname": "GuaranteeObligationsNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r53",
      "r105",
      "r106",
      "r108",
      "r109",
      "r111",
      "r241",
      "r248",
      "r252",
      "r266"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-csocl": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "negatedTotalLabel": "Loss before taxes on income"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-csocl"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TAXES ON INCOME [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r81",
      "r192",
      "r193",
      "r194",
      "r197",
      "r199",
      "r201",
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "TAXES ON INCOME"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/TaxesOnIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r82",
      "r95",
      "r96",
      "r104",
      "r191",
      "r198",
      "r200",
      "r267"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-csocl": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Taxes on income"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-csocl"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase in other accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase in trade payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Decrease in trade receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.",
        "label": "Increase (Decrease) in Accrued Interest Receivable, Net",
        "negatedLabel": "Decrease (increase) in interest receivables from short-term bank deposits"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedInterestReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Decrease in operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Decrease in other accounts receivable and prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Increase in long-term prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and income classified as other.",
        "label": "Schedule of Financial And Other Income, Net"
       }
      }
     },
     "localname": "InterestAndOtherIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-fint"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestIncomeDepositsWithFinancialInstitutions": {
     "auth_ref": [
      "r251",
      "r292",
      "r293"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-find": {
       "order": 1.0,
       "parentTag": "cgen_FinancialAndOtherIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest income derived from funds deposited with both domestic and foreign financial institutions including funds in money market and other accounts.",
        "label": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeDepositsWithFinancialInstitutions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-find"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue": {
     "auth_ref": [
      "r209",
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount on the investment owned.",
        "label": "Amount of investment in Compugen"
       }
      }
     },
     "localname": "InvestmentOwnedUnderlyingFaceAmountAtMarketValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-gd1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r30",
      "r80",
      "r119",
      "r213",
      "r230",
      "r244",
      "r259"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r37",
      "r80",
      "r119",
      "r133",
      "r134",
      "r135",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r144",
      "r145",
      "r205",
      "r206",
      "r207",
      "r213",
      "r228",
      "r229",
      "r230"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r19",
      "r20",
      "r80",
      "r119",
      "r133",
      "r134",
      "r135",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r144",
      "r145",
      "r205",
      "r206",
      "r207",
      "r213",
      "r228",
      "r229"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NON- CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r67",
      "r68",
      "r71"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r45",
      "r47",
      "r52",
      "r54",
      "r71",
      "r80",
      "r88",
      "r90",
      "r91",
      "r92",
      "r93",
      "r95",
      "r96",
      "r98",
      "r105",
      "r106",
      "r108",
      "r109",
      "r111",
      "r119",
      "r133",
      "r134",
      "r135",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r144",
      "r145",
      "r212",
      "r213",
      "r249",
      "r264"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://cgen.com/role/cgen-csocl": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "negatedTotalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows",
      "http://cgen.com/role/cgen-csocl",
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently adopted accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://cgen.com/role/cgen-csocl": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-csocl"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-csocl"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r222"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Current maturity of operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r222"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Long term operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right to use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GENERAL [Abstract]",
        "verboseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "GENERAL"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-g"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.",
        "label": "Other accounts payable and accrued expenses"
       }
      }
     },
     "localname": "OtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCIAL AND OTHER INCOME, NET [Abstract]",
        "verboseLabel": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r154",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "FINANCIAL AND OTHER INCOME, NET"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-fin"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-find": {
       "order": 3.0,
       "parentTag": "cgen_FinancialAndOtherIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Exchange rate differences and other"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-find"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherShortTermInvestments": {
     "auth_ref": [
      "r40",
      "r247",
      "r262"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term investments classified as other.",
        "label": "Short-term bank deposits"
       }
      }
     },
     "localname": "OtherShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Issuance expenses"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails",
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedLabel": "Investment in short-term bank deposits"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PostemploymentBenefitsLiabilityNoncurrent": {
     "auth_ref": [
      "r155",
      "r156"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a classified balance sheet, the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable after one year (or beyond the operating cycle if longer).",
        "label": "Accrued severance pay"
       }
      }
     },
     "localname": "PostemploymentBenefitsLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r31",
      "r32"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Other accounts receivable and prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.",
        "label": "Long-term prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from ordinary shares in offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from issuance of ordinary shares, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities": {
     "auth_ref": [
      "r61",
      "r117"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity.",
        "label": "Proceeds from maturity of short-term bank deposits"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from sales of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r65",
      "r177"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from exercise of options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from exercise of warrants",
        "verboseLabel": "Proceeds from warrant exercised"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows",
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyLeaseGuaranteeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A guarantee of performance by a third party lessee under terms of a lease agreement.",
        "label": "Office leases [Member]"
       }
      }
     },
     "localname": "PropertyLeaseGuaranteeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r14",
      "r15",
      "r122",
      "r230",
      "r253",
      "r260"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY BALANCES AND TRANSACTIONS [Abstract]",
        "verboseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r223",
      "r224",
      "r225",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTY BALANCES AND TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-rpbat"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned": {
     "auth_ref": [
      "r189",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.",
        "label": "Upfront payment received"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-gd1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r188",
      "r239",
      "r290"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-csocl": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development expenses, net"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-csocl"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r10",
      "r72",
      "r76"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s).",
        "label": "Percentage of workforce reduction from restructuring activities"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-gd1"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r150",
      "r181",
      "r230",
      "r258",
      "r274",
      "r276"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r85",
      "r86",
      "r87",
      "r89",
      "r94",
      "r96",
      "r120",
      "r178",
      "r179",
      "r180",
      "r195",
      "r196",
      "r211",
      "r271",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r78",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails",
      "http://cgen.com/role/cgen-set"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "terseLabel": "Schedule of Related Party Balances and Transactions"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/RelatedPartyBalancesAndTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r164",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Weighted-average Assumptions Used to Estimate Fair Value of Options Granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-set"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Expected risk free interest rate range, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Expected risk free interest rates range, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Ordinary shares available for issuance | shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Weighted average fair value of options granted during period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r162",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Stock options granted, exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r164",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Stock options granted, exercise price, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Stock options granted, exercise price, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r172",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r151",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-se1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Offering price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r77",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-sap1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r39",
      "r50",
      "r51",
      "r52",
      "r85",
      "r86",
      "r87",
      "r89",
      "r94",
      "r96",
      "r102",
      "r120",
      "r148",
      "r150",
      "r178",
      "r179",
      "r180",
      "r195",
      "r196",
      "r211",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r271",
      "r272",
      "r273",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails",
      "http://cgen.com/role/cgen-set",
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r102",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails",
      "http://cgen.com/role/cgen-set",
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r22",
      "r23",
      "r148",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Issuance of ordinary shares pursuant to the ESPP, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r148",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Issuance of shares, net, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityIssuanceOfSharesDetails",
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r23",
      "r148",
      "r150",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Options exercised, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r22",
      "r23",
      "r148",
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Issuance of ordinary shares pursuant to the ESPP"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r148",
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Issuance of shares, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r39",
      "r148",
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionPlanExpense": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for option under share-based payment arrangement.",
        "label": "Share based compensation stock options"
       }
      }
     },
     "localname": "StockOptionPlanExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r28",
      "r29",
      "r80",
      "r116",
      "r119",
      "r213",
      "r230"
     ],
     "calculation": {
      "http://cgen.com/role/cgen-cbs": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs",
      "http://cgen.com/role/cgen-socise1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/ShareholdersEquityScheduleOfStock-basedCompensationDetails",
      "http://cgen.com/role/cgen-set"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplyCommitmentArrangementMember": {
     "auth_ref": [
      "r21",
      "r243",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item is intended to be populated, by the entity, with Members identifying each supply commitment about which information required or determined to be disclosed is being provided. If only one such commitment exists, this item may be used to capture such information; if multiple commitments exist, this item is the dimensional default, which will aggregate such information, as appropriate."
       }
      }
     },
     "localname": "SupplyCommitmentArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplyCommitmentAxis": {
     "auth_ref": [
      "r21",
      "r243",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by arrangements in which the entity has committed resources to supply goods or services to a customer.",
        "label": "Supply Commitment [Axis]"
       }
      }
     },
     "localname": "SupplyCommitmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted average number of ordinary shares used in computing basic and diluted net loss per share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cgen.com/role/cgen-csocl"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "http://asc.fasb.org/topic&trid=49130413"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410138&loc=d3e79691-111665"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410138&loc=d3e79708-111665"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "http://asc.fasb.org/topic&trid=2122503"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "10",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=6431724&loc=d3e32938-113948"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "10",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=6438156&loc=d3e57880-113973"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.5)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r291": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r292": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r293": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(6))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>41
<FILENAME>0001178913-21-002429-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-21-002429-xbrl.zip
M4$L#!!0    ( +4X_%(X[*OFD L  'IC   1    8V=E;BTR,#(Q,#8S,"YX
M<V3M7$MSVS@2OL^OX/JRF:J1)=F3[-AE9XJ6*(=5,NF5Z$ER2D$D)*%"@AP
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MX$$: !NF;/8*XE/;]R3QX-UY.H/HJ*!Z_XNB7/VKUU,^W<RFRMBW0V'9RHA
MP*"C/"&V5KC%*IJS@LJ2^)YR?ZZ, 0/*?$,9]*C2Z\DQ ,8^DP**IG@0! @O
M_:C%VT(;EXE1S.!2D?JY%")>GU#D!:[0JWRV)G!Y?2(6VTL6^L4&[BF7*"$A
MO@LK=HKH[G,6.W3EFJ;;>9,1 +$+@Q2V3S\@?@ )0UP-J4'W7TLF!R[;RL19
M$$;=%<D%B[8B<1;H=E.:@,"VTG 6RBWH']]U8A2+BZ&('P\SO6CCD0T(>1P
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MN">,RY-T+7XKK>DQES<>U?',*2D+:LK0F2V^C>:N^E'5^/O_ U!+ P04
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MH</HO1]]B8Z B4D[1D3(\5HEQB.52LG)V-B?MHCZ0J(=#CXDE2UIOT2&])N
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MZ78Z#B@X[##;;4]9WOQGWOGI&@39B@XX$K:@Y_9^.Z]P6!KW4HIV+O'@H.F
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M&"30:Y8WNOB<#N0RH(S6>V"TD;^0'4#XVS DVKMZ938#F[J(S.#+U%[%<#Y
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MU=5Z3=+76BW4TUIM9L6W#*/7'G0&F#15V\84,WBS2:(B^QF);)<<PN=^N,]
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M#,>C,]#+"<_>>])Y/>'(+Y=[-2N&7:H03A5XFATZ&WG>ZDG1(0TO!ED^-/H
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MDTR5?9Y[YTXRCULZMIQHUY9\99W)9%-;*9B$).RA2 U(V=;4_O&+!RE1) B
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MK%S1'V=DD3S73C:;V"I1.,/)R:AU*&&-F>_"FON$C_K4*] AF_6S8T,X1,;
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M?K*VVR8QH#X==60S3/+3-D+'";,U:PKCO#7BZ:Q,)W$L+MJ?=L0JW20[ZKR
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M$-@\8TTV&YP=BIXDW&= <=#I0+557]9/3UMR6DLPF-W=31;<?H'1])I9.>9
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MTIZT-%/:/U91<5$[0RFW9F?] 6\-"&WNQ=UAO4QD!R8&XK"]9\VW(J^2#?.
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M">W4J#S#%;4[F-)X]RH2Q;];W<94$5K..E+S4$^X8>U!0>#7M30KS%C.%#*
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MWQ$)EWW&(@'Y<"+_=DA;X84?UF2Q*G C3Y0:!LZ?'>&1<VCF"\P-1MA+I3J
M:RO3A]U#^K!;<G0O7VDB'E>[X(1RNY08W'/1K4+Q:XA]%Z^K$DU0KV9$N;QD
M+W"V"O/$ BZ@D";^7"V^>&^YY9V%VZ _">A<MK([9B'E0\JJ( ^-L;<N_B=<
M_ERGH4)IQK66ZTF&G??3X/G<Q>1<-%[\(+60&O!__(QK?<13(BKSPP':.!X[
M#<[]?-6^-$5=NMU61-=N&_]QBY_]U6_RQ?F"]PX_[#@SXJVI%>O9,B"N6A,
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M+V< TU5UABQK*  ,0K-N-'-.*.'F[A$;KB)CDX<["^,#"^6.E#D 8!#F5IO
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M$T=<<-+@0BEK*2MJ3 P^AGN*%@MON3F,!&6$R! QE3M 8H@L ,R-0MEK[R;
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MDK>OXFH^PU*+]1_7=GA1IE\KR[2.[Y+0-1? G-5 %L8^H'#V?\R(,]MM8:*
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M;RG..E)+'RUP93I'24\PS"#'<<S<L66?.;N*5*^['2<6(MYP)UZ4&,&R$K=
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ML>-'4OFW;*WQ0$^/:[KV1A<^/]2\/QV3)';>'OA3 *7>_K_9^$!BX>U!MW-
M;GPWG;P],,S!(G\V,O"M-;@*I'=AZFY%(?3$"C5AHII8 <C;8A./[5=FMZN1
M_)_7A;#A3[I&\/_7>?,X>A3O>$H#>>V:QCX-T_(JGUL:TS#QX(I4!@?O/D33
M639F(?G*9E&<)F3$G"ATR3\R&L/\A0;]RI(L2)-Z^9!2&Y3Z9G0QAR-^T?_S
M48K9"6B2"*U[[B?I%0[E@"OBOUA?-_N#OMXQAY[5,P9VU^Q;@Y[NZ$.K,] !
M^PX+@AEU73!.;P]T\3V944=^+Z2OHC72N*)#\+N;3SP?^0"G<<WBU'=HD(\>
M=/(16=)<O_PT,,W>$5A;]X$VA89=U>;!PI/2(A7(\!.23AB)PF .E)O.:#@G
M[)H&&4W1-E,RBU(0%I\&))F'#!1X CV0-/9GP% [B)QO8,1(Y)$O__/U[!,P
M[^S3V16A@+(O)RV#^"%OWP&<^(X&[6$G,9N J^!?LZ*K*,0F\,Z3B^//A'Z'
M<6$;E'QC<^+ZGL=B/HPTBO,V14_(#+:H4 7Z%D@&7^,E7L$E1,)+@[S5T5F_
MQZCNN@/+U"FEEF/T!H,N[=F.UW>>+>3_F+G<Z81_*?'B:$H\/TY21!,G%^ M
M]5L2Q1\N/_=U@WR9T(01@TRC, +(Q70VY[#$9Z*I[8<"NC=^.B&7,^@E^N4G
MHV\=:00PGJ"1 0BGY'CTX5(HVV02W1 WBSDVX)99!"ZS@+KK)PQ[ PV=QE&
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MS(T82, D?2ZD4;GR&V[T9/J*2:Q* "U%>[5$M!<^Q^6\).4:N[J)K%M3AS7
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M*T@G=@JR9\10L1T?7DNL$41Z;/CXD9SZ.T6N3PP='VX'B-%*<42LF%'<JAI
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M)%PL@ZATRKB^R,LNR'3*32<)SMR1*<$IP<DMF1*<DDQ>R938E*DD.Z:2(#M
M[DS1:#*))AW$4W$0]PXR-=<$F;12H:SQE?=15FOUJMJHYN1L;T&5$J^1^S=$
MB?EE3ZV8#7L>)F>C+(^YEIQX*IRH;<6)/.1;U-6*S*:2G)DOSMR0*Z&5MF)-
M+G(E&G6U4>?;@-T!37E/C)#,FKD:+6_BU>,D-6A-M=[@.U]))C6(M0RBTBDC
MS"(ONR#3*;<_)#AS1Z8$IP0GMV1*<$HR>2538E,F-;SF"?;"PSOQ"W9UDYSS
M*>)2B4JGF(&E2FK_5BW1OU7;J])]]8ABEL1 OPR!VHYPFE&J@Z95U49=[N&<
MD (04IWNS:S5HS$K/2WK-5ZEH>07S[RT3>O+F>\&F$SZ$O/]'YZX;T&9Y@[4
M@I I)N_5=N:]W9,:WL*'>VSI5&HR$TGRJ\C\RM7Q/#F'@2!D<HS6#=JEOJUV
MD7I#I@&DCNL/Y+K(]F7T1T9_MA<[C>P<2OT1VY?=@%SJC2(P9AWA:335:E4&
M>*09D%-^;&;,CYNL@TT\*B,[?*%9$#*%9+I2\3"1G;<SX#ZF>:DJM:-D5($9
M589T))GBH'6#6M%V#>E(A2$S?%Z!&P$&[5OBC!3'-4R;="WQJ$.M3 .7?.DK
MOJ/X8ZRT^W=W0JZDJ'2**:;2#W0_7 )0>S*UG!EFP>F[P-7'R,-W%K*]C&)$
MY9I:*\M#;J1=D5.&33]Q_6!)0&OY58:+N 6V(&2*R7^[9\QFE@BT-2_NU99(
MZDS)LR+SK(P<23+%0>L&#;-UFK?4'3(A*+[!M T8YF6A,?65OYJ3J>/ZR(8O
MI\@@[40+Y*>7RU^FS@B%2&&(2 Z1[DRFV/80PRB%%@DPX1!-0+1ANECW'==3
MD&TH (%"_*60&!"53HYE'5>:610@2-4LX2KAR@N9',-U@R5YX**EEO'OP/,G
M@%!OX*SY)0WE4UOB*F%*W./_!*9G^KB/W2=3Q\Q0O<>Z\VC3IU";-8NV=6I3
MX[MQI&1P+LCDF,&YTD<YAX$@9'*,U@WJ:.\J)ZEH9"I-QJDT7>PKEN/E/D:Q
M>):S=EZ=^HKG6*9QV,.<#Q'&>*>A"*NJ3]BRY (J$O02]!+T$O02]!+T^0#]
MAN-D2KO7DF]WM P8ZAU;=R;X%JSU+$^5T9IJI<CW@19;^S.+E\K3E^5+%$Z$
MR+P?/L,%%TEYH)6VKF67#']$AA<TPR45??+D&YZB,SQ)55&F4WQURQ.9$IP2
MG-R2*<$IP<DMF1*<DDQ>R938E)OYKWF"WY!%VV(@CW3&^&=@8Z5<5!428U ^
M!#8*#-/'!E>AK\/O]9>G+XKA!$,+B[[5?ZR19)/F5"ZF'M:\<U5^X@;6#Z,7
M^)Z/;%+-DU4_U;+:U.IJLY23^BU!51QW+'V,T]:%9G$M&Q8_R$GMI7).VK-+
M;I;<?!1N+FW%S;NW\<B:LZM:4:W4&I*[)7=+[MYZ)[I<WHJ]M\M&.01?SW>H
M*\6Z6JKSS>!OV:(^M?03*0,XT?"532+@*+I;*Y;52FE7R[QXX)A;:7\@K089
M+_RA8\SH!P3 (!\,\^E]J4SFB!R>[31M+2'_AU&2_"_!Z\AQ?-OQ,0-K]V=U
M5*S52\WJ$%>,2J4\U(WA$#7+#8(M=N>]0P8P]OWIY<7%\_/S^<O0M<X=]_&B
M5"R6+USX^B*Z]TQYF5B7%K(?OYQAN_#0/_MZCZ<N]D@EG8)L!4V<P":%4,_8
M5?PQ7/F[=DXQ&CWB*P=S-QAC!>FD%0VR9Z";%4(8T.]B,@83^/K1198R1:Y/
MXK^D^S%P.\V50SXVE)%I(ULWX1;/APNTCO \HW$M8Y,4*IJCV4:FH5Q!_IO&
M[;J%D4N8?/SID/;YV=<;0"% IOFI$'VHACQ-Z/L\=N-M B;YZ2*E9"&>77Q-
MCF6*'G%AZ&+TJX!&\*I+9#VCF?>)#)X-/".I\+JJ:*Y#%.4V0\.58KGY$Z Q
M=EP@SP-X+9#TC,DC82TL@TS85>_'W</W=E>Y'5R?*ZWNM=(9])7^P[=^Y[K3
MNO_S\P5YPO$8IKQ>-K\^E&Z_=]NY;@W:UTI_ /_\:'=A,+T;Y:K5_UVYN>W]
MT0_'PT"Q-1R4))@3Y":II;VHT@<(:#I^N]?#+U:AMO]B/9SWS\'8LBSD>B#M
M0+XY@8=LPSLBX-:*L;]\ILJ>K?J7,[+L8&MARPK[CM$MB'#O$>3PV1**8  Z
MW'59C-YTB0+?"3<@QQ@9:S<OT[8HZQ791OAM(1G=L0BFOIS5SA9I+I&IW2(E
M_?W&]8JY^AJ7]<T790+7QYZ";0,;2>G'.>G1AO>"/! ,>SLGIDM>SXS72TN\
MKFDYYW7B^XO,+ +1>=(@*XH,LDV98U(@2^,K2UYYB'+TQ&>8B]AM":.A6>1>
MOBMO[;"V]!$&UAV7=M^ZA.%AUS+MA5V"*^2-E9'E/'O*R'4FBC/%Y';[42$Q
M\2?3-[%W*3(07E5[G!(MRN2*0J<$@?06%P0HO2%LU-]8*U%/I34=USOAVI&K
M';)*=MG[\!#9=F&KN<][ HMDR@,P97H?]F*"*8O'9LJR6JY7\LF4V96\\6$U
MR.8G7,2-WE7VY&XVY61*:/(QFSGP);7UV26)UOF*2YKAN^P$-Q>#1:*;%E;L
MR-V$J^2S3L)S 3G\S;338W-2ZTC6%G,VY61*:/(QFWES4K941VO/%N5H!:5*
M>;<@RH88RMZ'!]$&&=^6#P8ZB2-_I)KD8#+%9+?T=NY;A"P/QFY-SBO?I;L)
MY%R3\C+=E#I="IDMA,S>/>*3,,NB94ZEF ?1(O6X9+$E%JL4]]7C&;-8N5[/
M XN=J-O>L747@TVG?( %I9\^DNBP!\:+2SMO3M%,I=%CCI94ZGP>DR$JVJY*
M7W_$]F4_@MH=FG6QGV4N1"VG>1#2'#A1[MO ?*5=S8'#,-_74C$7%G>^G?GO
M"'0\+=&8NF0CV)\IR#84LHL\)3O*BF%Z4\=#%D\K)[4^EUJ_O*^K3T!(LA][
M=A_D2F]T%T+QSD*VWXZ@F$4X7QR!)*T R8UOL0(J^P8%]F/&%\^\M$WKRYGO
M!IA,Z!*?<766\MMR<$\T/G =1@464\8L>HEBEO1E"SQR0H<G@P120+TFH':N
M8J)N2A2EBM#8L7L1%F_)W_>$N-[HP<,M L,L8PCE:B["F])8D+RXS(L[%R^]
M-R^6RM4\\&*^8PNQQ?#!M!,["J29JXL]G^2G8_.)M!8,NT1X8\?U"_#M1!DB
M^Q<@9.IXIB^KI*4 >T6 [9TYN"K#6KH.+HS1"5%Z'X,TXRV)2K&<!Q$FS8D3
MY<9-D<"],PN/S8Y?RR*E]YYRA?0>40K?109>L#(X6EAI1_!H1^R=K9@JN,C!
M"]Y<8F7J *G%?&RO2OM!<N$2%U;W3FC<APO%W;DX^;@"V8GPQ]BE)\<$K/P]
M6F::QC!U\129AH)?2)6*- "DZ'E-].R<N;A>]-PQ\%WC$79=;+09!ENVT2.8
MI2'13/L]E32!.K!Q"W=I$'#(E3NG-/+#E?DH.SK1:$)<$P&6AN78CVQO0EH5
M4G[M%A"M[IT:N5: A8(KBSSMG$9 I2$A&7&%$?=.BSP"(U;SRHGY#D<DC02V
MY3!%,[G?(.71%H[-WJW<UT<Z[QCX!@2)66R0U@0JFN 6U=(8X)#Y]F[9?C3F
MJPL4/)!U%+N;"TN[%Z'=0+<N$,M[D4$&*<ZV%&?9YD FQ5G+-L(TK%L3#4V+
MMHC.0+PUZG+'0MH6N63&;#,@C\&,FEHNR:(*[LV'36685@B(&4^K)HT%+@.A
M&68ZTIW3>>E7EE(I47VI-<413G*;0G+G6[BSEF$&Y%&XLU07*$HHRRAVLC*,
M,%5&F2)"O#EEG9_AF_O?T&3ZZ?ID8A1#QS6P&SU+.Z].?<5S+--('GTNA.Q[
MIY%D)1[WZR^Y*ANC++"[)+([]CWV,'+U,;A:U^ ]6 YM>1-N]&9[1F==H(;W
M:]9+.PVK1C(_)\R_7W]+#IF_U!2_*VTJ\PL:@=EVXRJ'EHT@DDL05<'3;,K)
ME-#D8S;SYDJG#KB[S>FZ>=<FTE3FQ%3>N^P 8'P%*+YSG2?3P,:WV8-'>K#$
M8<16C.5,O>&R6BN)'^:7#K'D\F-R^=XU#>_$Y9I:K8E?Z2 ]WUS8*H*(*$%T
M D^S*2=30I./V3P)S_>S-T5V]';Z"%#]CDNCZI<P/.Q:IHV3%A6Q/921Y3R'
M[7]-^PE[2Z[RY><+\ERNK .IAB2O\TIESB=30O.T$Z,;:]4/.+$ZQD:H2L )
M#5R2".V,9%?Y4^?;?8LX:GM79T=@)+_XP: (M@QM&#$CV01>RS:ND&5YO='O
MV#(&3GC3K(_U\.8LJD<U59--8J4:R"=S[EV]S0=S:E6UF@_FS)MWNYV]T:'.
M*CTBU[2EC2'%V+Z[-WN7;=^%XFK@M/3_!*:+^P2$ \#@')M92*IJ7:U4!*H,
ME<57DB/?Q)%[UVX?BR.U8D4LR_[$FL5MB%($KCXF=57.2)F&!RO3=B\X.EB9
MIS64%@.7\FGOTNT5^;1PMC>X/6N/]]ZGK:PF?FF3M!DD3V[%D_6]"[:/RI-:
M,:<\>9HQB,4]#P^1EK,G:UC(=%0NXK+UO4_02<9E^X#EWNB@HE <0<BMCI=)
MY;GEXKU/W'D#%\N3^+BQ/V1".._B11!YSM-LRLF4T.1C-O/FKFXNA9Z&]67*
M<*9\".NB/Z9F>^==MTCKE@_K-NNZZ$Z$Y2PK)DDY=*4L4, N @-W4EGZJ6)S
M\J; >];%SP=AY7GQ<Z.AUO,2A%^\5)Z^K$@" J;<[/!+GYAW42:([N!I-N5D
M2FCR,9LGX1._O4AZ9-K(UF61M.3U/,VFG$P)33YF4SHG4BM(UN-C-N5D2FCR
M,9MY<T[VR2\U/2\ UX/6KCBN 7Z(.U.\,7()(3;.?8*I9.:W;KMETD^C$\*P
M-[IR)A/'[ON._BN+>I6R0)V'N05TOL1^3O@NDU89A^*[>D75*O4\L)Z@KN,^
MM@!^P:YNLCK69^2ZR):]+J0<>DT.[=_J(B&'_F!P:X<(S"+1II*/@\^EZI<L
MM\QR^_>R."S+:36U5LR%P2U# XOF@#,E*YE[:T F /(AX/9OAI$L5".^3(\!
M-Y)R1A8Q!9'Z9G&KL67Z;EZYM[%_VXPC<*]64NN-7-HH@D0FY*8V[])'$''/
MTVS*R930Y&,V\^:Y;E^%FI9$FW>-(DU>/DS>O?LCK2E8NXFPG&GM:3,?P;G\
M:5_)QGRP\=X-DH[*QEJQK%;S$822/JQH%H<@<D@0P<_3;,K)E-#D8S9/PH?M
MV+J+R:D!IDU]695YM*2U[Q,8 23WBK3Z=;'GNZ;N@X]+O^=H-:5ZX=&&W;L-
M$C%@R?_:<P3>Q^ C7[1L8_%"XLX[&)YC1)B^QNS?]HMN!0;8O_!AC.Q'?(]\
MW!Z-L)Y%M]^Z2(<1<,L=^5(=.6'BO1L@"<?$9;54%ZAM]\XN8)X\W*OMS13D
M*_X8*T,,3[%)3-X9T0M3"C&>EE>&Y?,;SUNJ36MYO1$5G5JI4-8R%9U9F#-J
M0Q/H^#=N+049G\\M/]?2^%EK\LG/3;61C^K3DPC'R.@]1U)*$+7 TVS*R930
MY&,V3]OCQ?#5"?NZY>F+8CC!T,)'-(TWK^'?-Z_ UL;RL8:6D:U<3_5]#Q'[
MS\!6;JC5D@SF<ZE))'_SR=^--;$M+OE;*ZM:/H);TAG.C>7"DYJ0'H=4NIQ.
MIH2F=(;9N'8^YZ ?3*<6)L<"(TLQ3$^W'"]P:4<1, ,*U&].'!D(KK,\"4$R
M??YF4TZFA"8?LRG=%ZDN)$]R/IMR,B4T^9C-/+DO=X&KCQ'K9SAUG2D0.:,^
M!]G9FQ(G)>\:0X;R^0SE[]WN\ :9[K^0%>#>J.5YV/=:.F#9S:116CD7!>;Y
MTZV2B;EDXN;>70\/R<3Y/(,AET[K/=:Q^80 [IX"R$*Z#H/RB;'"CF/B:=VD
M<7(Z<FWGUE;Z([8O$VCNV2V&Y=ZH3Y&<10]FK98'P2:M$\G%Q^'BG3M;'8.+
M=S5.B@>.Y93>L#>Z8JY<^$/'F-$/9 +)!\-\.@;XM=I:,@=C3"V+R139,[++
M:CL^O!;64T& %P#(HXLL98I</\IB!MC0 C%$,IW#[5FXQ?/A @F:>.=LT3*?
M_7\'GF^.9ALGG,XH^6\:4G0+(Y< 9/SID$;0V=>;W_[V4BH6FY\*T8=:B ="
MW^>Q&QNK3(3014HIO3N[^)H<RQ0]XL+0Q>A7 8W@59?(>D8S[Q,9/!OX@1"U
M*G.:ZQ!%98RAX6JUW/@)T!@[[E*B 'W/,R:/A+6P#)I6W_MQ]_"]W55N!]?G
M2JM[K70&?:7_\*W?N>ZT[O]<V/ _ L.4M\MY2!M*MS=H]Y5!3[GJ=?N]V\YU
M:]"^5FXZW5;WJM.Z5?H#N/"CW1WTPT$Q9&R-"26)Z 3-29+)@"[31PF0.KYU
M<_@5*ZP7<:^NV,-Y_QQ4MV4AUR/-E_RQ$WC(-CSE W[1,5F!,1.(!BGA"/\"
M^8<^+B:B,-W5#29 OSY7MB  ]HWG]=Q'9)O_2S-JKF*Y"W^T;.,.="Y)I"%_
M]D8WD2#NQW+X.LZO&<";OUGT)$<,BGA*TG7< )]]/?S"K!44,%_;L)*B718B
M1ME\_Q09I"D) []6.Z\UV'M K+3O6[=);LM\V,NJB3*O%M\4'K14*,'OE+^:
MDZGC^LCVEVAN+'^;.FWH?&$>%D==/B_6V&U7H-(#,-F46]\X5SX0Q?W;?P+'
M_W3%=#W[0W%<A:HH[>I3] OV]_6GCXH)A@ H3=.FYA4H^$>L$A/ !00%8'/1
M#"X'["^V;6+@)VPY;.,DM"B4<-;A;LO\7V)?F+Y'-UM<$_OD:&ER8\! '*:$
ML0=.+>032]%3? =8"9X)\PO6";Q",=S@48%?/^*P]"I\,U@CKD=FNT#C0DE2
M0\;&< NV:$&63HXY=15S,@G YJ%WSLX58@]%,T3GH?F)_!3>"R0^X?#V@F.3
MV-(CD&E.,4UR(U:1Z0$]U$IR,8XG3J$31P8-IM0$X,0HIY-!G@9WCK'^:^J8
MI)+,GQ,0SP:I*$M.DS530;O\J!<U^F^S6**S\*WUIZ(UB]52M;)F(,FUBRD'
M$QUFV"8]?0#]8"%9,[;6JX,-AP"<H <>4&61D5@S$IZ:S& %0$V%R\((V&+B
M**!@BER06H] ED[D\#!,(F2KZZ<-91UNL/U(!@4L"R]%;#[9>OS"!&WNE#P;
M*\/ M CC*$,B%S.S6=]1, PW"882L20B@S_"%_#W&"/C/P%8]Q1EP"._P_+
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M))#]\Q<%/E"^^,OGB[$_L;[^?U!+ P04    " "U./Q2>!9(<P0(   F(
M$    &5X:&EB:71?.3DM,RYH=&W5&MMNVSCV?8']AS/NM)T!;,5VDJ:)TP >
MQRV\F]O&R</,&RW1-E&)U)*4'>_7SR$IR9)\3UOL3("@"GGN]R/U<JJC\.J?
M_P"XG%(2V"=\UDR'].KRR/V;'O[4:, -\RE7-  M+N"/?W]Q5_;G6OA)1+D&
M7U*B$211C$^@?_VE^SAF(3XK>'B\QT<*9]ZIU_*:!>R>B!>23:8:6N?GI]"
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M_ E02P$"% ,4    " "U./Q2..RKYI +  !Z8P  $0              @ $
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M;BTR,#(Q,#8S,%]P<F4N>&UL4$L! A0#%     @ M3C\4I&:PM.I"P  0$L
M  X              ( !)'D  &-G96XV:S V,C$N:'1M4$L! A0#%     @
MM3C\4MJ7MXH3(P  CL,! !               ( !^80  &5X:&EB:71?.3DM
M,2YH=&U02P$"% ,4    " "U./Q2'=M:>21E  !/=0< $
M@ $ZJ   97AH:6)I=%\Y.2TR+FAT;5!+ 0(4 Q0    ( +4X_%)X%DAS! @
M "8@   0              "  8P- 0!E>&AI8FET7SDY+3,N:'1M4$L%!@
0   )  D 00(  +X5 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
